Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer, January 2015

Free Subscription


Abstracts

Retrieve all available abstracts of the following 1647 articles:
HTML format


 

Single Articles

  1. COZAR JM, Minana B, Palou-Redorta J, Medina RA, et al
    Comparative analysis of the incidence of bladder cancer in the communities of Andalusia, Catalonia and Madrid in 2011.
    Actas Urol Esp. 2014 Dec 29. pii: S0210-4806(14)00399.
    Abstract     Related articles   

  2. YU G, Yao W, Xiao W, Li H, et al
    MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
    J Exp Clin Cancer Res. 2014;33:779.
    Abstract     Related articles   

  3. LIU J, Cheng S, Zhang Y, Li H, et al
    Association between polymorphisms in the integrin gene predicted microRNA binding sites and bladder cancer risk.
    Int J Clin Exp Med. 2014;7:4398-405.
    Abstract     Related articles   

  4. WANG YY, Wang XL, Yu ZJ
    Vitamin C and E intake and risk of bladder cancer: a meta-analysis of observational studies.
    Int J Clin Exp Med. 2014;7:4154-64.
    Abstract     Related articles   

  5. CHENG S, Liu J, Zhang Y, Lin Y, et al
    Association detection between genetic variants in the microRNA binding sites of toll-like receptors signaling pathway genes and bladder cancer susceptibility.
    Int J Clin Exp Pathol. 2014;7:8118-26.
    Abstract     Related articles   

  6. ZENG T, Peng L, Chao C, Fu B, et al
    miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
    Int J Clin Exp Pathol. 2014;7:7653-62.
    Abstract     Related articles   

  7. MA T, Xiao P, Xu Y, Liu Y, et al
    [Expression and correlation of CIP2A and OPN in bladder cancer].
    Zhonghua Yi Xue Za Zhi. 2014;94:3005-7.
    Abstract     Related articles   

  8. DENG H, Lv L, Li Y, Zhang C, et al
    The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer.
    Biochim Biophys Acta. 2014 Dec 24. pii: S0925-4439(14)00407.
    Abstract     Related articles   

  9. ARCANGELI G, Arcangeli S, Strigari L
    A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC).
    Crit Rev Oncol Hematol. 2014 Dec 4. pii: S1040-8428(14)00194.
    Abstract     Related articles   

  10. LIU Z, Chen G, Zhu Y, Li D, et al
    Simultaneous radical cystectomy and colorectal cancer resection for synchronous muscle invasive bladder cancer and cT3 colorectal cancer: Our initial experience in five patients.
    J Res Med Sci. 2014;19:1012-5.
    Abstract     Related articles   

  11. SMAL MP, Rolevich AI, Polyakov SL, Krasny SA, et al
    FGFR3 and TP53 mutations in a prospective cohort of Belarusian bladder cancer patients.
    Exp Oncol. 2014;36:246-51.
    Abstract     Related articles   

  12. KERNAN WN, Viscoli CM, Varughese MC
    Litigation seeking access to data from ongoing clinical trials: a threat to clinical research.
    JAMA Intern Med. 2014;174:1502-4.
    Abstract     Related articles   

  13. MELLO MM, Cohen IG
    Clinical trials and the right to remain silent.
    JAMA Intern Med. 2014;174:1505-6.
    Abstract     Related articles   

  14. PIETZAK EJ, Malkowicz SB
    Does quantification of smoking history correlate with initial bladder tumor grade and stage?
    Curr Urol Rep. 2014;15:416.
    Abstract     Related articles   

  15. CHANG CH, Fu YC, Li JR, Shu KH, et al
    Anticancer benefits of early versus late use of rapamycin in a rat model of urothelial carcinoma.
    Transplant Proc. 2014;46:1240-2.
    Abstract     Related articles   

  16. CHOI CH, Lee SO, Smith G
    Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder.
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  17. HASSOUNA H, Broome JD, Swalem K, Manikandan R, et al
    Xanthoma of the urinary bladder: a rare benign condition which may be mistaken for malignancy.
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  18. SAPRE N, Herle P, Anderson PD, Corcoran NM, et al
    Molecular biomarkers for predicting outcomes in urothelial carcinoma of the bladder.
    Pathology. 2014;46:274-82.
    Abstract     Related articles   

  19. JACKSON L, Bourke AG, Abdul Aziz F, Taylor D, et al
    Radioactive seed localisation to guide removal of impalpable lymph nodes (radioguided occult lesion localisation using iodine-125 seeds, "ROLLIS").
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  20. YAMAC AH, Insanic D, Bockmeyer C
    Cardiac metastasis from a urothelial cell carcinoma: a commented case report.
    Cardiovasc Pathol. 2014;23:178-80.
    Abstract     Related articles   

  21. GANAPATHI RN, Ganapathi MK
    Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs.
    Urol Oncol. 2014;32:1-4.
    Abstract     Related articles   

  22. WANG Y, Chuang J, Chang T, Won S, et al
    Antiangiogenesis as the novel mechanism for justicidin A in the anticancer effect on human bladder cancer.
    Anticancer Drugs. 2015.
    Abstract     Related articles   

  23. JIN Y, Lu J, Wen J, Shen Y, et al
    Regulation of growth of human bladder cancer by miR-192.
    Tumour Biol. 2015.
    Abstract     Related articles   

  24. GREIFE A, Tukova J, Steinhoff C, Scott SD, et al
    Establishment and characterization of a bladder cancer cell line with enhanced doxorubicin resistance by mevalonate pathway activation.
    Tumour Biol. 2015.
    Abstract     Related articles   

  25. MCNAIR HA, Hafeez S, Taylor H, Lalondrelle S, et al
    Radiographer led plan selection for bladder cancer radiotherapy; initiating a training programme and maintaining competency.
    Br J Radiol. 2015 Jan 7:20140690.
    Abstract     Related articles   

  26. SHU J, Huang M, Tian Q, Shui Q, et al
    Downregulation of angiogenin inhibits the growth and induces apoptosis in human bladder cancer cells through regulating AKT/mTOR signaling pathway.
    J Mol Histol. 2015.
    Abstract     Related articles   

  27. SUO S, Chen X, Ji X, Zhuang Z, et al
    Investigation of the Non-Gaussian Water Diffusion Properties in Bladder Cancer Using Diffusion Kurtosis Imaging: A Preliminary Study.
    J Comput Assist Tomogr. 2015.
    Abstract     Related articles   

  28. FANG D, Zhang L, Li X, Yu W, et al
    Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value.
    Ann Surg Oncol. 2015.
    Abstract     Related articles   

  29. SHEN C, Sun Z, Chen D, Su X, et al
    Developing urinary metabolomic signatures as early bladder cancer diagnostic markers.
    OMICS. 2015;19:1-11.
    Abstract     Related articles   

  30. LENIS AT, Chamie K
    Bladder cancer in 2014: From the genomic frontier to immunotherapeutics.
    Nat Rev Urol. 2015 Jan 6. doi: 10.1038/nrurol.2014.
    Abstract     Related articles   


  31. Bladder cancer: Timing of chemotherapy after radical cystectomy.
    Nat Rev Urol. 2015 Jan 6. doi: 10.1038/nrurol.2014.
    Abstract     Related articles   

  32. IZUMI K, Taguri M, Miyamoto H, Hara Y, et al
    Androgen deprivation therapy prevents bladder cancer recurrence.
    Oncotarget. 2014.
    Abstract     Related articles   

  33. MAMMADOV E, Aslan G, Tuna B, Bozkurt O, et al
    Can Recurrence and Progression be Predicted by HYAL-1 Expression in Primary T1 Bladder Cancer?
    Asian Pac J Cancer Prev. 2014;15:10401-5.
    Abstract     Related articles   

  34. LIANG Z, Li S, Xu X, Xu X, et al
    MicroRNA-576-3p Inhibits Proliferation in Bladder Cancer Cells by Targeting Cyclin D1.
    Mol Cells. 2014 Dec 30. doi: 10.14348/molcells.2015.2146.
    Abstract     Related articles   

  35. GARG M
    Prognostic and therapeutic applications of the molecular events in clinical management of urothelial carcinoma of bladder.
    J Exp Ther Oncol. 2014;10:301-16.
    Abstract     Related articles   

  36. LI W, Liang Y, Deavers MT, Kamat AM, et al
    Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants.
    Am J Clin Pathol. 2014;142:864-71.
    Abstract     Related articles   

  37. XU XD, Wu XH, Fan YR, Tan B, et al
    Exosome-derived microRNA-29c induces apoptosis of BIU-87 cells by down regulating BCL-2 and MCL-1.
    Asian Pac J Cancer Prev. 2014;15:3471-6.
    Abstract     Related articles   

  38. DAI J, Tang K, Xiao W, Yu G, et al
    Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
    Asian Pac J Cancer Prev. 2014;15:3369-75.
    Abstract     Related articles   

  39. RAUSCH S, Gakis G, Stenzl A
    [Transurethral resection of bladder tumors: management of complications].
    Urologe A. 2014;53:695-8.
    Abstract     Related articles   

  40. GARG M, Sankhwar SN, Goel A, Kumar M, et al
    Effect of intravesical immunotherapy on sperm parameters in young patients with non--muscle-invasive bladder carcinoma: prospective analysis.
    Clin Genitourin Cancer. 2014;12:e83-6.
    Abstract     Related articles   

  41. NECCHI A, Mariani L, Giannatempo P, Raggi D, et al
    Long-term efficacy and safety outcomes of modified (simplified) MVAC (methotrexate/vinblastine/doxorubicin/cisplatin) as frontline therapy for unresectable or metastatic urothelial cancer.
    Clin Genitourin Cancer. 2014;12:203-209.
    Abstract     Related articles   

  42. MOSSANEN M, Lee F, Cheng H, Harris W, et al
    Nonresponse to neoadjuvant chemotherapy for muscle-invasive urothelial cell carcinoma of the bladder.
    Clin Genitourin Cancer. 2014;12:210-3.
    Abstract     Related articles   

  43. BRUINS HM, Arends TJ, Pelkman M, Hulsbergen-van de Kaa CA, et al
    Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series.
    Clin Genitourin Cancer. 2014;12:190-5.
    Abstract     Related articles   

  44. SCHNEIDER SA, Sukov WR, Frank I, Boorjian SA, et al
    Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome.
    Mod Pathol. 2014;27:758-64.
    Abstract     Related articles   

  45. WEI L, Li Q, Liang H, Jianbo L, et al
    The quality of life in patients during intravesical treatment and correlation with local symptoms.
    J Chemother. 2014;26:165-8.
    Abstract     Related articles   

  46. MISRA S, Gupta A, Symes A, Duncan J, et al
    Haemophagocytic syndrome after intravesical bacille Calmette-Guerin instillation.
    Scand J Urol. 2014;48:328-30.
    Abstract     Related articles   

  47. GEORGE J, De D, Mahajan R, Saikia UN, et al
    Acute generalized exanthematous pustulosis caused by gemcitabine.
    Int J Dermatol. 2014;53:e184-5.
    Abstract     Related articles   

  48. SPAIRANI C, Squillaci S, Pitino A, Ferrari M, et al
    A case of concomitant occurrence of solitary fibrous tumor and urothelial high-grade invasive carcinoma of the urinary bladder.
    Int J Surg Pathol. 2014;22:252-9.
    Abstract     Related articles   

  49. RAUSCH S, Lotan Y, Youssef RF
    Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: a contemporary review with focus on nonbilharzial squamous cell carcinoma.
    Urol Oncol. 2014;32:32.
    Abstract     Related articles   

  50. SUN M, Ravi P, Karakiewicz PI, Sukumar S, et al
    Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy?
    Urol Oncol. 2014;32:27.
    Abstract     Related articles   

  51. XU ST, Guo C, Ding X, Fan WJ, et al
    Role of osteopontin in the regulation of human bladder cancer proliferation and migration in T24 cells.
    Mol Med Rep. 2015 Jan 15. doi: 10.3892/mmr.2015.3202.
    Abstract     Related articles   

  52. TSAI YC, Ho PY, Tzen KY, Tuan TF, et al
    Synergistic Blockade of EGFR and HER2 by New Generation EGFR Tyrosine Kinase Inhibitor Enhances Radiation Effect in Bladder Cancer Cells.
    Mol Cancer Ther. 2015 Jan 14. pii: molcanther.0951.2013.
    Abstract     Related articles   

  53. LU CS, Hsieh JL, Lin CY, Tsai HW, et al
    Potent antitumor activity of Oct4 and hypoxia dual-regulated oncolytic adenovirus against bladder cancer.
    Gene Ther. 2015 Jan 15. doi: 10.1038/gt.2014.
    Abstract     Related articles   

  54. KATAFIGIOTIS I, Athanasiou A, Levis PK, Fragkiadis E, et al
    Metastasis to sartorius muscle from a muscle invasive bladder cancer.
    Case Rep Med. 2014;2014:524757.
    Abstract     Related articles   

  55. TODENHOFER T, Hennenlotter J, Esser M, Mohrhardt S, et al
    Stepwise application of urine markers to detect tumor recurrence in patients undergoing surveillance for non-muscle-invasive bladder cancer.
    Dis Markers. 2014;2014:973406.
    Abstract     Related articles   

  56. ZHANG T, Shen Y, Chen Y, Hsieh JT, et al
    The ATM Inhibitor KU55933 Sensitizes Radio-resistant Bladder Cancer Cells with DAB2IP Gene Defect.
    Int J Radiat Biol. 2015.
    Abstract     Related articles   

  57. KITAMURA H, Kakehi Y
    Treatment and management of high-grade T1 bladder cancer: what should we do after second TUR?
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  58. SPENCER ES, Smith AB
    Exploring the 3 As of cystectomy access to care for muscle-invasive bladder cancer.
    Urol Oncol. 2015 Jan 8. pii: S1078-1439(14)00435.
    Abstract     Related articles   

  59. SHAHBAZFAR AA, Zare P, Ranjbaran M, Tayefi-Nasrabadi H, et al
    A survey on anticancer effects of artemisinin, iron, miconazole, and butyric acid on 5637 (bladder cancer) and 4T1 (Breast cancer) cell lines.
    J Cancer Res Ther. 2014;10:1057-62.
    Abstract     Related articles   

  60. YAMADA Y, Kobayashi S, Isoshima S, Arima K, et al
    The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis.
    J Cancer Res Ther. 2014;10:878-82.
    Abstract     Related articles   

  61. COLOMBO R, Pellucchi F, Moschini M, Gallina A, et al
    Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients.
    World J Urol. 2015.
    Abstract     Related articles   

  62. MARAVER A, Fernandez-Marcos PJ, Cash TP, Mendez-Pertuz M, et al
    NOTCH pathway inactivation promotes bladder cancer progression.
    J Clin Invest. 2015 Jan 9. pii: 78185. doi: 10.1172/JCI78185.
    Abstract     Related articles   

  63. SHEEHAN L, Anwar A, Kommu S
    Presentation of case: Bladder cancer in an 18 year old female patient.
    Int J Surg Case Rep. 2014;7C:42-46.
    Abstract     Related articles   

  64. SEMILIA M, Hennenlotter J, Pavone C, Bischoff T, et al
    Expression patterns and prognostic role of transketolase-like 1 in muscle-invasive bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  65. ZHOU B, Yi H, Tan J, Wu Y, et al
    Anti-Proliferative Effects of Polyphenols from Pomegranate Rind (Punica granatum L.) on EJ Bladder Cancer Cells Via Regulation of p53/miR-34a Axis.
    Phytother Res. 2015 Jan 8. doi: 10.1002/ptr.5267.
    Abstract     Related articles   

  66. HAFEZ N, Petrylak DP
    Could PD-L1 prove to be an effective therapeutic target for bladder cancer?
    Immunotherapy. 2015;7:1-2.
    Abstract     Related articles   

  67. MAZUL-SUNKO B, Gilja I, Jelisavac M, Kozul I, et al
    Thoracic epidural analgesia for radical cystectomy improves bowel function even in traditional perioperative care: a retrospective study in eighty-five patients.
    Acta Clin Croat. 2014;53:319-25.
    Abstract     Related articles   

  68. BURKI T
    Cancer survivors continue to smoke.
    Lancet Oncol. 2014;15:e423.
    Abstract     Related articles   

  69. TIMAR J
    [Molecular classification of urogenital cancers].
    Magy Onkol. 2014;58:157-60.
    Abstract     Related articles   

  70. KIM SK, Hwan Kim J, Yun SJ, Kim WJ, et al
    APPEX: analysis platform for the identification of prognostic gene expression signatures in cancer.
    Bioinformatics. 2014;30:3284-6.
    Abstract     Related articles   

  71. ZHAO SD, Parmigiani G, Huttenhower C, Waldron L, et al
    Mas-o-menos: a simple sign averaging method for discrimination in genomic data analysis.
    Bioinformatics. 2014;30:3062-9.
    Abstract     Related articles   

  72. SRIVASTAVA AK, Singh PK, Singh D, Dalela D, et al
    Evaluation of urinary XIAP as a diagnostic biomarker of carcinoma of urinary bladder.
    Tumour Biol. 2014;35:8243-8.
    Abstract     Related articles   

  73. SUTOH YONEYAMA M, Hatakeyama S, Habuchi T, Inoue T, et al
    Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis.
    Eur J Cell Biol. 2014;93:157-69.
    Abstract     Related articles   

  74. WANG SS, Hsieh MJ, Ou YC, Chen CS, et al
    Impacts of ICAM-1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.
    Tumour Biol. 2014;35:7483-90.
    Abstract     Related articles   

  75. CHEBIL I, Nicolle R, Santini G, Rouveirol C, et al
    Hybrid method inference for the construction of cooperative regulatory network in human.
    IEEE Trans Nanobioscience. 2014;13:97-103.
    Abstract     Related articles   

  76. COLGATE C, Derry F, Allison HC, van Middendorp JJ, et al
    'To cystoscope or not to cystoscope' Was that really the question?
    Spinal Cord. 2014;52:499.
    Abstract     Related articles   

  77. EL MASRI Y WS, Patil S, Prasanna KV, Chowdhury JR, et al
    To cystoscope or not to cystoscope patients with traumatic spinal cord injuries managed with indwelling urethral or suprapubic catheters? That is the question!
    Spinal Cord. 2014;52:500.
    Abstract     Related articles   

  78. PRICEMAN SJ, Shen S, Wang L, Deng J, et al
    S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3.
    Cell Rep. 2014;6:992-9.
    Abstract     Related articles   

  79. SINGH PK, Srivastava AK, Dalela D, Rath SK, et al
    Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.
    Immunobiology. 2014;219:469-74.
    Abstract     Related articles   

  80. ROMANELLI V, Nakabayashi K, Vizoso M, Moran S, et al
    Variable maternal methylation overlapping the nc886/vtRNA2-1 locus is locked between hypermethylated repeats and is frequently altered in cancer.
    Epigenetics. 2014;9:783-90.
    Abstract     Related articles   

  81. GIACOIA EG, Miyake M, Lawton A, Goodison S, et al
    PAI-1 leads to G1-phase cell-cycle progression through cyclin D3/cdk4/6 upregulation.
    Mol Cancer Res. 2014;12:322-34.
    Abstract     Related articles   

  82. CUGATI S, Gilhotra JS, Lake S, Gordon DL, et al
    Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma.
    Clin Experiment Ophthalmol. 2014;42:494-5.
    Abstract     Related articles   

  83. AHMADI N, Delprado WJ, Brooks AJ, Brenner PC, et al
    Cancer identified incidentally in the prostate following radical cystoprostatectomy: an Australian study.
    ANZ J Surg. 2014;84:473-6.
    Abstract     Related articles   

  84. GOUVEIA MJ, Santos J, Brindley PJ, Rinaldi G, et al
    Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer.
    Cancer Lett. 2015 Jan 20. pii: S0304-3835(15)00040.
    Abstract     Related articles   

  85. AHN TS, Kim HS, Jeong CW, Kwak C, et al
    Extracapsular Extension of Pelvic Lymph Node Metastasis is an Independent Prognostic Factor in Bladder Cancer: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2015.
    Abstract     Related articles   


  86. Less invasive approach to bladder cancer has similar survival rates to open surgery.
    Nurs Stand. 2015;29:16.
    Abstract     Related articles   

  87. NARAYAN V, Vaughn D
    Pharmacokinetic and toxicity considerations in the use of neoadjuvant chemotherapy for bladder cancer.
    Expert Opin Drug Metab Toxicol. 2015.
    Abstract     Related articles   

  88. SOAVE A, Engel O, von Amsberg G, Becker A, et al
    The management of advanced bladder cancer in the era of targeted therapies.
    Minerva Urol Nefrol. 2015.
    Abstract     Related articles   

  89. OKAZAKI S, Hori J, Kita M, Yamaguchi S, et al
    [A case of eosinophilic cystitis mimicking an invasive bladder cancer].
    Hinyokika Kiyo. 2014;60:635-9.
    Abstract     Related articles   

  90. ESPEJO-HERRERA N, Cantor KP, Malats N, Silverman DT, et al
    Nitrate in drinking water and bladder cancer risk in spain.
    Environ Res. 2015;137C:299-307.
    Abstract     Related articles   

  91. RIEGER C, Kunhardt D, Kaufmann A, Schendel D, et al
    Characterization of different carbon nanotubes for the development of a mucoadhesive drug delivery system for intravesical treatment of bladder cancer.
    Int J Pharm. 2015;479:357-363.
    Abstract     Related articles   

  92. NAKAI Y, Anai S, Onishi S, Masaomi K, et al
    Protoporphyrin IX induced by 5-aminolevulinic acid in bladder cancer cells in voided urine can be extracorporeally quantified using a spectrophotometer.
    Photodiagnosis Photodyn Ther. 2015 Jan 13. pii: S1572-1000(14)00173.
    Abstract     Related articles   

  93. WETTERAUER C, Weibel M, Gsponer JR, Vlajnic T, et al
    Incidental prostate cancer prevalence at radical cystoprostatectomy--importance of the histopathological work-up.
    Virchows Arch. 2014;465:629-36.
    Abstract     Related articles   

  94. HAMILTON SN, Tyldesley S, Hamm J, Jiang WN, et al
    Incidence of Second Malignancies in Prostate Cancer Patients Treated With Low-Dose-Rate Brachytherapy and Radical Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2014 Sep 17. pii: S0360-3016(14)03539.
    Abstract     Related articles   

  95. FARAJ SF, Chaux A, Gonzalez-Roibon N, Munari E, et al
    ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder.
    Hum Pathol. 2014;45:2233-9.
    Abstract     Related articles   

  96. THOENY HC, Froehlich JM, Triantafyllou M, Huesler J, et al
    Metastases in Normal-sized Pelvic Lymph Nodes: Detection with Diffusion-weighted MR Imaging.
    Radiology. 2014 Jun 2:132921.
    Abstract     Related articles   

  97. HAYASHI M, Bernert H, Kagohara LT, Maldonado L, et al
    Epigenetic inactivation of VGF associated with Urothelial Cell Carcinoma and its potential as a non-invasive biomarker using urine.
    Oncotarget. 2014;5:3350-61.
    Abstract     Related articles   

  98. CHEN HA, Su CM, Hsieh HY, Tung CL, et al
    Clinical significance of survivin expression in patients with urothelial carcinoma.
    Dis Markers. 2014;2014:574985.
    Abstract     Related articles   

  99. ROSIK L, Niegisch G, Fischer U, Jung M, et al
    Limited efficacy of specific HDAC6 inhibition in urothelial cancer cells.
    Cancer Biol Ther. 2014;15:742-57.
    Abstract     Related articles   

  100. HADDAD H, Sundaram S, Magro C, Gergis U, et al
    Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature.
    Hematol Oncol Stem Cell Ther. 2014;7:90-2.
    Abstract     Related articles   

  101. MAI KT, Ball CG, Kos Z, Belanger EC, et al
    Three-dimensional cell groups with disordered nuclei and cellular discohesion (3DDD) are associated with high sensitivity and specificity for cystoscopic urine cytopathological diagnosis of low-grade urothelial neoplasia.
    Diagn Cytopathol. 2014;42:555-63.
    Abstract     Related articles   

  102. HIRASHIMA K, Uchino R, Kume S, Iyama K, et al
    Intra-abdominal mucinous adenocarcinoma of urachal origin: report of a case.
    Surg Today. 2014;44:1156-60.
    Abstract     Related articles   

  103. LAMPROS M, Stavros G, Foteini K, Georgios D, et al
    Endothelin-1 overexpression: a potential biomarker of unfavorable prognosis in non-metastatic muscle-invasive bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  104. ROSE M, Schubert C, Dierichs L, Gaisa NT, et al
    OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
    Epigenetics. 2014;9:1626-40.
    Abstract     Related articles   

  105. MATSUMOTO Y, Samma S, Fukui S, Nakai Y, et al
    External beam radiation plus concurrent intra-arterial chemotherapy with low dose cisplatin for muscle invasive bladder cancer.
    Indian J Urol. 2015;31:52-6.
    Abstract     Related articles   

  106. LIEDBERG F, Hagberg O, Holmang S, Hosseini Aliabad A, et al
    Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study.
    Scand J Urol. 2015.
    Abstract     Related articles   

  107. KOLLBERG P, Almquist H, Blackberg M, Cronberg C, et al
    [F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
    Scand J Urol. 2015.
    Abstract     Related articles   

  108. EISSA S, Matboli M, Hegazy MG, Kotb YM, et al
    Evaluation of urinary microRNA panel in bladder cancer diagnosis: relation to bilharziasis.
    Transl Res. 2015 Jan 7. pii: S1931-5244(15)00003.
    Abstract     Related articles   

  109. CHAU C, Wheater M, Geldart T, Crabb SJ, et al
    Clinical outcomes following neoadjuvant cisplatin-based chemotherapy for bladder cancer in elderly compared with younger patients.
    Eur J Cancer Care (Engl). 2015 Jan 25. doi: 10.1111/ecc.12282.
    Abstract     Related articles   

  110. JANASZEK-SEYDLITZ W, Prygiel M, Bucholc B, Wiatrzyk A, et al
    Effect of Different Bacillus Calmette-Guerin Substrains on Growth Inhibition of T24 Bladder Cancer Cells and Cytokines Secretion by BCG Activated Peripheral Blood Mononuclear Cells of PBMCs.
    Adv Clin Exp Med. 2014;23:877-84.
    Abstract     Related articles   

  111. DENG X, Zhang X, Cheng Y, Yang X, et al
    XRCC1 polymorphisms associated with survival among Chinese bladder cancer patients receiving epirubicin and mitomycin C.
    Tumour Biol. 2015.
    Abstract     Related articles   

  112. FUJINO T, Kubota M, Nishiyama R, Kanno T, et al
    [A case of lymphoepithelioma-like carcinoma of the bladder].
    Hinyokika Kiyo. 2014;60:507-11.
    Abstract     Related articles   

  113. MURAMATSU H, Kanao K, Morinaga S, Kajikawa K, et al
    [A case of neuroendocrine carcinoma in a diverticulum of the bladder].
    Hinyokika Kiyo. 2014;60:439-42.
    Abstract     Related articles   

  114. BARROW TM, Michels KB
    Epigenetic epidemiology of cancer.
    Biochem Biophys Res Commun. 2014;455.
    Abstract     Related articles   

  115. DE LAMBERT G, Haie-Meder C, Guerin F, Boubnova J, et al
    A new surgical approach of temporary ovarian transposition for children undergoing brachytherapy: technical assessment and dose evaluation.
    J Pediatr Surg. 2014;49:1177-80.
    Abstract     Related articles   

  116. MATSUMOTO K, Ikeda M, Sato Y, Kuruma H, et al
    Loss of periplakin expression is associated with pathological stage and cancer-specific survival in patients with urothelial carcinoma of the urinary bladder.
    Biomed Res. 2014;35:201-6.
    Abstract     Related articles   

  117. TON NU TN, Kassouf W, Ahmadi-Kaliji B, Charbonneau M, et al
    The value of the "suspicious for urothelial carcinoma" cytology category: a correlative study of 4 years including 337 patients.
    Cancer Cytopathol. 2014;122:796-803.
    Abstract     Related articles   

  118. VALENTIN L
    Imaging techniques in the management of abnormal vaginal bleeding in non-pregnant women before and after menopause.
    Best Pract Res Clin Obstet Gynaecol. 2014;28:637-54.
    Abstract     Related articles   

  119. HOOSEIN MM, Rajesh A
    MR imaging of the urinary bladder.
    Magn Reson Imaging Clin N Am. 2014;22:129-34.
    Abstract     Related articles   

  120. ZHANG J, Miao L, Guo S, Zhang Y, et al
    Synergistic anti-tumor effects of combined gemcitabine and cisplatin nanoparticles in a stroma-rich bladder carcinoma model.
    J Control Release. 2014;182:90-6.
    Abstract     Related articles   

  121. CANO-GARCIA MC, Fernandez-Aparicio T, Hidalgo-Agullo G, Reina-Alcaina L, et al
    Outpatient holmium laser treatment for recurrent low-grade superficial bladder cancer under local anesthesia.
    Minerva Urol Nefrol. 2015.
    Abstract     Related articles   

  122. RISPLER DT, Stirton JW, Gilde AK, Kane KR, et al
    Mycobacterium bovid Infection of Total Knee Arthroplasty After Bacille Calmette-Guerin Therapy for Bladder Cancer.
    Am J Orthop (Belle Mead NJ). 2015;44:E46-E48.
    Abstract     Related articles   

  123. OVERBY A, Baevre MS, Thangstad OP, Bones AM, et al
    Disintegration of microtubules in Arabidopsis thaliana and bladder cancer cells by isothiocyanates.
    Front Plant Sci. 2015;6:6.
    Abstract     Related articles   

  124. SERRETTA V, Sommatino F, Gesolfo CS, Franco V, et al
    Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy.
    Urol Ann. 2015;7:21-5.
    Abstract     Related articles   

  125. WANG K, Liu T, Liu C, Meng Y, et al
    TERT Promoter Mutations and TERT mRNA but Not FGFR3 Mutations Are Urinary Biomarkers in Han Chinese Patients With Urothelial Bladder Cancer.
    Oncologist. 2015 Feb 5. pii: theoncologist.2014-0391.
    Abstract     Related articles   


  126. PGE2 Blockade Prevents CSC Repopulation and Bladder Cancer Chemoresistance.
    Cancer Discov. 2015;5:104.
    Abstract     Related articles   

  127. DENG Y, Bai H, Hu H
    rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expression.
    Biochem Biophys Res Commun. 2015 Feb 2. pii: S0006-291X(15)00148.
    Abstract     Related articles   

  128. CHEN X, Xie W, Gu P, Cai Q, et al
    Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation.
    Sci Rep. 2015;5:8293.
    Abstract     Related articles   

  129. LOPEZ-BELTRAN A, Santoni M, Massari F, Ciccarese C, et al
    Bladder Cancer: Molecular Determinants of Personalized Therapy.
    Curr Drug Targets. 2015.
    Abstract     Related articles   

  130. BRAICU C, Cojocneanu-Petric R, Chira S, Truta A, et al
    Clinical and pathological implications of miRNA in bladder cancer.
    Int J Nanomedicine. 2015;10:791-800.
    Abstract     Related articles   

  131. RAN J, Wang Y, Zhang W, Ma M, et al
    Research on the bioactivity of isoquercetin extracted from marestail on bladder cancer EJ cell and the mechanism of its occurrence.
    Artif Cells Nanomed Biotechnol. 2015.
    Abstract     Related articles   

  132. GUANCIAL EA, Rosenberg JE
    The Role of Genomics in the Management of Advanced Bladder Cancer.
    Curr Treat Options Oncol. 2015.
    Abstract     Related articles   

  133. WANG QH, Ji ZG, Chen ZG, Li HZ, et al
    Serum CA 19-9 as a good prognostic biomarker in patients with bladder cancer.
    Int J Surg. 2015 Jan 31. pii: S1743-9191(15)00049.
    Abstract     Related articles   

  134. LI M, Cai Y, Zhao H, Xu Z, et al
    Overexpression of HMGB3 protein promotes cell proliferation, migration and is associated with poor prognosis in urinary bladder cancer patients.
    Tumour Biol. 2015.
    Abstract     Related articles   

  135. SIDAWAY P
    Bladder cancer: uPAR expression indicates worse prognosis of urothelial carcinoma.
    Nat Rev Urol. 2015 Feb 3. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  136. SANCHEZ A, Wszolek MF
    Bladder cancer: Quality of life in patients with non-muscle-invasive bladder cancer.
    Nat Rev Urol. 2015 Feb 3. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  137. HAMMAM O, Wishahiz M, Khalil H, El Ganzouri H, et al
    Expression of cytokeratin 7,20,14 in urothelial carcinoma and squamous cell carcinoma of the Egyprian urinary bladder cancer.
    J Egypt Soc Parasitol. 2014;44:733-40.
    Abstract     Related articles   

  138. LIU H, Wang XC, Hu GH, Guo ZF, et al
    Fruit and vegetable consumption and risk of bladder cancer: an updated meta-analysis of observational studies.
    Eur J Cancer Prev. 2015.
    Abstract     Related articles   

  139. OSMAN MA, Gabr AM, Elkady MS
    Neoadjuvant chemotherapy versus cystectomy in management of stages II, and III urinary bladder cancer.
    Arch Ital Urol Androl. 2014;86:278-83.
    Abstract     Related articles   

  140. BROWER V
    Anti-PD-L1 antibody active in metastatic bladder cancer.
    Lancet Oncol. 2015;16:e11.
    Abstract     Related articles   

  141. KAWAHARA T, Kashiwagi E, Ide H, Li Y, et al
    Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.
    Oncotarget. 2015.
    Abstract     Related articles   

  142. JEONG IG, Hong S, You D, Hong JH, et al
    FDG PET-CT for Lymph Node Staging of Bladder Cancer: A Prospective Study of Patients with Extended Pelvic Lymphadenectomy.
    Ann Surg Oncol. 2015.
    Abstract     Related articles   

  143. MASSARI F, Ciccarese C, Santoni M, Brunelli M, et al
    The route to personalized medicine in bladder cancer: where do we stand?
    Target Oncol. 2015.
    Abstract     Related articles   

  144. ZHANG X, Han C, He J
    Research progress of oncogene and tumor suppressor gene in bladder cancer.
    Panminerva Med. 2015.
    Abstract     Related articles   

  145. FERNANDEZ-MARCOS PJ, Serrano M, Maraver A
    Bladder cancer and the Notch pathway.
    Oncotarget. 2014.
    Abstract     Related articles   

  146. ASTRAM A, Khadijah A, Yuri P, Zulfan A, et al
    Effective Dose and Adverse Effects of Maintenance Bacillus Calmette-Gue'Rin in Intermediate and High Risk Non-muscle Invasive Bladder Cancer: a Meta-analysis of Randomized Clinical Trial.
    Acta Med Indones. 2014;46:298-307.
    Abstract     Related articles   

  147. DAVIS BW, Ostrander EA
    Domestic dogs and cancer research: a breed-based genomics approach.
    ILAR J. 2014;55:59-68.
    Abstract     Related articles   

  148. SONG L, Xing N, Niu Y, Zhang J, et al
    [Mid-long-term follow-up of radical cystectomy with orthotopic ileal neobladder in women patients with bladder carcinoma].
    Zhonghua Yi Xue Za Zhi. 2014;94:932-4.
    Abstract     Related articles   

  149. CHEN SK, Chung CA, Cheng YC, Huang CJ, et al
    Toll-like receptor 6 and connective tissue growth factor are significantly upregulated in mitomycin-C-treated urothelial carcinoma cells under hydrostatic pressure stimulation.
    Genet Test Mol Biomarkers. 2014;18:410-6.
    Abstract     Related articles   

  150. GAISA NT, Wilms H, Wild PJ, Jakse G, et al
    In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance.
    Virchows Arch. 2015.
    Abstract     Related articles   

  151. PEDROSA JA, Koch MO, Kaimakliotis HZ, Monn MF, et al
    Three-tiered nodal classification system for bladder cancer: a new proposal.
    Future Oncol. 2015;11:399-408.
    Abstract     Related articles   

  152. JOZWICKI W, Brozyna AA, Siekiera J, Slominski AT, et al
    Expression of RCAS1 Correlates with Urothelial Bladder Cancer Malignancy.
    Int J Mol Sci. 2015;16:3783-3803.
    Abstract     Related articles   

  153. PARK JC, Hahn NM
    Bladder cancer: a disease ripe for major advances.
    Clin Adv Hematol Oncol. 2014;12:838-845.
    Abstract     Related articles   

  154. SHIN JH, Choi S, Lee YR, Park MS, et al
    APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer.
    Cancer Res Treat. 2015 Jan 2. doi: 10.4143/crt.2014.
    Abstract     Related articles   

  155. RIVIERE A, Ploussard G, Desgrandchamps F
    [Bladder cancer: interpretation of management guidelines].
    Rev Prat. 2014;64:1415-9.
    Abstract     Related articles   

  156. GAUTHIER H, Serrate C, Pouessel D, Le Maignan C, et al
    [Management of metastatic bladder cancer].
    Rev Prat. 2014;64:1405-7.
    Abstract     Related articles   

  157. PASHOOTAN P, Legrand G, Ploussard G
    [Muscle invasive bladder cancer].
    Rev Prat. 2014;64:1391-2.
    Abstract     Related articles   

  158. POLETAJEW S, Lisinski J, Moskal K, Ornat J, et al
    The time from diagnosis of bladder cancer to radical cystectomy in Polish urological centres - results of CysTiming Poland study.
    Cent European J Urol. 2014;67:329-32.
    Abstract     Related articles   

  159. OZTURK H, Karapolat I
    Efficacy of F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy.
    Exp Ther Med. 2015;9:717-724.
    Abstract     Related articles   

  160. KARL A, Herrmann TR
    En bloc resection of urothelial cancer within the urinary bladder: the upcoming gold standard? : Re: Kramer MW, Wolters M, Cash H, Jutzi S, Imkamp F, Kuczyk MA, Merseburger AS, Herrmann TR. Current evidence of transurethral Ho:YAG and Tm:YAG treatment
    World J Urol. 2015.
    Abstract     Related articles   

  161. HENNEQUIN C, Menard J, Quero L
    [Chemotherapy and radiotherapy association in bladder cancer: an alternative to surgery?].
    Rev Prat. 2014;64:1393-5.
    Abstract     Related articles   

  162. EL MRINI M, Xylinas E
    [Diagnostic and prognostic markers in non-muscle invasive bladder cancer].
    Rev Prat. 2014;64:1386-7.
    Abstract     Related articles   

  163. IRANI J
    [Non-muscle invasive bladder cancer].
    Rev Prat. 2014;64:1382-5.
    Abstract     Related articles   

  164. LEGRAND G, Guy L
    [Medical and economic cost of bladder cancer in France].
    Rev Prat. 2014;64:1381.
    Abstract     Related articles   

  165. DESGRANDCHAMPS F, Hennequin C, Culine S
    [Bladder cancer and urothelial tumors. New therapeutic strategies].
    Rev Prat. 2014;64:1363-4.
    Abstract     Related articles   

  166. WU D, Zhang Z, Pan H, Fan Y, et al
    Upregulation of the B7/CD28 family member B7-H3 in bladder cancer.
    Oncol Lett. 2015;9:1420-1424.
    Abstract     Related articles   

  167. ARENDS TJ, Lammers RJ, Falke J, van der Heijden AG, et al
    Pharmacokinetic, Pharmacodynamic, and Activity Evaluation of TMX-101 in a Multicenter Phase 1 Study in Patients With Papillary Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2014 Dec 31. pii: S1558-7673(14)00284.
    Abstract     Related articles   

  168. DEWAELE T, D'Hooghe L, Weyers S, Devisschere P, et al
    Leiomyoma of the urinary bladder.
    JBR-BTR. 2014;97:263.
    Abstract     Related articles   

  169. TRITSCHLER S
    [Microscopic hematuria].
    MMW Fortschr Med. 2014;156:66.
    Abstract     Related articles   

  170. TIAN W, Guner G, Miyamoto H, Cimino-Mathews A, et al
    Utility of uroplakin II expression as a marker of urothelial carcinoma.
    Hum Pathol. 2015;46:58-64.
    Abstract     Related articles   

  171. LAMM SH, Robbins S, Chen R, Lu J, et al
    Discontinuity in the cancer slope factor as it passes from high to low exposure levels--arsenic in the BFD-endemic area.
    Toxicology. 2014;326:25-35.
    Abstract     Related articles   

  172. HUANG M-, Luo D-, Xie X-, Zhu L, et al
    Cutaneous metastasis of colonic adenocarcinoma presenting as multiple agminated papules over the trunk and thighs.
    G Ital Dermatol Venereol. 2014;149:474-7.
    Abstract     Related articles   

  173. PIERRE K, Borer J, Phelps A, Chow JS, et al
    Bladder exstrophy: current management and postoperative imaging.
    Pediatr Radiol. 2014;44:768-86.
    Abstract     Related articles   

  174. PARK JY, Jeon TJ, Ryu MJ, Shin WC, et al
    Urachal cancer with direct caecal invasion: differential diagnosis from primary colon cancer.
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  175. RAMIS R, Gomez-Barroso D, Lopez-Abente G
    Cluster detection of diseases in heterogeneous populations: an alternative to scan methods.
    Geospat Health. 2014;8:517-26.
    Abstract     Related articles   

  176. MADKA V, Mohammed A, Li Q, Zhang Y, et al
    Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic mice.
    Cancer Prev Res (Phila). 2014;7:708-16.
    Abstract     Related articles   

  177. NG CY, Huang WH, Huang HC, Wang LJ, et al
    Localized bladder amyloidosis mimicking bladder carcinoma.
    Kidney Int. 2014;85:1245.
    Abstract     Related articles   

  178. GAYA JM, Matulay J, Badalato GM, Holder DD, et al
    The role of preoperative prostatic urethral biopsy in clinical decision-making at the time of radical cystectomy.
    Can J Urol. 2014;21:7228-33.
    Abstract     Related articles   

  179. LI R, Abela L, Moore J, Woods LM, et al
    Control of data quality for population-based cancer survival analysis.
    Cancer Epidemiol. 2014;38:314-20.
    Abstract     Related articles   

  180. XIAO M, Shen Y, Chen L, Liao Z, et al
    The rs7003908 (T>G) polymorphism in the XRCC7 gene and the risk of cancers.
    Mol Biol Rep. 2014;41:3577-82.
    Abstract     Related articles   

  181. ANCEDY Y, Thuaire C, Garot J
    Voluminous pseudotumoral lipomatous hypertrophy of the interatrial septum.
    Arch Cardiovasc Dis. 2014;107:343-4.
    Abstract     Related articles   

  182. EIFLER JB, Scarpato KR, Clark PE
    Management of noninvasive bladder cancers.
    Curr Opin Oncol. 2015.
    Abstract     Related articles   

  183. DUNN M
    Bladder cancer: a focus on sexuality.
    Clin J Oncol Nurs. 2015;19:68-73.
    Abstract     Related articles   

  184. GOSTEK JA, Awsiuk K, Pabijan J, Rysz J, et al
    Differentiation between single bladder cancer cells using PCA of ToF-SIMS mass spectra.
    Anal Chem. 2015.
    Abstract     Related articles   

  185. ZHAO YG, Shi BY, Qian YY, Bai HW, et al
    Dynamic expression changes between non-muscle-invasive bladder cancer and muscle-invasive bladder cancer.
    Tumori. 2014;100:273e-81e.
    Abstract     Related articles   

  186. ZHANG YR, Shi L, Wu H, Tang DD, et al
    Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer.
    Tumori. 2014;100:660-6.
    Abstract     Related articles   

  187. OZTURK H
    Detecting Metastatic Bladder Cancer Using 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography.
    Cancer Res Treat. 2015 Feb 12. doi: 10.4143/crt.2014.
    Abstract     Related articles   

  188. CUI J, Sun W, Hao X, Wei M, et al
    EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells.
    Cancer Cell Int. 2015;15:4.
    Abstract     Related articles   

  189. SANTOS F, Dragomir A, Kassouf W, Franco E, et al
    Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer.
    Curr Oncol. 2015;22:e20-6.
    Abstract     Related articles   

  190. DEL CANTO M, Garcia-Martinez L, Fernandez-Villa T, Molina AJ, et al
    Municipal distribution and trends in bladder cancer incidence in health area of Leon, Spain (1996-2010).
    Actas Urol Esp. 2015 Feb 11. pii: S0210-4806(14)00368.
    Abstract     Related articles   

  191. NARUKAWA T, Hara T, Arai E, Komiyama M, et al
    Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  192. ALEXIEV BA, Drachenberg CB, Papadimitriou JC
    Polyomavirus-cystitis associated with in situ and invasive urothelial carcinoma in a heart transplant recipient: evidence suggesting sequential progression/evolution from infection to carcinoma.
    Transplantation. 2015;99:e3-4.
    Abstract     Related articles   

  193. TANNOCK IF
    Cancer: Resistance through repopulation.
    Nature. 2015;517:152-3.
    Abstract     Related articles   

  194. SCHIFFMANN J, Gandaglia G, Larcher A, Sun M, et al
    Contemporary 90-day mortality rates after radical cystectomy in the elderly.
    Eur J Surg Oncol. 2014;40:1738-45.
    Abstract     Related articles   

  195. ROUANNE M, Girma A, Neuzillet Y, Vilain D, et al
    Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
    Eur J Surg Oncol. 2014;40:1724-30.
    Abstract     Related articles   

  196. KATAOKA TR, Yamashita N, Furuhata A, Hirata M, et al
    An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall.
    World J Surg Oncol. 2014;12:186.
    Abstract     Related articles   

  197. ERDOGAR N, Iskit AB, Eroglu H, Sargon MF, et al
    Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: safety and efficacy.
    Int J Pharm. 2014;471.
    Abstract     Related articles   

  198. NIEUWENHUIJZEN JA, de Vries RR, van Tinteren H, Bex A, et al
    Follow-up after cystectomy: regularly scheduled, risk adjusted, or symptom guided? Patterns of recurrence, relapse presentation, and survival after cystectomy.
    Eur J Surg Oncol. 2014;40:1677-85.
    Abstract     Related articles   

  199. JIANG L, Dong P, Zhang Z, Li C, et al
    Akt phosphorylates Prohibitin 1 to mediate its mitochondrial localization and promote proliferation of bladder cancer cells.
    Cell Death Dis. 2015;6:e1660.
    Abstract     Related articles   

  200. RYAN PRITCHARD E, Waddell JA, Solimando DA Jr
    Gemcitabine and Carboplatin (renally dosed) regimen for bladder cancer.
    Hosp Pharm. 2015;50:103-7.
    Abstract     Related articles   

  201. ZHANG X, Han C, He J
    Recent Advances in the Diagnosis and Management of Bladder Cancer.
    Cell Biochem Biophys. 2015.
    Abstract     Related articles   


  202. [DNA repair XRCC1, XPD genes polymorphism as associated with the development of bladder cancer and renal cell carcinoma].
    Genetika. 2014;50:481-90.
    Abstract     Related articles   

  203. HUANG H, Jin J, Li X
    Re: Factors affecting recurrence and progression of high grade non invasive bladder cancer treated by intravesical BCG.
    Pak J Med Sci. 2014;30:1432.
    Abstract     Related articles   

  204. WANG M, Wang XJ, Ma YF, Ma XB, et al
    PSCA rs2294008 C > T polymorphism contributes to gastric and bladder cancer risk.
    Ther Clin Risk Manag. 2015;11:237-45.
    Abstract     Related articles   

  205. DENG SP, Zhu L, Huang DS
    Mining the bladder cancer-associated genes by an integrated strategy for the construction and analysis of differential co-expression networks.
    BMC Genomics. 2015;16 Suppl 3:S4.
    Abstract     Related articles   

  206. YANG X, Monn MF, Liu L, Liu Y, et al
    Incidental prostate cancer in Asian men: High prevalence of incidental prostatic adenocarcinoma in Chinese patients undergoing radical cystoprostatectomy for treatment of bladder cancer and selection of candidates for prostate-sparing cystectomy.
    Prostate. 2015 Feb 19. doi: 10.1002/pros.22966.
    Abstract     Related articles   

  207. SHUKLA P, Bindal P, Gupta A, Lohr JW, et al
    Quiz page march 2015: unexplained kidney failure in a patient with bladder cancer.
    Am J Kidney Dis. 2015;65:A17-9.
    Abstract     Related articles   

  208. MAHDAVINEZHAD A, Mousavibahar SH, Poorolajal J, Yadegarazari R, et al
    Association between Tissue miR-141, miR-200c and miR-30b and Bladder Cancer: A Matched Case-Control Study.
    Urol J. 2015;12:2010-3.
    Abstract     Related articles   

  209. KRABBE LM, Schmidt S
    [Intravesical gemcitabine for non-muscle invasive bladder cancer.]
    Urologe A. 2015.
    Abstract     Related articles   

  210. COMPERAT E, Larre S, Roupret M, Neuzillet Y, et al
    Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old.
    Virchows Arch. 2015.
    Abstract     Related articles   

  211. DURIEUX-PAILLARD S
    [Migration and infectious diseases: there are more than Ebola].
    Rev Med Suisse. 2014;10:2292-3.
    Abstract     Related articles   

  212. RU Y, Kechris KJ, Tabakoff B, Hoffman P, et al
    The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations.
    Nucleic Acids Res. 2014;42:e133.
    Abstract     Related articles   

  213. WEILANDT M, Koch A, Rieder H, Deenen R, et al
    Target genes of recurrent chromosomal amplification and deletion in urothelial carcinoma.
    Cancer Genomics Proteomics. 2014;11:141-53.
    Abstract     Related articles   

  214. SFAKIANOS JP, Lin Gellert L, Maschino A, Gotto GT, et al
    The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder.
    Urol Oncol. 2014;32:657-62.
    Abstract     Related articles   

  215. SPIEGELBERG C, Giedl J, Gaisa NT, Rogler A, et al
    Frequency of activating mutations in FGFR2 exon 7 in bladder tumors from patients with early-onset and regular-onset disease.
    Int J Clin Exp Pathol. 2014;7:1708-13.
    Abstract     Related articles   

  216. ZIEMBA JB, Golan R, Skokan A, Patel D, et al
    The clinical presentation and outcome of urothelial atypia on biopsy of the bladder.
    Urol Oncol. 2014;32:645-7.
    Abstract     Related articles   

  217. LOUGHLIN KR
    The Hedgehog pathway: potential biomarker and therapeutic applications in urologic malignancies.
    Urol Oncol. 2014;32:546-8.
    Abstract     Related articles   

  218. AHMADI H, Djaladat H, Cai J, Miranda G, et al
    Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder.
    Urol Oncol. 2014;32:648-56.
    Abstract     Related articles   

  219. POTRETZKE A, Hillman L, Wong K, Shi F, et al
    NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder.
    Urol Oncol. 2014;32:631-6.
    Abstract     Related articles   

  220. MARTIN RM, Kerr M, Teo MT, Jevons SJ, et al
    Post-transcriptional regulation of MRE11 expression in muscle-invasive bladder tumours.
    Oncotarget. 2014;5:993-1003.
    Abstract     Related articles   

  221. SUKOSD F, Ivanyi B, Pajor L
    Accurate determination of the pathological stage with gross dissection protocol for radical cystectomy.
    Pathol Oncol Res. 2014;20:677-85.
    Abstract     Related articles   

  222. KLATTE T, Xylinas E, Rieken M, Roupret M, et al
    Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Urol Oncol. 2014;32:625-30.
    Abstract     Related articles   

  223. DAL MORO F, Bovo A, Crestani A, Vettor R, et al
    Effect of Hypertension on Outcomes of High-Risk Patients After BCG-Treated Bladder Cancer: A Single-Institution Long Follow-Up Cohort Study.
    Medicine (Baltimore). 2015;94:e589.
    Abstract     Related articles   

  224. WANG L, Liu Y, Du L, Li J, et al
    Identification and validation of reference genes for the detection of serum microRNAs by reverse transcriptionquantitative polymerase chain reaction in patients with bladder cancer.
    Mol Med Rep. 2015 Mar 4. doi: 10.3892/mmr.2015.3428.
    Abstract     Related articles   

  225. KIM J, Kim WJ
    Will the 40-gene expression classifier predict responders to EGFR targeted chemotherapy for the invasive bladder cancer patients?
    Ann Transl Med. 2015;3:18.
    Abstract     Related articles   

  226. RIGAUD J, Leger A, Devilder MC, Bouchot O, et al
    Development of Predictive Value of Urinary Cytokine Profile Induced During Intravesical Bacillus Calmette-Guerin Instillations for Bladder Cancer.
    Clin Genitourin Cancer. 2015 Jan 21. pii: S1558-7673(15)00007.
    Abstract     Related articles   

  227. HASHASH JG, Habib-Bein N, Khalid A, Francis FF, et al
    Recurrent bladder cancer presenting as rectal linitis plastica.
    Endoscopy. 2015;47 Suppl 1:E102-3.
    Abstract     Related articles   

  228. ROGLER A, Kendziorra E, Giedl J, Stoehr C, et al
    Functional analyses and prognostic significance of SFRP1 expression in bladder cancer.
    J Cancer Res Clin Oncol. 2015.
    Abstract     Related articles   

  229. LYKKE MR, Nielsen TK, Ebbensgaard NA, Zieger K, et al
    Reducing recurrence in non-muscle-invasive bladder cancer using photodynamic diagnosis and immediate post-transurethral resection of the bladder chemoprophylaxis.
    Scand J Urol. 2015.
    Abstract     Related articles   

  230. YABE N, Murai S, Kunugi C, Nakadai J, et al
    [Synchronous male bladder cancer and breast cancer - a case report].
    Gan To Kagaku Ryoho. 2014;41:1978-80.
    Abstract     Related articles   

  231. WANG YU, Liu AN, Zhao SH
    Association between B7-H1 expression and bladder cancer: a meta-analysis.
    Genet Mol Res. 2015;14:1277-86.
    Abstract     Related articles   

  232. HAN KS, You D, Jeong IG, Kwon T, et al
    Is Intravesical Bacillus Calmette-Guerin Therapy Superior to Chemotherapy for Intermediate-risk Non-muscle-invasive Bladder Cancer?: An Ongoing Debate.
    J Korean Med Sci. 2015;30:252-8.
    Abstract     Related articles   

  233. ISLAM SS, Mokhtari RB, Noman AS, Uddin M, et al
    Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Mol Carcinog. 2015 Mar 1. doi: 10.1002/mc.22300.
    Abstract     Related articles   

  234. KUMARI N, Saxena S, Agrawal U
    Exosomal protein interactors as emerging therapeutic targets in urothelial bladder cancer.
    J Egypt Natl Canc Inst. 2015 Feb 25. pii: S1110-0362(15)00008.
    Abstract     Related articles   

  235. LI T, Yang L, Fu SJ, Xiao EL, et al
    Subcutaneous Injections of the Mannose-Sensitive Hemagglutination Pilus Strain of Pseudomonas aeruginosa Stimulate Host Immunity, Reduce Bladder Cancer Size and Improve Tumor Survival in Mice.
    Cell Biochem Biophys. 2015.
    Abstract     Related articles   

  236. MCKIBBEN MJ, Woods ME
    Preoperative imaging for staging bladder cancer.
    Curr Urol Rep. 2015;16:496.
    Abstract     Related articles   

  237. LI W, Kidiyoor A, Hu Y, Guo C, et al
    Evaluation of transforming growth factor-beta1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells.
    Tumour Biol. 2015;36:1155-62.
    Abstract     Related articles   

  238. MAZZUCCHELLI R, Scarpelli M, Galosi AB, Di Primio R, et al
    Pathology of upper tract urothelial carcinoma with emphasis on staging.
    Int J Immunopathol Pharmacol. 2014;27:509-16.
    Abstract     Related articles   

  239. BARANYAI T
    [Novelties and new possibilities in radiological diagnostics of tumors of the prostate, seminal vesicle, testicle and penis].
    Magy Onkol. 2014;58:290-300.
    Abstract     Related articles   

  240. MCNEIL BK, Sorbellini M, Grubb RL 3rd, Apolo A, et al
    Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder.
    J Transl Med. 2014;12:199.
    Abstract     Related articles   

  241. SAINT-JACQUES N, Parker L, Brown P, Dummer TJ, et al
    Arsenic in drinking water and urinary tract cancers: a systematic review of 30 years of epidemiological evidence.
    Environ Health. 2014;13:44.
    Abstract     Related articles   

  242. GLUKHOV AI, Grigorieva YE, Gordeev SA, Vinarov AZ, et al
    [Development of noninvasive bladder cancer diagnosis on basis of telomerase and it's subunits hTERT and hTR detection].
    Biomed Khim. 2015;61:150-160.
    Abstract     Related articles   

  243. LUBET RA, Scheiman JM, Bode A, White J, et al
    Prevention of Chemically Induced Urinary Bladder Cancers by Naproxen: Protocols to Reduce Gastric Toxicity in Humans Do Not Alter Preventive Efficacy.
    Cancer Prev Res (Phila). 2015.
    Abstract     Related articles   

  244. WU W, Tong Y, Zhao Q, Yu G, et al
    Coffee consumption and bladder cancer: a meta-analysis of observational studies.
    Sci Rep. 2015;5:9051.
    Abstract     Related articles   

  245. CAO QF, Qian SB, Wang N, Zhang L, et al
    TRPM2 Mediates Histone Deacetylase Inhibition-Induced Apoptosis in Bladder Cancer Cells.
    Cancer Biother Radiopharm. 2015;30:87-93.
    Abstract     Related articles   

  246. HO PL, Williams SB, Kamat AM
    Immune therapies in non-muscle invasive bladder cancer.
    Curr Treat Options Oncol. 2015;16:315.
    Abstract     Related articles   

  247. KIM K, Cho YM, Park BH, Lee JL, et al
    Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
    Int J Clin Exp Pathol. 2015;8:743-50.
    Abstract     Related articles   

  248. SMITH SG, Koppolu BP, Ravindranathan S, Kurtz SL, et al
    Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer.
    Cancer Immunol Immunother. 2015.
    Abstract     Related articles   

  249. LU K
    Adjuvant chemotherapy in locally advanced bladder cancer.
    Lancet Oncol. 2015;16:e103-4.
    Abstract     Related articles   

  250. JIANG Z, Kong C, Zhang Z, Zhu Y, et al
    Reduction of protein kinase C alpha (PKC-alpha) promote apoptosis via down-regulation of Dicer in bladder cancer.
    J Cell Mol Med. 2015 Mar 5. doi: 10.1111/jcmm.12503.
    Abstract     Related articles   

  251. MITRAKAS L, Gravas S, Karasavvidou F, Dimakopoulos G, et al
    Erratum to: Endothelin-1 overexpression: a potential biomarker of unfavorable prognosis in non-metastatic muscle-invasive bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  252. JERECZEK-FOSSA BA, Colombo R, Magnani T, Fodor C, et al
    Urinary bladder preservation for muscle-invasive bladder cancer: a survey among radiation oncologists of Lombardy, Italy.
    Tumori. 2015;0:0.
    Abstract     Related articles   

  253. TSUMURA H, Matsumoto K, Ikeda M, Yanagita K, et al
    High Expression Level of Preoperative Serum Uroplakin III is Associated with Biologically Aggressive Bladder Cancer.
    Asian Pac J Cancer Prev. 2015;16:1539-43.
    Abstract     Related articles   

  254. BERNARDO C, Costa C, Sousa N, Amado F, et al
    Patient-derived bladder cancer xenografts: a systematic review.
    Transl Res. 2015 Feb 12. pii: S1931-5244(15)00040.
    Abstract     Related articles   

  255. FOULKS JM, Carpenter KJ, Luo B, Xu Y, et al
    A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomas.
    Neoplasia. 2014;16:403-12.
    Abstract     Related articles   

  256. BEN ABDELKRIM S, Rammeh S, Ziadi S, Tlili T, et al
    Expression of topoisomerase II alpha, ki67, and p53 in primary non-muscle-invasive urothelial bladder carcinoma.
    J Immunoassay Immunochem. 2014;35:358-67.
    Abstract     Related articles   

  257. ZHANG N, Li D, Shao J, Wang X, et al
    Animal models for bladder cancer: The model establishment and evaluation (Review).
    Oncol Lett. 2015;9:1515-1519.
    Abstract     Related articles   

  258. GRUBER K
    Coffee consumption and bladder cancer are linked, analysis shows.
    BMJ. 2015;350:h1477.
    Abstract     Related articles   

  259. PICHLER R, Borena W, Schafer G, Manzl C, et al
    Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot.
    World J Urol. 2015.
    Abstract     Related articles   

  260. CAO M, Yang G, Pan J, Sun J, et al
    Repeated transurethral resection for non-muscle invasive bladder cancer.
    Int J Clin Exp Med. 2015;8:1416-9.
    Abstract     Related articles   

  261. REXER H
    [Study on the treatment of nonmuscle invasive bladder cancer : A phase III efficacy study for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) AB 40/11 of the AUO].
    Urologe A. 2015;54:406-8.
    Abstract     Related articles   

  262. OLBERT PJ, Ohlmann CH, Schwentner C
    [Therapy of low-grade nonmuscle-invasive bladder cancer].
    Urologe A. 2015.
    Abstract     Related articles   

  263. ROSENKRANTZ AB, Balar AV, Huang WC, Jackson K, et al
    Comparison of Coregistration Accuracy of Pelvic Structures Between Sequential and Simultaneous Imaging During Hybrid PET/MRI in Patients with Bladder Cancer.
    Clin Nucl Med. 2015.
    Abstract     Related articles   

  264. ENGEL O, Soave A, Peine S, Kluth LA, et al
    The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.
    World J Urol. 2015.
    Abstract     Related articles   

  265. SIDAWAY P
    Bladder cancer: Urinary EGFR and EpCAM predict cancer-specific survival.
    Nat Rev Urol. 2015 Mar 17. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  266. POWLES T
    Immunotherapy: The development of immunotherapy in urothelial bladder cancer.
    Nat Rev Clin Oncol. 2015 Mar 17. doi: 10.1038/nrclinonc.2015.
    Abstract     Related articles   

  267. MAO XP, Zhang LS, Huang B, Zhou SY, et al
    Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer.
    J Transl Med. 2015;13:438.
    Abstract     Related articles   

  268. ANTONOVA O, Yossifova L, Staneva R, Stevanovic S, et al
    Changes in the gene expression profile of the bladder cancer cell lines after treatment with Helix lucorum and Rapana venosa hemocyanin.
    J BUON. 2015;20:180-7.
    Abstract     Related articles   

  269. SEAH JA, Leibowitz-Amit R, Atenafu EG, Alimohamed N, et al
    Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2015 Feb 7. pii: S1558-7673(15)00015.
    Abstract     Related articles   

  270. ZHUANG CL, Fu X, Liu L, Liu YC, et al
    Synthetic miRNA sponges driven by mutant hTERT promoter selectively inhibit the progression of bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  271. PATEL SG, Cohen A, Weiner AB, Steinberg GD, et al
    Intravesical therapy for bladder cancer.
    Expert Opin Pharmacother. 2015.
    Abstract     Related articles   

  272. LU S, Neoh KG, Kang ET, Mahendran R, et al
    Mucoadhesive Polyacrylamide Nanogel as a Potential Hydrophobic Drug Carrier for Intravesical Bladder Cancer Therapy.
    Eur J Pharm Sci. 2015 Mar 12. pii: S0928-0987(15)00106.
    Abstract     Related articles   

  273. SAVIO AL, da Silva GN, Salvadori DM
    Inhibition of bladder cancer cell proliferation by allyl isothiocyanate (mustard essential oil).
    Mutat Res. 2015;771:29-35.
    Abstract     Related articles   

  274. UYSAL B, Beyzadeoglu M, Demiral S, Gamsiz H, et al
    Outcomes of trimodality approach in the management of T2N0M0 bladder cancer.
    Tumori. 2015;0:0.
    Abstract     Related articles   

  275. DECKER B, Parker HG, Dhawan D, Kwon EM, et al
    Homologous Mutation to Human BRAF V600E is Common in Naturally Occurring Canine Bladder Cancer-Evidence for a Relevant Model System and Urine-based Diagnostic Test.
    Mol Cancer Res. 2015 Mar 12. pii: molcanres.0689.2014.
    Abstract     Related articles   

  276. HAMMAM O, Wishahi M, Hindawi A, Mosaad M, et al
    Superiority of fluorescent in situ hybridization over immunohistochemistry in detection of HER2 gene in carcinoma of the urinary bladder associated with and without schistosomiasis.
    J Egypt Soc Parasitol. 2014;44:719-31.
    Abstract     Related articles   

  277. LIN JA, Nakamoto T, Yeh SD
    Ultrasound standard for obturator nerve block: the modified Taha's approach.
    Br J Anaesth. 2015;114:337-9.
    Abstract     Related articles   

  278. KIM JW, Tomita Y, Trepel J, Apolo AB, et al
    Emerging immunotherapies for bladder cancer.
    Curr Opin Oncol. 2015.
    Abstract     Related articles   

  279. CARLSSON J, Wester K, De La Torre M, Malmstrom PU, et al
    EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides.
    Radiol Oncol. 2015;49:50-8.
    Abstract     Related articles   

  280. ZHANG H, Xing W, Kang Q, Chen C, et al
    Diagnostic value of [F] FDG-PET and PET/CT in urinary bladder cancer: a meta-analysis.
    Tumour Biol. 2015.
    Abstract     Related articles   

  281. TSCHUI J, Vassella E, Bandi N, Baumgartner U, et al
    Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer.
    Virchows Arch. 2015.
    Abstract     Related articles   

  282. MUTHUSWAMY R, Wang L, Pitteroff J, Gingrich JR, et al
    Combination of IFNalpha and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction.
    J Immunother Cancer. 2015;3:6.
    Abstract     Related articles   

  283. GAKIS G, Stenzl A, Horn T, Gschwend JE, et al
    [Non-muscle-invasive high-grade bladder cancer].
    Urologe A. 2015.
    Abstract     Related articles   

  284. HOSEN MB, Salam MA, Islam MF, Hossain A, et al
    Association of TP53 gene polymorphisms with susceptibility of bladder cancer in Bangladeshi population.
    Tumour Biol. 2015.
    Abstract     Related articles   

  285. SIDAWAY P
    Bladder cancer: Blue dye used to selectively label bladder tumours in rats.
    Nat Rev Urol. 2015 Mar 24. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  286. KAMAT AM, Flaig TW, Grossman HB, Konety B, et al
    Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer.
    Nat Rev Urol. 2015 Mar 24. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  287. FU X, Liu Y, Zhuang C, Liu L, et al
    Synthetic artificial microRNAs targeting UCA1-MALAT1 or c-Myc inhibit malignant phenotypes of bladder cancer cells T24 and 5637.
    Mol Biosyst. 2015.
    Abstract     Related articles   

  288. HONG JH
    Early isolated bone metastases without local recurrence in non-muscle invasive bladder cancer.
    Int J Surg Case Rep. 2015;10:41-44.
    Abstract     Related articles   

  289. PALMER S, Litvinova K, Rafailov EU, Nabi G, et al
    Detection of urinary bladder cancer cells using redox ratio and double excitation wavelengths autofluorescence.
    Biomed Opt Express. 2015;6:977-86.
    Abstract     Related articles   

  290. GAN Y, Tan J, Yang J, Zhou Y, et al
    Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
    Med Oncol. 2015;32:594.
    Abstract     Related articles   

  291. POWLES T
    O2.2PDL1 blockade in metastatic bladder cancer.
    Ann Oncol. 2015;26 Suppl 2:ii2.
    Abstract     Related articles   

  292. BEGNINI KR, Buss JH, Collares T, Seixas FK, et al
    Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer.
    Appl Microbiol Biotechnol. 2015.
    Abstract     Related articles   

  293. SCHENCK M, Lummen G
    [Superficial bladder cancer : Transurethral resection and instillation therapy].
    Urologe A. 2015.
    Abstract     Related articles   

  294. FROHNER M, Rubben H
    [Treatment of bladder cancer in the elderly].
    Urologe A. 2015.
    Abstract     Related articles   

  295. BERNDT A, Richter P, Kosmehl H, Franz M, et al
    Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.
    Cell Adh Migr. 2015;9.
    Abstract     Related articles   

  296. HELENIUS M, Brekkan E, Dahlman P, Lonnemark M, et al
    Bladder cancer detection in patients with gross haematuria: Computed tomography urography with enhancement-triggered scan versus flexible cystoscopy.
    Scand J Urol. 2015.
    Abstract     Related articles   

  297. BAHARLOU R, Khezri A, Razmkhah M, Habibagahi M, et al
    Increased interleukin-17 transcripts in peripheral blood mononuclear cells, a link between T-helper 17 and proinflammatory responses in bladder cancer.
    Iran Red Crescent Med J. 2015;17:e9244.
    Abstract     Related articles   

  298. BANSAL N, Gupta A, Sankhwar SN
    Proteometabolomics of bladder cancer: Current and future prospects.
    Cancer Biomark. 2015.
    Abstract     Related articles   

  299. LI K, Chen X, Liu C, Gu P, et al
    Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells.
    Biochem Biophys Res Commun. 2015 Mar 17. pii: S0006-291X(15)00477.
    Abstract     Related articles   

  300. ZHANG Y, Yang D, Zhu JH, Chen MB, et al
    The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studies.
    Cancer Invest. 2015;33:39-40.
    Abstract     Related articles   

  301. KAKOI N, Katayama H, Kawamura S, Ito S, et al
    [Paraganglioma of the bladder : two case reports].
    Hinyokika Kiyo. 2014;60:561-6.
    Abstract     Related articles   

  302. WADA N, Okazaki S, Kobayashi S, Hashizume K, et al
    [Perioperative complications of transurethral resection of bladder tumor in patients receiving antithrombotic therapy].
    Hinyokika Kiyo. 2014;60:531-5.
    Abstract     Related articles   

  303. HOLE B, Whittlestone T, Tomson C
    Investigating asymptomatic invisible haematuria.
    BMJ. 2014;349:g6768.
    Abstract     Related articles   

  304. CHAU K, Rosen L, Coutsouvelis C, Fenelus M, et al
    Accuracy and risk of malignancy for diagnostic categories in urine cytology at a large tertiary institution.
    Cancer Cytopathol. 2015;123:10-8.
    Abstract     Related articles   

  305. MATHEW P
    The hemostatic system as a therapeutic target in urothelial carcinoma.
    Oncology (Williston Park). 2014;28:816.
    Abstract     Related articles   

  306. LOKESHWAR SD, Ruiz-Cordero R, Hupe MC, Jorda M, et al
    Impact of 2004 ISUP/WHO classification on bladder cancer grading.
    World J Urol. 2015.
    Abstract     Related articles   

  307. SIROHI B, Rastogi S, Singh A, Sheth V, et al
    Use of gemcitabine-platinum in Indian patients with advanced gall bladder cancer.
    Future Oncol. 2015;11:1191-1200.
    Abstract     Related articles   

  308. CHEN CJ, Hsieh MC, Liao WT, Chan YT, et al
    Allopurinol and the incidence of bladder cancer: a Taiwan national retrospective cohort study.
    Eur J Cancer Prev. 2015.
    Abstract     Related articles   

  309. TAKAI T, Inamoto T, Komura K, Yoshikawa Y, et al
    Feasibility of Photodynamic Diagnosis for Challenging TUR- Bt Cases Including Muscle Invasive Bladder Cancer, BCG Failure or 2nd-TUR.
    Asian Pac J Cancer Prev. 2015;16:2297-301.
    Abstract     Related articles   

  310. POLAT F, Diler SB, Azazi I, Oden A, et al
    T-786C, G894T, and Intron 4 VNTR (4a/b) Polymorphisms of the Endothelial Nitric Oxide Synthase Gene in Bladder Cancer Cases.
    Asian Pac J Cancer Prev. 2015;16:2199-202.
    Abstract     Related articles   

  311. MATSUMOTO R, Tsuda M, Wang L, Maishi N, et al
    CRK adaptor protein induces epithelial-mesenchymal transition and metastasis of bladder cancer cells via HGF/c-Met feedback loop.
    Cancer Sci. 2015 Mar 28. doi: 10.1111/cas.12662.
    Abstract     Related articles   

  312. MAHDAVINEZHAD A, Mousavi-Bahar SH, Poorolajal J, Yadegarazari R, et al
    Evaluation of miR-141, miR-200c, miR-30b Expression and Clinicopathological Features of Bladder Cancer.
    Int J Mol Cell Med. 2015;4:32-9.
    Abstract     Related articles   

  313. RABOW MW, Benner C, Shepard N, Meng MV, et al
    Concurrent urologic and palliative care after cystectomy for treatment of muscle-invasive bladder cancer.
    Urol Oncol. 2015 Mar 23. pii: S1078-1439(15)00075.
    Abstract     Related articles   

  314. HERR HW, Milan TN, Dalbagni G
    BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: A prospective cohort outcomes study.
    Urol Oncol. 2015;33:108.
    Abstract     Related articles   

  315. BORAH S, Xi L, Zaug AJ, Powell NM, et al
    Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
    Science. 2015;347:1006-10.
    Abstract     Related articles   

  316. SIEFKER-RADTKE AO, Gao J
    Towards effective adjuvant treatment for urothelial cancer.
    Lancet Oncol. 2015;16:9-10.
    Abstract     Related articles   

  317. STERNBERG CN, Skoneczna I, Kerst JM, Albers P, et al
    Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
    Lancet Oncol. 2015;16:76-86.
    Abstract     Related articles   

  318. BOSSE KR, Shukla AR, Pawel B, Chikwava KR, et al
    Malignant rhabdoid tumor of the bladder and ganglioglioma in a 14 year-old male with a germline 22q11.2 deletion.
    Cancer Genet. 2014;207:415-9.
    Abstract     Related articles   

  319. LOFFEL LM, Kleeb B, Burkhard FC, Wuethrich PY, et al
    Perioperative use of crystalloids in patients undergoing open radical cystectomy: balanced Ringer's maleate versus a glucose 5%/potassium-based balanced solution: study protocol for a randomized controlled trial.
    Trials. 2014;15:276.
    Abstract     Related articles   

  320. CHEN SP, Liao JC
    Confocal laser endomicroscopy of bladder and upper tract urothelial carcinoma: a new era of optical diagnosis?
    Curr Urol Rep. 2014;15:437.
    Abstract     Related articles   

  321. KOWALIK C, Gee JR, Sorcini A, Moinzadeh A, et al
    Underutilization of immediate intravesical chemotherapy following TURBT: results from NSQIP.
    Can J Urol. 2014;21:7266-70.
    Abstract     Related articles   

  322. PALLESCHI G, Pastore AL, Evangelista S, Silvestri L, et al
    Bone metastases from bladder perivascular epithelioid cell tumor - an unusual localization of a rare tumor: a case report.
    J Med Case Rep. 2014;8:227.
    Abstract     Related articles   

  323. ANDERSEN CL, Siersma VD, Hasselbalch HC, Lindegaard H, et al
    Eosinophilia in routine blood samples as a biomarker for solid tumor development - A study based on the Copenhagen Primary Care Differential Count (CopDiff) Database.
    Acta Oncol. 2014;53:1245-50.
    Abstract     Related articles   

  324. GUANCIAL EA, Werner L, Bellmunt J, Bamias A, et al
    FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.
    Cancer Med. 2014;3:835-44.
    Abstract     Related articles   

  325. SUO ST, Chen XX, Fan Y, Wu LM, et al
    Histogram analysis of apparent diffusion coefficient at 3.0 T in urinary bladder lesions: correlation with pathologic findings.
    Acad Radiol. 2014;21:1027-34.
    Abstract     Related articles   

  326. SPINAPOLICE EG, Fuccio C, Rubino B, Palumbo R, et al
    Penile metastases from bladder and prostate cancer detected by PET/CT: a report of 3 cases and a review of literature.
    Clin Genitourin Cancer. 2014;12:e155-9.
    Abstract     Related articles   

  327. GONZALES-VIERA O, Quevedo T, Chavera A, Perales-Camacho R, et al
    Primary urinary bladder haemangiosarcoma in a captive saddleback tamarin (Saguinus fuscicollis).
    J Med Primatol. 2014;43:272-5.
    Abstract     Related articles   

  328. LIU L, Chen M, Li Y, Wang L, et al
    Technique selection of bricker or wallace ureteroileal anastomosis in ileal conduit urinary diversion: a strategy based on patient characteristics.
    Ann Surg Oncol. 2014;21:2808-12.
    Abstract     Related articles   

  329. WANG HH, Wu MM, Chan MW, Pu YS, et al
    Long-term low-dose exposure of human urothelial cells to sodium arsenite activates lipocalin-2 via promoter hypomethylation.
    Arch Toxicol. 2014;88:1549-59.
    Abstract     Related articles   

  330. ANAGNOSTIS P, Karras SN
    Should we stop prescribing pioglitazone?
    Br J Clin Pharmacol. 2014;78:438-9.
    Abstract     Related articles   

  331. HANAZONO K, Fukumoto S, Endo Y, Ueno H, et al
    Ultrasonographic findings related to prognosis in canine transitional cell carcinoma.
    Vet Radiol Ultrasound. 2014;55:79-84.
    Abstract     Related articles   

  332. KE HL, Lin J, Ye Y, Wu WJ, et al
    Genetic Variations in Glutathione Pathway Genes Predict Cancer Recurrence in Patients Treated with Transurethral Resection and Bacillus Calmette-Guerin Instillation for Non-muscle Invasive Bladder Cancer.
    Ann Surg Oncol. 2015.
    Abstract     Related articles   

  333. OZYALVACLI ME, Ozyalvacli G, Kocaaslan R, Cecen K, et al
    Neutrophil-lymphocyte ratio as a predictor of recurrence and progression in patients with high-grade pT1 bladder cancer.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  334. TAOKA R, Williams SB, Ho PL, Kamat AM, et al
    In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  335. INOUE K, Anai S, Fujimoto K, Hirao Y, et al
    Oral 5-aminolevulinic acid mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A randomized, double-blind, multicentre phase II/III study.
    Photodiagnosis Photodyn Ther. 2015 Apr 2. pii: S1572-1000(15)00035.
    Abstract     Related articles   

  336. XU N, Shao MM, Zhang HT, Jin MS, et al
    Aldehyde dehydrogenase 1 (ALDH1) expression is associated with a poor prognosis of bladder cancer.
    Cancer Epidemiol. 2015 Apr 2. pii: S1877-7821(15)00068.
    Abstract     Related articles   

  337. TADIN T, Sotosek S, Rahelic D, Fuckar Z, et al
    Diagnostic accuracy of ultrasound T-staging of the urinary bladder cancer in comparison with histology in elderly patients.
    Coll Antropol. 2014;38:1123-6.
    Abstract     Related articles   

  338. YIN WY, Lee MC, Lai NS, Lu MC, et al
    BK virus as a potential oncovirus for bladder cancer in a renal transplant patient.
    J Formos Med Assoc. 2015;114:373-4.
    Abstract     Related articles   

  339. XU SQ, Buraschi S, Morcavallo A, Genua M, et al
    A novel role for drebrin in regulating progranulin bioactivity in bladder cancer.
    Oncotarget. 2015.
    Abstract     Related articles   

  340. BELLMUNT J
    Bladder cancer.
    Hematol Oncol Clin North Am. 2015;29:xiii-xiv.
    Abstract     Related articles   

  341. MCCONKEY DJ, Choi W, Ochoa A, Siefker-Radtke A, et al
    Therapeutic Opportunities in the Intrinsic Subtypes of Muscle-Invasive Bladder Cancer.
    Hematol Oncol Clin North Am. 2015;29:377-394.
    Abstract     Related articles   

  342. SONPAVDE G, Jones BS, Bellmunt J, Choueiri TK, et al
    Future Directions and Targeted Therapies in Bladder Cancer.
    Hematol Oncol Clin North Am. 2015;29:361-376.
    Abstract     Related articles   

  343. ABIDA W, Bajorin DF, Rosenberg JE
    First-Line Treatment and Prognostic Factors of Metastatic Bladder Cancer for Platinum-Eligible Patients.
    Hematol Oncol Clin North Am. 2015;29:319-328.
    Abstract     Related articles   

  344. LEOW JJ, Fay AP, Mullane SA, Bellmunt J, et al
    Perioperative Therapy for Muscle Invasive Bladder Cancer.
    Hematol Oncol Clin North Am. 2015;29:301-318.
    Abstract     Related articles   

  345. PRESTON MA, Lerner SP, Kibel AS
    New Trends in the Surgical Management of Invasive Bladder Cancer.
    Hematol Oncol Clin North Am. 2015;29:253-269.
    Abstract     Related articles   

  346. WILLIS D, Kamat AM
    Nonurothelial Bladder Cancer and Rare Variant Histologies.
    Hematol Oncol Clin North Am. 2015;29:237-252.
    Abstract     Related articles   

  347. ORSOLA A, Palou J, Solsona E
    High-Risk Nonmuscle Invasive Bladder Cancer.
    Hematol Oncol Clin North Am. 2015;29:227-236.
    Abstract     Related articles   

  348. SUN M, Trinh QD
    Diagnosis and Staging of Bladder Cancer.
    Hematol Oncol Clin North Am. 2015;29:205-218.
    Abstract     Related articles   

  349. MARTIN-DOYLE W, Kwiatkowski DJ
    Molecular Biology of Bladder Cancer.
    Hematol Oncol Clin North Am. 2015;29:191-203.
    Abstract     Related articles   

  350. MALATS N, Real FX
    Epidemiology of Bladder Cancer.
    Hematol Oncol Clin North Am. 2015;29:177-189.
    Abstract     Related articles   

  351. SUGISHITA K, Mouri G, Nishimura Y, Takeuchi I, et al
    [Adenocarcinoma arising in an ileum segment of Scheele's ring 50 years after cystoplasty].
    Nihon Hinyokika Gakkai Zasshi. 2014;105:207-11.
    Abstract     Related articles   

  352. GUILLAUME L, Guy L
    [Epidemiology of and risk factors for bladder cancer and for urothelial tumors].
    Rev Prat. 2014;64:1372-4.
    Abstract     Related articles   

  353. ALLORY Y
    [Classification and natural history of bladder tumors].
    Rev Prat. 2014;64:1365-6.
    Abstract     Related articles   

  354. DAVIN JL
    [Management and complications of urinary diversions].
    Rev Prat. 2014;64:1400-3.
    Abstract     Related articles   

  355. RIVIERE A, Ploussard G, Desgranchamps F
    [Intravesical instillation for bladder tumors].
    Rev Prat. 2014;64:1388-9.
    Abstract     Related articles   

  356. LEGRAND G, Guy L
    [Urothelial tumors, occupational diseases].
    Rev Prat. 2014;64:1375-8.
    Abstract     Related articles   

  357. TEMRAZ S, Mukherji D, Farhat ZA, Nasr R, et al
    Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis.
    BMC Urol. 2014;14:76.
    Abstract     Related articles   

  358. TELLI O, Sarici H, Ozgur BC, Doluoglu OG, et al
    Urothelial cancer of bladder in young versus older adults: clinical and pathological characteristics and outcomes.
    Kaohsiung J Med Sci. 2014;30:466-70.
    Abstract     Related articles   

  359. TOPAZIO L, Miano R, Maurelli V, Gaziev G, et al
    Could hyaluronic acid (HA) reduce Bacillus Calmette-Guerin (BCG) local side effects? Results of a pilot study.
    BMC Urol. 2014;14:64.
    Abstract     Related articles   

  360. DORNELAS CA, Cavalcanti BC, Magalhaes HI, Jamacaru FV, et al
    Potential chemoprotective effects of green propolis, L-lysine and celecoxib on bone marrow cells and peripheral blood lymphocytes of Wistar rats subjected to bladder chemical carcinogenesis.
    Acta Cir Bras. 2014;29:423-8.
    Abstract     Related articles   

  361. GHERARDI A, Bevilacqua A
    Manual stage acquisition and interactive display of digital slides in histopathology.
    IEEE J Biomed Health Inform. 2014;18:1413-22.
    Abstract     Related articles   

  362. QIN M, Wang G, Sun Y, He Q, et al
    Plasmacytoid urothelial carcinoma of the bladder.
    Indian J Pathol Microbiol. 2014;57:320-2.
    Abstract     Related articles   

  363. OZGUR BC, Koseoglu E, Arik AI, Sarici H, et al
    Synchronous bladder and prostate cancers in the specimens of radical cystoprostatectomy: a multicenter retrospective analysis.
    Kaohsiung J Med Sci. 2014;30:371-5.
    Abstract     Related articles   

  364. KAO YT, Hsu WC, Hu HT, Hsu SH, et al
    Involvement of p38 mitogen-activated protein kinase in acquired gemcitabine-resistant human urothelial carcinoma sublines.
    Kaohsiung J Med Sci. 2014;30:323-30.
    Abstract     Related articles   

  365. ALI AS, Hayes MC, Birch B, Dudderidge T, et al
    Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion.
    Eur J Surg Oncol. 2015;41:295-9.
    Abstract     Related articles   

  366. MENON S, Goyal P, Suryawanshi P, Tongaonkar H, et al
    Paraganglioma of the urinary bladder: a clinicopathologic spectrum of a series of 14 cases emphasizing diagnostic dilemmas.
    Indian J Pathol Microbiol. 2014;57:19-23.
    Abstract     Related articles   

  367. YANG M, Zheng Z, Zhuang Z, Zhao X, et al
    ImmunoCyt and cytology for diagnosis of bladder carcinoma: a meta analysis.
    Chin Med J (Engl). 2014;127:758-64.
    Abstract     Related articles   

  368. HAMELIN-MORRISSETTE J, Cloutier S, Girouard J, Belgorosky D, et al
    Identification of an anti-inflammatory derivative with anti-cancer potential: The impact of each of its structural components on inflammatory responses in macrophages and bladder cancer cells.
    Eur J Med Chem. 2015;96:259-268.
    Abstract     Related articles   

  369. XU Y, Luo S, Liu Y, Li J, et al
    Retraction Note: Integrated gene network analysis and text mining revealing PIK3R1 regulated by miR-127 in human bladder cancer.
    Eur J Med Res. 2015;20:43.
    Abstract     Related articles   

  370. BI D, Ning H, Liu S, Que X, et al
    Gene expression patterns combined with network analysis identify hub genes associated with bladder cancer.
    Comput Biol Chem. 2015;56:71-83.
    Abstract     Related articles   

  371. MAO XP, Zhang LS, Huang B, Zhou SY, et al
    Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer.
    J Transl Med. 2015;13:86.
    Abstract     Related articles   

  372. WANG X, Zhang L, Ding N, Yang X, et al
    Identification and characterization of DNAzymes targeting DNA methyltransferase I for suppressing bladder cancer proliferation.
    Biochem Biophys Res Commun. 2015 Apr 15. pii: S0006-291X(15)00699.
    Abstract     Related articles   

  373. BUNIMOVICH-MENDRAZITSKY S, Halachmi S, Kronik N
    Improving Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer by adding interleukin 2 (IL-2): a mathematical model.
    Math Med Biol. 2015.
    Abstract     Related articles   

  374. YANG T, Shi R, Chang L, Tang K, et al
    Huachansu suppresses human bladder cancer cell growth through the Fas/Fasl and TNF- alpha/TNFR1 pathway in vitro and in vivo.
    J Exp Clin Cancer Res. 2015;34:21.
    Abstract     Related articles   

  375. QIN X, Zhang H, Wan F, Zhu Y, et al
    Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study.
    World J Surg Oncol. 2015;13:132.
    Abstract     Related articles   

  376. TANEJA SS
    Management of high grade bladder cancer: a multidisciplinary approach.
    Urol Clin North Am. 2015;42:xi-xii.
    Abstract     Related articles   

  377. JORDAN EJ, Iyer G
    Targeted Therapy in Advanced Bladder Cancer: What Have We Learned?
    Urol Clin North Am. 2015;42:253-262.
    Abstract     Related articles   

  378. JOHNSON DC, Greene PS, Nielsen ME
    Surgical Advances in Bladder Cancer: At What Cost?
    Urol Clin North Am. 2015;42:235-252.
    Abstract     Related articles   

  379. LUCCA I, de Martino M, Klatte T, Shariat SF, et al
    Novel Biomarkers to Predict Response and Prognosis in Localized Bladder Cancer.
    Urol Clin North Am. 2015;42:225-233.
    Abstract     Related articles   

  380. BALAR AV, Milowsky MI
    Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer: A Model for Rational Accelerated Drug Development.
    Urol Clin North Am. 2015;42:217-224.
    Abstract     Related articles   

  381. MITRA AP, Lerner SP
    Potential Role for Targeted Therapy in Muscle-Invasive Bladder Cancer: Lessons from the Cancer Genome Atlas and Beyond.
    Urol Clin North Am. 2015;42:201-215.
    Abstract     Related articles   

  382. SFAKIANOS JP, Galsky MD
    Neoadjuvant Chemotherapy in the Management of Muscle-Invasive Bladder Cancer: Bridging the Gap Between Evidence and Practice.
    Urol Clin North Am. 2015;42:181-187.
    Abstract     Related articles   

  383. PREMO C, Apolo AB, Agarwal PK, Citrin DE, et al
    Trimodality Therapy in Bladder Cancer: Who, What, and When?
    Urol Clin North Am. 2015;42:169-180.
    Abstract     Related articles   

  384. BOEHM BE, Svatek RS
    Novel Therapeutic Approaches for Recurrent Nonmuscle Invasive Bladder Cancer.
    Urol Clin North Am. 2015;42:159-168.
    Abstract     Related articles   

  385. ZLATEV DV, Altobelli E, Liao JC
    Advances in Imaging Technologies in the Evaluation of High-Grade Bladder Cancer.
    Urol Clin North Am. 2015;42:147-157.
    Abstract     Related articles   

  386. SHAH BK, Mandal R
    Survival trends in metastatic bladder cancer in the United States: A population based study.
    J Cancer Res Ther. 2015;11:124-8.
    Abstract     Related articles   

  387. SUN H, Tian J, Xian W, Xie T, et al
    miR-34a Inhibits Proliferation and Invasion of Bladder Cancer Cells by Targeting Orphan Nuclear Receptor HNF4G.
    Dis Markers. 2015;2015:879254.
    Abstract     Related articles   

  388. HASSAN EH, Gerges SS, El-Atrebi KA, El-Bassyouni HT, et al
    The role of H. pylori infection in gall bladder cancer: clinicopathological study.
    Tumour Biol. 2015.
    Abstract     Related articles   

  389. HUDDART RA, Jones R, Choudhury A
    A New Dawn for Bladder Cancer? Recommendations from the National Institute for Health and Care Excellence (NICE) on Managing Bladder Cancer.
    Clin Oncol (R Coll Radiol). 2015 Apr 10. pii: S0936-6555(15)00130.
    Abstract     Related articles   

  390. LOMBARD AP, Mooso BA, Libertini SJ, Lim RM, et al
    miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1.
    Mol Carcinog. 2015 Apr 11. doi: 10.1002/mc.22319.
    Abstract     Related articles   

  391. XU Y, Guan W, Chen W, Xie C, et al
    Comparing the treatment outcomes of potassium-titanyl-phosphate laser vaporization and transurethral electroresection for primary nonmuscle-invasive bladder cancer: A prospective, randomized study.
    Lasers Surg Med. 2015 Apr 9. doi: 10.1002/lsm.22342.
    Abstract     Related articles   

  392. SHI MD, Shiao CK, Lee YC, Shih YW, et al
    Apigenin, a dietary flavonoid, inhibits proliferation of human bladder cancer T-24 cells via blocking cell cycle progression and inducing apoptosis.
    Cancer Cell Int. 2015;15:33.
    Abstract     Related articles   

  393. MEHTA N, Rathore RS, Pillai BS, Sam MP, et al
    Intrinsic tumour factors affecting recurrence in non muscle invasive bladder cancer: a hospital based study from India.
    Asian Pac J Cancer Prev. 2015;16:2675-7.
    Abstract     Related articles   

  394. HUANG YL, Chen J, Yan W, Zang D, et al
    Diagnostic accuracy of cytokeratin-19 fragment (CYFRA 21-1) for bladder cancer: a systematic review and meta-analysis.
    Tumour Biol. 2015.
    Abstract     Related articles   

  395. MATSUMOTO K, Hayakawa N, Nakamura S, Oya M, et al
    Bladder metastasis from renal cell carcinoma: retrospective analysis of 65 reported cases.
    Clin Exp Metastasis. 2015;32:135-41.
    Abstract     Related articles   

  396. TOHI Y, Taketa S, Yamamoto A, Sakura Y, et al
    [An ileal neobladder-enteric fistula 10 years after a radical cystectomy with ileal neobladder construction].
    Hinyokika Kiyo. 2014;60:631-3.
    Abstract     Related articles   

  397. WISHAHI M, Elganzoury H, Elhouly A, Badawi M, et al
    Urothelial carcinoma of the urinary bladder mixed with squamous differentiation or squamous cell carcinoma in areas with schistosomiasis is showing high risk of recurrence and poor survival.
    J Egypt Soc Parasitol. 2014;44:467-73.
    Abstract     Related articles   

  398. DIP N, Reis ST, Abe DK, Viana NI, et al
    Micro RNA expression and prognosis in low-grade non-invasive urothelial carcinoma.
    Int Braz J Urol. 2014;40:644-9.
    Abstract     Related articles   

  399. DOETZER K, Bruendl J, Muller-Wille R, Goessmann H, et al
    [Utero-iliac fistula - successful therapy with stent graft implantation].
    Rofo. 2015;187:192-4.
    Abstract     Related articles   

  400. XIAO N, Jiang LM, Ge B, Zhang TY, et al
    Over-expression of TRPM8 is associated with poor prognosis in urothelial carcinoma of bladder.
    Tumour Biol. 2014;35:11499-504.
    Abstract     Related articles   

  401. SRIVASTAVA AK, Singh PK, Rath SK, Dalela D, et al
    Appraisal of diagnostic ability of UCA1 as a biomarker of carcinoma of the urinary bladder.
    Tumour Biol. 2014;35:11435-42.
    Abstract     Related articles   

  402. OYINLOYE B, Adenowo F, Gxaba N, Kappo A, et al
    The promise of antimicrobial peptides for treatment of human schistosomiasis.
    Curr Drug Targets. 2014;15:852-9.
    Abstract     Related articles   

  403. ZHANG Y, Huang YS, Lin WQ, Zhang SD, et al
    NBS1 Glu185Gln polymorphism and susceptibility to urinary system cancer: a meta-analysis.
    Tumour Biol. 2014;35:10723-9.
    Abstract     Related articles   

  404. KOO KC, Yoon YE, Chung BH, Hong SJ, et al
    Analgesic opioid dose is an important indicator of postoperative ileus following radical cystectomy with ileal conduit: experience in the robotic surgery era.
    Yonsei Med J. 2014;55:1359-65.
    Abstract     Related articles   

  405. BARLOW CM
    What does DNR/DNI really mean?
    Nursing. 2014;44:65.
    Abstract     Related articles   

  406. ENGS SF
    Mrs. M's garden.
    Nursing. 2014;44:48-9.
    Abstract     Related articles   

  407. EROL B, Pelit ES, Bektas S, Simsek A, et al
    Aggressive vaginal angiomyxoma mimicking a bladder mass.
    Urol J. 2014;11:1710-3.
    Abstract     Related articles   

  408. SUN B, Yan JM, Li JY, Guo HQ, et al
    Long-term follow-up on the effects of sigmoid-rectal pouch for urinary diversion.
    Urol J. 2014;11:1629-35.
    Abstract     Related articles   

  409. LIU HW, Lin CP, Liou YJ, Hsu KW, et al
    NBT-II cell locomotion is modulated by restricting the size of focal contacts and is improved through EGF and ROCK signaling.
    Int J Biochem Cell Biol. 2014;51:131-41.
    Abstract     Related articles   

  410. CHEN F, Li Q, Yu Y, Yang W, et al
    Association of vitamin C, vitamin D, vitamin E and risk of bladder cancer: a dose-response meta-analysis.
    Sci Rep. 2015;5:9599.
    Abstract     Related articles   

  411. WU L, Chaffee KG, Parker AS, Sicotte H, et al
    Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  412. SHIOTA M, Yokomizo A, Takeuchi A, Imada K, et al
    Secondary bladder cancer after anticancer therapy for prostate cancer: reduced comorbidity after androgen-deprivation therapy.
    Oncotarget. 2015.
    Abstract     Related articles   

  413. HIZLI F, Argun G, Guney I, Guven O, et al
    Obturator nerve block transurethral surgery for bladder cancer: comparison of inguinal and intravesical approaches: prospective randomized trial.
    Ir J Med Sci. 2015.
    Abstract     Related articles   

  414. WILLIAMS SB, Ye Y, Huang M, Chang DW, et al
    Mitochondrial DNA Content as Risk Factor for Bladder Cancer and its Association with Mitochondrial DNA Polymorphisms.
    Cancer Prev Res (Phila). 2015 Apr 20. pii: canprevres.0414.2014.
    Abstract     Related articles   

  415. GAN Y, Tan J, Yang J, Zhou Y, et al
    Erratum to: Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
    Med Oncol. 2015;32:611.
    Abstract     Related articles   

  416. VOM DORP F, Lummen G, Rubben H
    [Nonmuscle-invasive bladder cancer].
    Urologe A. 2015;54:479.
    Abstract     Related articles   

  417. DING W, Tong S, Gou Y, Sun C, et al
    Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groups.
    World J Urol. 2015.
    Abstract     Related articles   

  418. MANSOUR AM, Soloway MS, Eldefrawy A, Singal R, et al
    Prognostic significance of cystoscopy findings following neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Can J Urol. 2015;22:7690-7.
    Abstract     Related articles   

  419. KALEVA AI, Hone RW, Szakacs SM, Streeter E, et al
    Tongue metastasis from a poorly differentiated urothelial carcinoma of the bladder.
    Ann R Coll Surg Engl. 2015;97:e30-1.
    Abstract     Related articles   

  420. FELDEN A, Vaz G, Kreps S, Anract P, et al
    A cemented acetabular component with a reinforcement cross provides excellent medium-term fixation in total hip arthroplasty after pelvic irradiation.
    Bone Joint J. 2015;97-B:177-84.
    Abstract     Related articles   

  421. LEE HY, Li CC, Huang CN, Li WM, et al
    INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.
    J Surg Oncol. 2015;111:414-22.
    Abstract     Related articles   

  422. ZUO RC, Apolo AB, DiGiovanna JJ, Parnes HL, et al
    Cutaneous adverse effects associated with the tyrosine-kinase inhibitor cabozantinib.
    JAMA Dermatol. 2015;151:170-7.
    Abstract     Related articles   

  423. LEE HW, Wang HT, Weng MW, Hu Y, et al
    Acrolein- and 4-Aminobiphenyl-DNA adducts in human bladder mucosa and tumor tissue and their mutagenicity in human urothelial cells.
    Oncotarget. 2014;5:3526-40.
    Abstract     Related articles   

  424. MAHMOOD H, Faheem M, Saleem T, Irfan J, et al
    Transitional cell carcinoma of urinary bladder in a breast cancer survivor.
    J Coll Physicians Surg Pak. 2014;24 Suppl 1:S60-2.
    Abstract     Related articles   

  425. BEYAN C, Kaptan K
    Variant hairy cell leukemia following papillary urothelial neoplasm of bladder.
    J Coll Physicians Surg Pak. 2014;24 Suppl 1:S27-8.
    Abstract     Related articles   

  426. TANAKA N, Kikuchi E, Kanao K, Matsumoto K, et al
    Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
    Ann Surg Oncol. 2014;21:3151-8.
    Abstract     Related articles   

  427. MALLEN E, Gil P, Gil MJ
    Risk groups in bladder cancer patients treated with radical cystectomy.
    Int Braz J Urol. 2015;41:30-39.
    Abstract     Related articles   

  428. LIU J, Cao J, Zhao X
    miR-221 facilitates the TGFbeta1-induced epithelial-mesenchymal transition in human bladder cancer cells by targeting STMN1.
    BMC Urol. 2015;15:36.
    Abstract     Related articles   

  429. HASHASH JG, Habib-Bein N, Khalid A, Francis FF, et al
    Recurrent bladder cancer presenting as rectal linitis plastica.
    Endoscopy. 2015;47.
    Abstract     Related articles   

  430. ZEKRI AR, Hassan ZK, Bahnassy AA, Khaled HM, et al
    Differentially expressed genes in metastatic advanced egyptian bladder cancer.
    Asian Pac J Cancer Prev. 2015;16:3543-9.
    Abstract     Related articles   

  431. HAGHDOOST AA, Baneshi MR, Haji-Maghsoodi S, Molavi-Vardanjani H, et al
    Application of a Network Scale-up Method to Estimate the Size of Population of Breast, Ovarian/Cervical, Prostate and Bladder Cancers.
    Asian Pac J Cancer Prev. 2015;16:3273-7.
    Abstract     Related articles   

  432. EKIN RG, Akarken I, Cakmak O, Tarhan H, et al
    Results of Intravesical Chemo-Hyperthermia in High-risk Non-muscle Invasive Bladder Cancer.
    Asian Pac J Cancer Prev. 2015;16:3241-5.
    Abstract     Related articles   

  433. RAMIREZ-BACKHAUS M, Fernandez-Serra A, Rubio-Briones J, Cruz Garcia P, et al
    External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes.
    Actas Urol Esp. 2015 Apr 24. pii: S0210-4806(15)00078.
    Abstract     Related articles   

  434. WANG C, Ge Q, Chen Z, Hu J, et al
    A New Double Stranded RNA Suppresses Bladder Cancer Development by Upregulating p21 (Waf1/CIP1) Expression.
    Biomed Res Int. 2015;2015:304753.
    Abstract     Related articles   

  435. WANG H, Men CP
    Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis.
    Lab Med. 2015;46:118-22.
    Abstract     Related articles   

  436. DEL ZINGARO M, Bruno R, Nunzi E, Porena M, et al
    First transurethral resection (TUR) and second TUR in intermediate-high risk bladder cancer: impact of the surgeon's volume on the recurrence and progression of primary bladder cancer.
    Minerva Urol Nefrol. 2015.
    Abstract     Related articles   

  437. TINAWI-ALJUNDI R, King L, Knuth ST, Gildea M, et al
    One-year monitoring of an oligonucleotide fluorescence in situ hybridization probe panel laboratory-developed test for bladder cancer detection.
    Res Rep Urol. 2015;7:49-55.
    Abstract     Related articles   

  438. FONTANA PP, Gregorio SA, Rivas JG, Sanchez LC, et al
    Perioperative and survival outcomes of laparoscopic radical cystectomy for bladder cancer in patients over 70 years.
    Cent European J Urol. 2015;68:24-9.
    Abstract     Related articles   

  439. BABJUK M
    Optimized management in patients with bladder cancer.
    Cent European J Urol. 2015;68:15-6.
    Abstract     Related articles   

  440. PATEL MI, Bang A, Gillett D, Cheluvappa R, et al
    Poor survival of females with bladder cancer is limited to those aged 70 years or over: a population-wide linkage study, New South Wales, Australia.
    Cancer Med. 2015 Apr 27. doi: 10.1002.
    Abstract     Related articles   

  441. OKOSHI K, Hasegawa S, Murakami T, Yamada M, et al
    Laparoscopic right hemicolectomy for metachronous ascending colon cancer with preservation of an ileal conduit constructed after previous radical cystectomy for bladder cancer.
    Asian J Endosc Surg. 2015;8:188-92.
    Abstract     Related articles   

  442. OZTURK H
    Evaluation of the response chemotherapy for penile metastasis of bladder cancer using 18F-fluorodeoxyglucose-PET/CT.
    Int J Surg Case Rep. 2015;11:33-36.
    Abstract     Related articles   

  443. GRIMM S, Jennek S, Singh R, Enkelmann A, et al
    Malignancy of bladder cancer cells is enhanced by tumor-associated fibroblasts through a multifaceted cytokine-chemokine loop.
    Exp Cell Res. 2015 Apr 22. pii: S0014-4827(15)00122.
    Abstract     Related articles   

  444. REDDY OL, Cates JM, Gellert LL, Crist HS, et al
    Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.
    Am J Pathol. 2015;185:1385-95.
    Abstract     Related articles   

  445. CONDE VR, Oliveira PF, Nunes AR, Rocha CS, et al
    The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism.
    Exp Cell Res. 2015 Apr 20. pii: S0014-4827(15)00141.
    Abstract     Related articles   

  446. TAPAK L, Saidijam M, Sadeghifar M, Poorolajal J, et al
    Competing Risks Data Analysis with High-dimensional Covariates: An application in Bladder Cancer.
    Genomics Proteomics Bioinformatics. 2015 Apr 20. pii: S1672-0229(15)00040.
    Abstract     Related articles   

  447. DIAZ DA, Pollack A, Reis IM, Mahmoud O, et al
    Neoadjuvant Radiotherapy Improves Survival in Patients With T2b/T3 Bladder Cancer: A Population-Based Analysis.
    Clin Genitourin Cancer. 2015 Mar 5. pii: S1558-7673(15)00040.
    Abstract     Related articles   

  448. MURAV'EV AN, Orlova NV, Blinova MI, Iudintseva NM, et al
    [Tissue engineering in urology, new approaches for urinary bladder reconstruction].
    Tsitologiia. 2015;57:14-8.
    Abstract     Related articles   

  449. CALAMARO P, Ravetti JL, Toncini C
    Paraganglioma of the urinary bladder: a challenging diagnosis in transurethral resection specimens: a case report.
    Anal Quant Cytopathol Histpathol. 2014;36:290-4.
    Abstract     Related articles   

  450. ALMEIDA M, Canas-Marques R, Lopez-Beltran A, Rebola J, et al
    Small cell carcinoma of the bladder associated with schistosomiasis: a case report.
    Anal Quant Cytopathol Histpathol. 2014;36:339-44.
    Abstract     Related articles   

  451. PUDASAINI S, Subedi N, Prasad KB, Rauniyar SK, et al
    Cystoscopic bladder biopsies: a histopathological study.
    Nepal Med Coll J. 2014;16:9-12.
    Abstract     Related articles   

  452. WERBROUCK C, Marrannes J, Verhamme L, Steenkiste E, et al
    Eosinophilic cystitis mimicking bladder tumor.
    JBR-BTR. 2014;97:375.
    Abstract     Related articles   

  453. FUJIMOTO T, Abe T, Okabe Y, Johshima K, et al
    [A case of adenocarcinoma occurring in the bladder mucosa after a surgical operation for colovesical fistula].
    Gan To Kagaku Ryoho. 2014;41:2462-4.
    Abstract     Related articles   

  454. ISHIKAWA H, Nishimura Y, Higashi Y, Yatsuoka T, et al
    [Transurethral resection of a intravesical recurrence of a tumor after resection of sigmoid colon cancer].
    Gan To Kagaku Ryoho. 2014;41:1799-801.
    Abstract     Related articles   

  455. STROPE SA
    Comparative effectiveness research in urologic cancers.
    Cancer Treat Res. 2015;164:221-35.
    Abstract     Related articles   

  456. KOIZUMI K, Kamigaito T, Maruyama A, Nakayama T, et al
    [Case report : bleeding from ileal conduit in a patient with portal hypertension due to liver cirrhosis type C].
    Hinyokika Kiyo. 2015;61:19-21.
    Abstract     Related articles   

  457. RAN J, Wang H, Hu T
    Clinical aspects of urea transporters.
    Subcell Biochem. 2014;73:179-91.
    Abstract     Related articles   

  458. GULAVITA P, Mai KT
    Urothelial bladder carcinoma metastasising to the scrotum mimicking primary extra-mammary Paget's disease.
    Pathology. 2014;46:256-7.
    Abstract     Related articles   

  459. MOON KC, Kim M, Kwak C, Kim HH, et al
    External validation of online predictive models for prediction of cancer-specific mortality and all-cause mortality in patients with urothelial carcinoma of the urinary bladder.
    Ann Surg Oncol. 2014;21:3132-41.
    Abstract     Related articles   

  460. SCHMID SC, Gschwend JE, Retz M
    [Current developments in the medical treatment of advanced urothelial carcinoma of the bladder].
    Aktuelle Urol. 2014;45:55-63.
    Abstract     Related articles   

  461. OSMONOV DK, Aksenov AV, Naumann CM, Junemann KP, et al
    [A serious complication after bladder embolisation due to massive tissue necrosis in the gluteal region].
    Aktuelle Urol. 2014;45:50-3.
    Abstract     Related articles   

  462. HEGELE A, Skrobek L, Schrader AJ
    [Update Urooncology: News with clinical relevance from major scientific meetings 2013].
    Aktuelle Urol. 2014;45:21-32.
    Abstract     Related articles   

  463. CHA TL, Chuang MJ, Tang SH, Wu ST, et al
    Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth.
    Mol Carcinog. 2015;54:167-77.
    Abstract     Related articles   

  464. OGOREVC E, Hudoklin S, Veranic P, Kralj-Iglic V, et al
    Extracellular vesicle-mediated transfer of membranous components from the highly malignant T24 urinary carcinoma cell line to the non-malignant RT4 urinary papilloma cell line.
    Protoplasma. 2014;251:699-702.
    Abstract     Related articles   

  465. CHOI YJ, Gabikian P, Zhu F, Appelbaum DE, et al
    Advanced neuroimaging studies in a patient with brain metastases from transitional cell carcinoma of the bladder.
    J Neuroimaging. 2014;24:429-31.
    Abstract     Related articles   

  466. TIMIRCI-KAHRAMAN O, Ozkan NE, Turan S, Farooqi AA, et al
    Genetic Variants in the Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and Death Receptor (DR4) Genes Contribute to Susceptibility to Bladder Cancer.
    Genet Test Mol Biomarkers. 2015.
    Abstract     Related articles   

  467. WANG Y, Wang G, Zhang X, Zhou X, et al
    gammasecretase inhibitor inhibits bladder cancer cell drug resistance and invasion by reducing epithelialmesenchymal transition.
    Mol Med Rep. 2015 May 7. doi: 10.3892/mmr.2015.3750.
    Abstract     Related articles   

  468. JIN N, Jin X, Gu X, Na W, et al
    Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis.
    Mol Med Rep. 2015 May 7. doi: 10.3892/mmr.2015.3739.
    Abstract     Related articles   

  469. CAPALBO E, Kluzer A, Peli M, Cosentino M, et al
    Bladder cancer diagnosis: the role of CT urography.
    Tumori. 2015;0:0.
    Abstract     Related articles   

  470. GHOSH N, Bandopadhyay R, Tirkey L, Das DK, et al
    Trend and pattern of various types of cancer with special reference to gall bladder cancer in north bengal medical college, west bengal, India: a 3 years record based study.
    Int J Prev Med. 2015;6:24.
    Abstract     Related articles   

  471. LI S, Li L, Zeng Q, Zhang Y, et al
    Characterization and noninvasive diagnosis of bladder cancer with serum surface enhanced Raman spectroscopy and genetic algorithms.
    Sci Rep. 2015;5:9582.
    Abstract     Related articles   

  472. ABDEL-MAGID AF
    Fibroblast Growth Factor Receptor 3 (FGF-R3): A Promising Therapeutic Target for the Treatment of Bladder Cancer.
    ACS Med Chem Lett. 2015;6:369-70.
    Abstract     Related articles   

  473. THANARAJASINGAM G, Milone M, Kohli M
    Paraneoplastic encephalopathy: an unusual presenting feature of bladder cancer metastasis.
    BMJ Case Rep. 2015;2015.
    Abstract     Related articles   

  474. RUBENWOLF P, Thomas C, Denzinger S, Hartmann A, et al
    Loss of AQP3 protein expression is associated with worse progression-free and cancer-specific survival in patients with muscle-invasive bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  475. TANABE K, Yoshida S, Koga F, Inoue M, et al
    High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol.
    Clin Genitourin Cancer. 2015 Mar 27. pii: S1558-7673(15)00067.
    Abstract     Related articles   

  476. ZHU H, Yun F, Shi X, Wang D, et al
    VEGFC inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
    Mol Med Rep. 2015 Apr 24. doi: 10.3892/mmr.2015.3684.
    Abstract     Related articles   

  477. ARCANGELI G, Strigari L, Arcangeli S
    Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials.
    Crit Rev Oncol Hematol. 2015 Apr 17. pii: S1040-8428(15)00072.
    Abstract     Related articles   

  478. LIU L, Liu Y, Zhuang C, Xu W, et al
    Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  479. GAO J, Yang PT, Diao Y, Kang HF, et al
    Effects of PSCA rs2294008 (C/T) and c-MYC rs9642880 (G/T) polymorphisms on bladder cancer: evidence from a meta-analysis.
    Int J Clin Exp Med. 2015;8:2156-64.
    Abstract     Related articles   

  480. XU C, Zeng XT, Liu TZ, Zhang C, et al
    Fruits and Vegetables Intake and Risk of Bladder Cancer: A PRISMA-Compliant Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.
    Medicine (Baltimore). 2015;94:e759.
    Abstract     Related articles   

  481. TOMLINSON B, Lin TY, Dall'Era M, Pan CX, et al
    Nanotechnology in bladder cancer: current state of development and clinical practice.
    Nanomedicine (Lond). 2015;10:1189-201.
    Abstract     Related articles   

  482. OSAKA Y, Watanabe I, Sumigawa H
    [Postoperative takotsubo cardiomyopathy caused by an ectopic paraganglinoma after gastric submucosal tumor resection].
    Masui. 2014;63:1280-3.
    Abstract     Related articles   

  483. KOZYRIN IA, Ermakov NA, Liadov VK, Kovalenko ZA, et al
    [Experience of two-staged liver resection (ALPPS)].
    Khirurgiia (Mosk). 2014;:24-8.
    Abstract     Related articles   

  484. LEHMANN M, Hoffmann MJ, Koch A, Ulrich SM, et al
    Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment.
    J Exp Clin Cancer Res. 2014;33:59.
    Abstract     Related articles   

  485. ABID Z, Cross AJ, Sinha R
    Meat, dairy, and cancer.
    Am J Clin Nutr. 2014;100 Suppl 1:386S-93S.
    Abstract     Related articles   

  486. YANG Y, Xu H, Shen J, Yang Y, et al
    RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells.
    Cell Death Dis. 2015;6:e1760.
    Abstract     Related articles   

  487. ZHANG S, Yu YH, Zhang Y, Qu W, et al
    Radiotherapy in muscle-invasive bladder cancer: the latest research progress and clinical application.
    Am J Cancer Res. 2015;5:854-68.
    Abstract     Related articles   

  488. ZHAO XL, Zhao ZH, Xu WC, Hou JQ, et al
    Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Int J Clin Exp Pathol. 2015;8:1954-60.
    Abstract     Related articles   

  489. DANCKERS M, Zhou F, Nimeh D, Belmont HM, et al
    Pulmonary metastasis in a patient with simultaneous bladder cancer and relapsing granulomatosis with polyangiitis.
    Am J Case Rep. 2015;16:287-91.
    Abstract     Related articles   

  490. SU CC, Liu SH, Lee KI, Huang KT, et al
    Cantharidin Induces Apoptosis Through the Calcium/PKC-Regulated Endoplasmic Reticulum Stress Pathway in Human Bladder Cancer Cells.
    Am J Chin Med. 2015;43:581-600.
    Abstract     Related articles   

  491. CHENG Y, Yang X, Deng X, Zhang X, et al
    MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
    Tumour Biol. 2015.
    Abstract     Related articles   

  492. KUANG LI, Song WJ, Qing HM, Yan S, et al
    CYFRA21-1 levels could be a biomarker for bladder cancer: a meta-analysis.
    Genet Mol Res. 2015;14:3921-31.
    Abstract     Related articles   

  493. SUN E, Nian X, Liu C, Fan X, et al
    Construction of recombinant human IFNalpha-2b BCG and its antitumor effects on bladder cancer cells in vitro.
    Genet Mol Res. 2015;14:3436-49.
    Abstract     Related articles   

  494. PENG Y, Dong W, Lin TX, Zhong GZ, et al
    MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.
    Oncotarget. 2015.
    Abstract     Related articles   

  495. UGURLU O, Baltaci S, Aslan G, Can C, et al
    Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer?
    Korean J Urol. 2015;56:357-64.
    Abstract     Related articles   

  496. WANG T, Liu Y, Yuan W, Zhang L, et al
    Identification of microRNAome in rat bladder reveals miR-1949 as a potential inducer of bladder cancer following spinal cord injury.
    Mol Med Rep. 2015 May 12. doi: 10.3892/mmr.2015.3769.
    Abstract     Related articles   

  497. CANYILMAZ E, Yoney A, Serdar L, Uslu GH, et al
    Long-term results of a concomitant boost radiotherapy technique for elderly patients with muscle-invasive bladder cancer.
    J Geriatr Oncol. 2015 May 7. pii: S1879-4068(15)00033.
    Abstract     Related articles   

  498. FEUERSTEIN MA, Jacobs M, Piciocchi A, Bochner B, et al
    Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review.
    Urol Oncol. 2015 May 5. pii: S1078-1439(15)00152.
    Abstract     Related articles   

  499. VETORAZZO FILHO JE, Bahia LA, Vedovato BC, Maron PE, et al
    Cystectomy with orthotopic ileal neobladder reconstruction for treatment of bladder contracture after intravesical bacillus Calmette-Guerin therapy.
    Einstein (Sao Paulo). 2014;12:502-4.
    Abstract     Related articles   

  500. ADRAKTAS D, Caserta M, Tchelepi H
    Paraganglioma of the urinary bladder.
    Ultrasound Q. 2014;30:233-5.
    Abstract     Related articles   

  501. YAN Y, Yang FQ, Zhang HM, Li J, et al
    Bromodomain 4 protein is a predictor of survival for urothelial carcinoma of bladder.
    Int J Clin Exp Pathol. 2014;7:4231-8.
    Abstract     Related articles   

  502. KANG YJ, Park DJ, Kim S, Kim SW, et al
    Vesicoenteric fistula due to bladder squamous cell carcinoma.
    Korean J Urol. 2014;55:496-8.
    Abstract     Related articles   

  503. CHO YH, Seo YH, Chung SJ, Hwang I, et al
    Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic score.
    Korean J Urol. 2014;55:453-9.
    Abstract     Related articles   

  504. ZHENG X, Zhuge J, Bezerra SM, Faraj SF, et al
    High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.
    J Hematol Oncol. 2014;7:47.
    Abstract     Related articles   

  505. PATHURI G, Madka V, Hedrick AF, Lightfoot SA, et al
    Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression.
    Mol Pharm. 2014;11:2948-53.
    Abstract     Related articles   

  506. ZHANG Q, Zhao Z, Ma Y, Wang H, et al
    Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
    Urol Oncol. 2014;32:798-805.
    Abstract     Related articles   

  507. LOURENCO LM, Pereira PM, Maciel E, Valega M, et al
    Amphiphilic phthalocyanine-cyclodextrin conjugates for cancer photodynamic therapy.
    Chem Commun (Camb). 2014;50:8363-6.
    Abstract     Related articles   

  508. EHDAIE B, Atoria CL, Lowrance WT, Herr HW, et al
    Adherence to surveillance guidelines after radical cystectomy: a population-based analysis.
    Urol Oncol. 2014;32:779-84.
    Abstract     Related articles   

  509. VAA B, Kohli M, Price KA, Swetz KM, et al
    Solitary cystic cerebellar metastasis in a patient with invasive transitional cell carcinoma of the bladder.
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  510. AGILLI M, Aydin I, Aydin FN, Kurt YG, et al
    Neutrophil-lymphocyte ratio evaluation in patients undergoing radical cystectomy.
    Urol Oncol. 2014;32:939.
    Abstract     Related articles   

  511. MONN MF, Cary KC, Kaimakliotis HZ, Flack CK, et al
    National trends in the utilization of robotic-assisted radical cystectomy: an analysis using the Nationwide Inpatient Sample.
    Urol Oncol. 2014;32:785-90.
    Abstract     Related articles   

  512. BEATTIE W, Qin X, Wang L, Ma H, et al
    Clog-free cell filtration using resettable cell traps.
    Lab Chip. 2014;14:2657-65.
    Abstract     Related articles   

  513. CHEUNG YK
    Simple benchmark for complex dose finding studies.
    Biometrics. 2014;70:389-97.
    Abstract     Related articles   

  514. AL BASHIR S, Yilmaz A, Gotto G, Trpkov K, et al
    Long term outcome of primary urothelial papilloma: a single institution cohort.
    Pathology. 2014;46:37-40.
    Abstract     Related articles   

  515. WANG HJ , Pui MH, Guo Y, Yang D, et al
    Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection.
    Abdom Imaging. 2013.
    Abstract     Related articles   

  516. PAKASH J, Goel A, Garg M
    Re: Value of immediate second resection of the tumor bed to improve the effectiveness of transurethral resection of bladder tumor.
    J Endourol. 2014;28:1246.
    Abstract     Related articles   

  517. APOLO AB, Vogelzang NJ, Theodorescu D
    New and promising strategies in the management of bladder cancer.
    Am Soc Clin Oncol Educ Book. 2015;35:105-12.
    Abstract     Related articles   

  518. LI Y, Deng H, Lv L, Zhang C, et al
    The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.
    Oncotarget. 2015;6:10195-206.
    Abstract     Related articles   

  519. TANG K, Zhou H, Xiao H, Zeng J, et al
    A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
    J Exp Clin Cancer Res. 2015;34:53.
    Abstract     Related articles   

  520. XU Z, Yu YQ, Ge YZ, Zhu JG, et al
    MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
    Tumour Biol. 2015.
    Abstract     Related articles   

  521. LI Q, Li JZ, Xu WH, Gao L, et al
    Pemetrexed in treating patients with metastatic bladder cancer.
    Asian Pac J Cancer Prev. 2015;16:3839-41.
    Abstract     Related articles   

  522. GAN C, Mostafid H, Khan MS, Lewis DJ, et al
    Corrigendum: BCG immunotherapy for bladder cancer-the effects of substrain differences.
    Nat Rev Urol. 2015 May 19. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  523. BRUNETTI J, Falciani C, Lelli B, Minervini A, et al
    Neurotensin branched Peptide as a tumor-targeting agent for human bladder cancer.
    Biomed Res Int. 2015;2015:173507.
    Abstract     Related articles   

  524. SANTACATERINA A, Platania A, Palazzolo C, Spatola C, et al
    Very elderly (>80 years), frail patients with muscle-invasive bladder cancer and comorbidities: is curative irradiation feasible?
    Tumori. 2015;0:0.
    Abstract     Related articles   

  525. HUANG L, Peng Y, Zhong G, Xie W, et al
    PBRM1 suppresses bladder cancer by cyclin B1 induced cell cycle arrest.
    Oncotarget. 2015.
    Abstract     Related articles   

  526. DIRIX P, Vingerhoedt S, Joniau S, Van Cleynenbreugel B, et al
    Hypofractionated palliative radiotherapy for bladder cancer.
    Support Care Cancer. 2015.
    Abstract     Related articles   

  527. WANG J, Zhang X, Wang L, Dong Z, et al
    Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer.
    J Surg Oncol. 2015 May 14. doi: 10.1002/jso.23937.
    Abstract     Related articles   

  528. EL-GAMAL EM, Gouida MS
    Flow cytometric study of cell cycle and DNA ploidy in belharzial bladder cancer.
    Clin Lab. 2015;61.
    Abstract     Related articles   

  529. SUN WX, Chen YH, Liu ZZ, Xie JJ, et al
    Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.
    Mol Genet Genomics. 2015;290:709-25.
    Abstract     Related articles   

  530. GRAVAS S, Stenzl A
    The Storz professional image enhancement system(spies) nonmuscle-invasive bladder cancer study:a multicenter international randomized controlled study.
    J Endourol. 2014;28:1254-5.
    Abstract     Related articles   

  531. KONG V, Rosewall T, Chen S, Craig T, et al
    Deriving patient-specific planning target volume for partial bladder image guided radiation therapy.
    Pract Radiat Oncol. 2014;4:323-9.
    Abstract     Related articles   

  532. TOBIS S, Heinlen JE, Ruel N, Lau C, et al
    Effect of alvimopan on return of bowel function after robot-assisted radical cystectomy.
    J Laparoendosc Adv Surg Tech A. 2014;24:693-7.
    Abstract     Related articles   

  533. JALIL R, Jahan KA, Brodie A, Kalsi J, et al
    The bladder or not the bladder that is the question!
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  534. BOLT HM
    Causation of human urothelial cancer: there are challenging new data!
    Arch Toxicol. 2014;88:1769-70.
    Abstract     Related articles   

  535. KNEZ VM, Barrow W, Lucia MS, Wilson S, et al
    Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature.
    J Med Case Rep. 2014;8:275.
    Abstract     Related articles   

  536. STOWERS KH, Hartman AD, Gustin J
    Diltiazem for the management of malignancy-associated perineal pain and tenesmus.
    J Palliat Med. 2014;17:1075-7.
    Abstract     Related articles   

  537. HABERMAN K, Wittig K, Yuh B, Ruel N, et al
    The effect of nerve-sparing robot-assisted radical cystoprostatectomy on erectile function in a preoperatively potent population.
    J Endourol. 2014;28:1352-6.
    Abstract     Related articles   

  538. CHAABANE A, M'Sakni I, Yahia M, Bougrine F, et al
    [Prognostic value of markers of aggressiveness of urinary bladder tumours evaluated by immunohistochemistry].
    Tunis Med. 2014;92:208-13.
    Abstract     Related articles   

  539. DESAI MM, de Abreu AL, Goh AC, Fairey A, et al
    Robotic intracorporeal urinary diversion: technical details to improve time efficiency.
    J Endourol. 2014;28:1320-7.
    Abstract     Related articles   

  540. ROY C, Deb AR, Pal M, Das D, et al
    Small cell carcinoma of the urinary bladder: a case report and review of the literature.
    J Indian Med Assoc. 2014;112:57-9.
    Abstract     Related articles   

  541. TREGLIA G, Ceriani L, Merlo E, Ruberto T, et al
    Added value of fused somatostatin receptor imaging/magnetic resonance imaging in a rare case of paraganglioma of the urinary bladder.
    Rev Esp Med Nucl Imagen Mol. 2014;33:122-4.
    Abstract     Related articles   

  542. EL GENDY H, Madkour B, Abdelaty S, Essawy F, et al
    Galectin 3 for the diagnosis of bladder cancer.
    Arab J Urol. 2014;12:178-81.
    Abstract     Related articles   

  543. OZYALVACLI G, Ozyalvacli ME, Astarci HM, Boran C, et al
    Evaluation of different p16 immunostaining methods and the prognostic role of p16/Ki-67 combined expression in non-muscle invasive bladder cancers.
    Pol J Pathol. 2015;66:57-66.
    Abstract     Related articles   

  544. POON SL, Huang MN, Choo Y, McPherson JR, et al
    Mutation signatures implicate aristolochic acid in bladder cancer development.
    Genome Med. 2015;7:38.
    Abstract     Related articles   

  545. DU M, Shi D, Yuan L, Li P, et al
    Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer.
    Sci Rep. 2015;5:10437.
    Abstract     Related articles   

  546. MOSCHINI M, Dell' Oglio P, Capogrosso P, Cucchiara V, et al
    Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution.
    Clin Genitourin Cancer. 2015 May 4. pii: S1558-7673(15)00093.
    Abstract     Related articles   

  547. HELENIUS M, Dahlman P, Lonnemark M, Brekkan E, et al
    Comparison of post contrast CT urography phases in bladder cancer detection.
    Eur Radiol. 2015.
    Abstract     Related articles   

  548. FUGE O, Vasdev N, Allchorne P, Green JS, et al
    Immunotherapy for bladder cancer.
    Res Rep Urol. 2015;7:65-79.
    Abstract     Related articles   

  549. AOUN F, El Rassy E, Kourie HR, Hawaux E, et al
    Vulvar metastasis from bladder cancer.
    Case Rep Obstet Gynecol. 2015;2015:324634.
    Abstract     Related articles   

  550. TAUBERT H, Wach S, Jung R, Pugia M, et al
    Piwil 2 expression is correlated with disease-specific and progression-free survival of chemotherapy-treated bladder cancer patients.
    Mol Med. 2015 May 13. doi: 10.2119/molmed.2014.00250.
    Abstract     Related articles   

  551. EARL J, Rico D, Carrillo-de-Santa-Pau E, Rodriguez-Santiago B, et al
    The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.
    BMC Genomics. 2015;16:403.
    Abstract     Related articles   

  552. KUZAKA B, Janiak M, Wlodarski KH, Radziszewski P, et al
    Expression of bone morphogenetic protein-2 and -7 in urinary bladder cancer predicts time to tumor recurrence.
    Arch Med Sci. 2015;11:378-84.
    Abstract     Related articles   

  553. CLAXTON LD
    The history, genotoxicity, and carcinogenicity of carbon-based fuels and their emissions. Part 3: diesel and gasoline.
    Mutat Res Rev Mutat Res. 2015;763:30-85.
    Abstract     Related articles   

  554. ERRICO A
    Immunotherapy: PD-1-PD-L1 axis: efficient checkpoint blockade against cancer.
    Nat Rev Clin Oncol. 2015;12:63.
    Abstract     Related articles   

  555. SEE WA
    Commentary on "Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle." Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenb
    Urol Oncol. 2014;32:1350.
    Abstract     Related articles   

  556. SEE WA
    Commentary on "Robot-assisted laparoscopic vs open radical cystectomy: Comparison of complications and perioperative oncological outcomes in 200 patients." Kader AK, Richards KA, Krane LS, Pettus JA, Smith JJ, Hemal AK, Division of Urology, UC San Die
    Urol Oncol. 2014;32:1348.
    Abstract     Related articles   

  557. KIM IK, Lee JY, Kwon JK, Park JJ, et al
    Prognostic factors for urachal cancer: a bayesian model-averaging approach.
    Korean J Urol. 2014;55:574-80.
    Abstract     Related articles   

  558. TARPLIN S, Osterberg EC, Robinson BD, Herman MP, et al
    Perivascular epithelioid cell tumour of the bladder.
    BMJ Case Rep. 2014;2014.
    Abstract     Related articles   

  559. ZHANG Y, Huang J, Feng H, Tang Y, et al
    Primary multiple clear cell variant urothelial carcinomas of urinary bladder: a rare case report.
    Int J Clin Exp Pathol. 2014;7:3385-8.
    Abstract     Related articles   

  560. CONTI SL, Honeycutt J, Odegaard JI, Gonzalgo ML, et al
    Alterations in DNA Methylation May Be the Key to Early Detection and Treatment of Schistosomal Bladder Cancer.
    PLoS Negl Trop Dis. 2015;9:e0003696.
    Abstract     Related articles   

  561. JAGER W, Xue H, Hayashi T, Janssen C, et al
    Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.
    Oncotarget. 2015.
    Abstract     Related articles   

  562. RAGER JE, Tilley SK, Tulenko SE, Smeester L, et al
    Identification of Novel Gene Targets and Putative Regulators of Arsenic-Associated DNA Methylation in Human Urothelial Cells and Bladder Cancer.
    Chem Res Toxicol. 2015.
    Abstract     Related articles   

  563. XU C, Zeng S, Zhang Z, Song R, et al
    Deceptive muscle invasive bladder cancer recurrence with benign biopsy foci after bladder sparing treatment.
    Medicine (Baltimore). 2015;94:e898.
    Abstract     Related articles   

  564. INAMOTO T, Taniguchi K, Takahara K, Iwatsuki A, et al
    Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft.
    Oncotarget. 2015.
    Abstract     Related articles   

  565. GOOSSENS ME, Zeegers MP, Bazelier MT, De Bruin ML, et al
    Risk of bladder cancer in patients with diabetes: a retrospective cohort study.
    BMJ Open. 2015;5:e007470.
    Abstract     Related articles   

  566. FRANTZI M, Latosinska A, Fluhe L, Hupe MC, et al
    Developing proteomic biomarkers for bladder cancer: towards clinical application.
    Nat Rev Urol. 2015 May 26. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  567. LEW CR, Guin S, Theodorescu D
    Targeting glycogen metabolism in bladder cancer.
    Nat Rev Urol. 2015 May 26. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   


  568. Bladder cancer: Dorsolateral peritoneal layer adaptation following PLND.
    Nat Rev Urol. 2015 May 26. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  569. CHENG C, Varn FS, Marsit CJ
    E2F4 Program is Predictive of Progression and Intravesical Immunotherapy Efficacy in Bladder Cancer.
    Mol Cancer Res. 2015 Jun 1. pii: molcanres.0120.2015.
    Abstract     Related articles   

  570. ZHANG GM, Zhu Y, Luo L, Wan FN, et al
    Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy.
    Tumour Biol. 2015.
    Abstract     Related articles   

  571. POLETAJEW S, Braticevici B, Brisuda A, Cauni V, et al
    Timing of radical cystectomy in Central Europe - multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients.
    Cent European J Urol. 2015;68:9-14.
    Abstract     Related articles   

  572. EKIN RG, Akarken I, Zorlu F, Tarhan H, et al
    Intravesical bacillus Calmette-Guerin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  573. NIWA N, Matsumoto K, Hayakawa N, Ito Y, et al
    Comparison of outcomes between ultrasonography and cystoscopy in the surveillance of patients with initially diagnosed TaG1-2 bladder cancers: A matched-pair analysis.
    Urol Oncol. 2015 May 28. pii: S1078-1439(15)00197.
    Abstract     Related articles   

  574. FANTONY JJ, Abern MR, Gopalakrishna A, Owusu R, et al
    Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer.
    Urol Oncol. 2015 May 28. pii: S1078-1439(15)00193.
    Abstract     Related articles   

  575. CHEN Q, Chong T, Yin J, Luo P, et al
    Molecular events are associated with resistance to vinblastine in bladder cancer.
    Cell Mol Biol (Noisy-le-grand). 2015;61:33-8.
    Abstract     Related articles   

  576. LAMMERS RJ, Hendriks JC, Rodriguez Faba OR, Witjes WP, et al
    Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation.
    World J Urol. 2015.
    Abstract     Related articles   

  577. MASSARI F, Santoni M, Ciccarese C, Brunelli M, et al
    Emerging concepts on drug resistance in bladder cancer: Implications for future strategies.
    Crit Rev Oncol Hematol. 2015 May 15. pii: S1040-8428(15)00094.
    Abstract     Related articles   

  578. LI HH, Rodriguez VL, Green OL, Hu Y, et al
    Patient-specific quality assurance for the delivery of (60)Co intensity modulated radiation therapy subject to a 0.35-T lateral magnetic field.
    Int J Radiat Oncol Biol Phys. 2015;91:65-72.
    Abstract     Related articles   

  579. SOGAARD KK, Farkas DK, Pedersen L, Weiss NS, et al
    Pneumonia and the incidence of cancer: a Danish nationwide cohort study.
    J Intern Med. 2015;277:429-38.
    Abstract     Related articles   

  580. LOU X, Zhuang Y, Zuo X, Jia Y, et al
    Real-time, Quantitative Lighting-up Detection of Telomerase in Urines of Bladder Cancer Patients by AIEgens.
    Anal Chem. 2015.
    Abstract     Related articles   

  581. COGOI S, Zorzet S, Shchekotikhin AE, Xodo LE, et al
    Potent Apoptotic Response Induced by Chloroacetamidine Anthrathiophenediones in Bladder Cancer Cells.
    J Med Chem. 2015.
    Abstract     Related articles   

  582. HORN T, Laus J, Seitz AK, Maurer T, et al
    The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  583. BOGGS DH, Guerrero M, Patel K, Chen S, et al
    Pelvic local recurrence in a patient with muscle-invasive bladder cancer treated with interstitial thermal therapy and interstitial brachytherapy.
    Pract Radiat Oncol. 2015 Jun 5. pii: S1879-8500(15)00149.
    Abstract     Related articles   

  584. LIN WC, Chen JH
    Pitfalls and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in the Diagnosis of Urinary Bladder Cancer.
    Transl Oncol. 2015;8:217-30.
    Abstract     Related articles   

  585. ISKENDER B, Izgi K, Karaca H, Canatan H, et al
    Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9.
    J Nat Med. 2015.
    Abstract     Related articles   

  586. SANGUEDOLCE F, Cormio A, Bufo P, Carrieri G, et al
    Molecular markers in bladder cancer: Novel research frontiers.
    Crit Rev Clin Lab Sci. 2015.
    Abstract     Related articles   

  587. PETRIOLI R, Roviello G, Fiaschi AI, Laera L, et al
    Carboplatin, methotrexate, vinblastine, and epirubicin (M-VECa) as salvage treatment in patients with advanced bladder cancer: a phase II study.
    Anticancer Drugs. 2015.
    Abstract     Related articles   

  588. AINE M, Eriksson P, Liedberg F, Sjodahl G, et al
    Biological determinants of bladder cancer gene expression subtypes.
    Sci Rep. 2015;5:10957.
    Abstract     Related articles   

  589. GAUTAM KA, Pooja S, Sankhwar SN, Sankhwar PL, et al
    c.29C>T polymorphism in the transforming growth factor-beta1 (TGFB1) gene correlates with increased risk of urinary bladder cancer.
    Cytokine. 2015 Jun 2. pii: S1043-4666(15)00203.
    Abstract     Related articles   

  590. YE Z, Hu J, Song X, Li F, et al
    A comparison of NBI and WLI cystoscopy in detecting non-muscle-invasive bladder cancer: A prospective, randomized and multi-center study.
    Sci Rep. 2015;5:10905.
    Abstract     Related articles   

  591. YEH CR, Hsu I, Song W, Chang H, et al
    Fibroblast ERalpha promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment.
    Am J Cancer Res. 2015;5:1146-57.
    Abstract     Related articles   

  592. TRINKLER F, Tuma J
    [Ultrasound diagnosis 63. Tumor of the bladder wall, partially necrotic (calcified)].
    Praxis (Bern 1994). 2015;104:431-3.
    Abstract     Related articles   

  593. JIA Z, Ai X, Sun F, Zang T, et al
    Identification of new hub genes associated with bladder carcinoma via bioinformatics analysis.
    Tumori. 2015;101:117-22.
    Abstract     Related articles   

  594. WU CT, Lin WY, Chang YH, Lin PY, et al
    DNMT1-dependent suppression of microRNA424 regulates tumor progression in human bladder cancer.
    Oncotarget. 2015.
    Abstract     Related articles   

  595. HUANG W, Chen Y, Liu Y, Zhang Q, et al
    Roles of ERbeta and GPR30 in Proliferative Response of Human Bladder Cancer Cell to Estrogen.
    Biomed Res Int. 2015;2015:251780.
    Abstract     Related articles   

  596. WALKER M, French SD, Feldman-Stewart D, Siemens DR, et al
    A call for theory-informed approaches to knowledge translation studies: an example of chemotherapy for bladder cancer.
    Curr Oncol. 2015;22:178-81.
    Abstract     Related articles   

  597. GUANCIAL EA, Roussel B, Bergsma DP, Bylund KC, et al
    Bladder cancer in the elderly patient: challenges and solutions.
    Clin Interv Aging. 2015;10:939-49.
    Abstract     Related articles   

  598. LIU Q, Zhang C, Ding X, Deng H, et al
    Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform.
    Sci Rep. 2015;5:11464.
    Abstract     Related articles   

  599. NOMURA S, Suzuki Y, Takahashi R, Terasaki M, et al
    Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy : DYRK2 is associated with survival in bladder cancer.
    BMC Urol. 2015;15:53.
    Abstract     Related articles   

  600. BOOTH BB, Rasmussen A, Jensen JB
    Evaluating sexual function in women after radical cystectomy as treatment for bladder cancer.
    Scand J Urol. 2015.
    Abstract     Related articles   

  601. CHUANG CH, Wu TF, Chen CH, Chang KC, et al
    Lab on a chip for multiplexed immunoassays to detect bladder cancer using multifunctional dielectrophoretic manipulations.
    Lab Chip. 2015.
    Abstract     Related articles   

  602. YUAN SY, Cheng CL, Ho HC, Wang SS, et al
    Nortriptyline induces mitochondria and death receptor-mediated apoptosis in bladder Cancer cells and inhibits bladder tumour growth in vivo.
    Eur J Pharmacol. 2015 Jun 15. pii: S0014-2999(15)30068.
    Abstract     Related articles   

  603. CHEN CL, Chung T, Wu CC, Ng KF, et al
    Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.
    Mol Cell Proteomics. 2015 Jun 16. pii: mcp.M115.051524.
    Abstract     Related articles   

  604. ZHU H, Yun F, Shi X, Wang D, et al
    Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin.
    Int J Mol Med. 2015 Jun 17. doi: 10.3892/ijmm.2015.2250.
    Abstract     Related articles   

  605. SHIM JS, Choi H, Noh TI, Tae JH, et al
    The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study.
    Korean J Urol. 2015;56:429-34.
    Abstract     Related articles   

  606. MA H, Zhang X, Li X, Li R, et al
    Electrochemical immunosensor for detecting typical bladder cancer biomarker based on reduced graphene oxide-tetraethylene pentamine and trimetallic AuPdPt nanoparticles.
    Talanta. 2015;143:77-82.
    Abstract     Related articles   

  607. HUPE MC, Kramer MW, Kuczyk MA, Merseburger AS, et al
    [Neoadjuvant or Adjuvant Chemotherapy for Bladder Cancer?].
    Aktuelle Urol. 2015;46:242-7.
    Abstract     Related articles   

  608. MAYR R, Pycha A
    [Influence of Comorbidity on Mortality and Morbidity in the Radical Cystectomy for Bladder Cancer].
    Aktuelle Urol. 2015;46:236-41.
    Abstract     Related articles   

  609. ERBEN P, Hartmann A, Bolenz C
    [Molecular Characterisation of Urothelial Bladder Cancer: Will it Improve Patient Care?].
    Aktuelle Urol. 2015;46:227-35.
    Abstract     Related articles   

  610. HARA T, Matsuyama H, Kamiryo Y, Hayashida S, et al
    Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged >/=75 years after radical cystectomy for treatment of bladder cancer.
    Int J Clin Oncol. 2015.
    Abstract     Related articles   

  611. POMMIER JD, Ben Lasfar N, Van Grunderbeeck N, Burdet C, et al
    Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
    Infect Dis (Lond). 2015.
    Abstract     Related articles   

  612. CHATTA D, Cottrell L, Burnett B, Laverty G, et al
    The use of water-soluble mucoadhesive gels for the intravesical delivery of epirubicin to the bladder for the treatment of non-muscle-invasive bladder cancer.
    J Pharm Pharmacol. 2015 Jun 16. doi: 10.1111/jphp.12441.
    Abstract     Related articles   

  613. KIM YW, Yoon HY, Seo SP, Lee SK, et al
    Clinical Implications and Prognostic Values of Prostate Cancer Susceptibility Candidate Methylation in Primary Nonmuscle Invasive Bladder Cancer.
    Dis Markers. 2015;2015:402963.
    Abstract     Related articles   

  614. CHEN CL, Liu CY, Cha TL, Hsu CY, et al
    Does radical cystectomy outperform other bladder preservative treatments in elderly patients with advanced bladder cancer?
    J Chin Med Assoc. 2015 Jun 11. pii: S1726-4901(15)00119.
    Abstract     Related articles   

  615. WANG G, Lam KM, Deng Z, Choi KS, et al
    Prediction of mortality after radical cystectomy for bladder cancer by machine learning techniques.
    Comput Biol Med. 2015;63:124-132.
    Abstract     Related articles   

  616. DU Y, Wang Y, Zhang F, Wu W, et al
    Regulation of metastasis of bladder cancer cells through the WNT signaling pathway.
    Tumour Biol. 2015.
    Abstract     Related articles   

  617. CODOLO G, Munari F, Fassan M, de Bernard M, et al
    Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model.
    J Vis Exp. 2015;.
    Abstract     Related articles   

  618. WAN GX, Chen P, Yu XJ, Di QS, et al
    Cyclooxygenase-2 polymorphisms and bladder cancer risk: a meta-analysis based on case-control studies.
    Int J Clin Exp Med. 2015;8:3935-45.
    Abstract     Related articles   

  619. GUO B, Che T, Shi B, Guo L, et al
    Interaction network analysis of differentially expressed genes and screening of cancer marker in the urine of patients with invasive bladder cancer.
    Int J Clin Exp Med. 2015;8:3619-28.
    Abstract     Related articles   

  620. KHMELEVSKY EV, Bychkova NM
    [Radiosensitivity of bone metastases from tumors in different primary sites].
    Vopr Onkol. 2015;61:77-84.
    Abstract     Related articles   

  621. CHA EK, Donahue TF, Bochner BH
    Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?
    Urol Clin North Am. 2015;42:189-99.
    Abstract     Related articles   

  622. WEN J, Li HZ, Ji ZG, Jin J, et al
    Effects of sunitinib malate on growth of human bladder transitional cell line T24 in vitro.
    Chin Med Sci J. 2015;30:51-5.
    Abstract     Related articles   

  623. SERONT E, Machiels JP
    Molecular biology and targeted therapies for urothelial carcinoma.
    Cancer Treat Rev. 2015;41:341-53.
    Abstract     Related articles   

  624. BARABAS-HAJDU E, Maier A, Coros F, Martha O, et al
    Retrovesical hydatidosis associated with urinary tract pathology - case report.
    Acta Microbiol Immunol Hung. 2015;62:21-7.
    Abstract     Related articles   

  625. WANG HJ, Pui MH, Guo Y, Li SR, et al
    Multiparametric 3-T MRI for Differentiating Low-Versus High-Grade and Category T1 Versus T2 Bladder Urothelial Carcinoma.
    AJR Am J Roentgenol. 2015;204:330-334.
    Abstract     Related articles   

  626. MATSUMOTO R, Takada N, Abe T, Minami K, et al
    Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis.
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  627. TIAN YF, Tang K, Guan W, Yang T, et al
    OK-432 Suppresses Proliferation and Metastasis by Tumor Associated Macrophages in Bladder Cancer.
    Asian Pac J Cancer Prev. 2015;16:4537-42.
    Abstract     Related articles   

  628. GARCIA-CUESTA EM, Lopez-Cobo S, Alvarez-Maestro M, Esteso G, et al
    NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation.
    Front Immunol. 2015;6:284.
    Abstract     Related articles   

  629. EISSA S, Matboli M, Shawky S, Essawy NO, et al
    Urine biomarkers of schistosomiais and its associated bladder cancer.
    Expert Rev Anti Infect Ther. 2015.
    Abstract     Related articles   

  630. CHOUDHURY A
    Molecular Biomarkers in Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2015;92:705-6.
    Abstract     Related articles   

  631. SOUSA A, Pineiro I, Aparici V, Neira P, et al
    Analysis of Budgetary Impact of moderate and high risk non muscle-invasive bladder cancer by means of neoadjuvant hyperthermia chemotherapy compared to the standard adjuvant treatment with BCG.
    Arch Esp Urol. 2015;68:482-492.
    Abstract     Related articles   

  632. KATO T, Nomura K, Kondo F, Wakisaka M, et al
    Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer.
    ScientificWorldJournal. 2015;2015:325305.
    Abstract     Related articles   

  633. MANI J, Antonietti P, Rakel S, Blaheta R, et al
    Knockdown of BAG3 sensitizes bladder cancer cells to treatment with the BH3 mimetic ABT-737.
    World J Urol. 2015.
    Abstract     Related articles   

  634. HOLLENBECK B
    Commentary on "Racial variation in the quality of surgical care for bladder cancer." Barocas DA, Alvarez J, Koyama T, Anderson CB, Gray DT, Fowke JH, You C, Chang SS, Cookson MS, Smith JA Jr, Penson DF, Department of Urologic Surgery, Vanderbilt Unive
    Urol Oncol. 2015 Jun 19. pii: S1078-1439(15)00223.
    Abstract     Related articles   

  635. RYBOTYCKA Z, Dlugosz A
    [Diagnostic significance of protein NMP22 in bladder cancer].
    Pol Merkur Lekarski. 2015;38:309-14.
    Abstract     Related articles   

  636. MAZZOLA CR, Chin J
    Targeting the VEGF pathway in metastatic bladder cancer.
    Expert Opin Investig Drugs. 2015;24:913-27.
    Abstract     Related articles   

  637. AMANTINI C, Morelli MB, Santoni M, Soriani A, et al
    Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.
    Oncoscience. 2015;2:395-409.
    Abstract     Related articles   

  638. LUTKENHAUS LJ, Visser J, de Jong R, Hulshof MC, et al
    Evaluation of delivered dose for a clinical daily adaptive plan selection strategy for bladder cancer radiotherapy.
    Radiother Oncol. 2015 Jun 18. pii: S0167-8140(15)00282.
    Abstract     Related articles   

  639. SHEVCHENKO AN, Shihjarova AI, Filatova EV, Tarnopol'skaja OV, et al
    [MODIFIED INTRAVESICAL CHEMOTHERAPY OF BLADDER CANCER].
    Urologiia. 2015;:54-7.
    Abstract     Related articles   

  640. KAYNAR M, Goktas S
    Neutrophil-to-lymphocyte ratio predicts progression and recurrence of non-muscle-invasive bladder cancer.
    Urol Oncol. 2015 Jun 16. pii: S1078-1439(15)00241.
    Abstract     Related articles   

  641. HE YD, Luo ZH, Yang M, Ruan XX, et al
    Prospective validation of DACH2 as a novel biomarker for prediction of metastasis and prognosis in muscle-invasive urothelial carcinoma of the bladder.
    Biochem Biophys Res Commun. 2015;459:416-23.
    Abstract     Related articles   

  642. TANG Y, Zhang X, Qi F, Chen M, et al
    Afatinib inhibits proliferation and invasion and promotes apoptosis of the T24 bladder cancer cell line.
    Exp Ther Med. 2015;9:1851-1856.
    Abstract     Related articles   

  643. TABATA M, Ikeda M, Urakami S, Takahashi S, et al
    Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy.
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  644. WANG X, Wu G, Cao G, Yang L, et al
    Zoledronic acid inhibits the pentose phosphate pathway through attenuating the RasTAp73G6PD axis in bladder cancer cells.
    Mol Med Rep. 2015 Jun 24. doi: 10.3892/mmr.2015.3995.
    Abstract     Related articles   

  645. DANCIK GM
    An online tool for evaluating diagnostic and prognostic gene expression biomarkers in bladder cancer.
    BMC Urol. 2015;15:59.
    Abstract     Related articles   

  646. KIM WJ
    Is 5 -AMP-Activated Protein Kinase Both Jekyll and Hyde in Bladder Cancer?
    Int Neurourol J. 2015;19:55-66.
    Abstract     Related articles   

  647. SHI H, Jiang H, Wang L, Cao Y, et al
    Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device.
    Cell Cycle. 2015.
    Abstract     Related articles   

  648. RUDZINSKI JK, Basappa NS, North S
    Perioperative chemotherapy for muscle invasive bladder cancer.
    Curr Opin Support Palliat Care. 2015.
    Abstract     Related articles   

  649. XIAO X, Ma G, Li S, Wang M, et al
    Functional POR A503V is associated with the risk of bladder cancer in a Chinese population.
    Sci Rep. 2015;5:11751.
    Abstract     Related articles   

  650. ROSE TL, Deal AM, Basch E, Godley PA, et al
    Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings.
    Urol Oncol. 2015 Jun 26. pii: S1078-1439(15)00272.
    Abstract     Related articles   

  651. CHEN GF, Shi TP, Wang BJ, Wang XY, et al
    EFFICACY OF DIFFERENT RESECTIONS ON NON-MUSCLE-INVASIVE BLADDER CANCER AND ANALYSIS OF THE OPTIMAL SURGICAL METHOD.
    J Biol Regul Homeost Agents. 2015;29:465-70.
    Abstract     Related articles   

  652. MORICEAU G, Vallard A, Rivoirard R, Mery B, et al
    Real-World Vinflunine Outcomes in Bladder Cancer in a Single-Institution Study: Moving Beyond Clinical Trials.
    Clin Genitourin Cancer. 2015 Jun 6. pii: S1558-7673(15)00122.
    Abstract     Related articles   

  653. LEO E, Molinari AL, Rossi G, Ferrari SA, et al
    Mycotic abdominal aortic aneurysm following adjuvant therapy with bacillus Calmette-Guerin (BCG) in patients with urothelial bladder cancer. A rare but misinterpreted complication.
    Ann Vasc Surg. 2015 Jun 23. pii: S0890-5096(15)00396.
    Abstract     Related articles   

  654. AHMED M, Kanji A, Begum T
    Gynaecomastia: an unusual presenting symptom of bladder cancer.
    BMJ Case Rep. 2015;2015.
    Abstract     Related articles   

  655. KUMAR A
    A retained catheter in the radial artery.
    J Perioper Pract. 2015;25:39.
    Abstract     Related articles   

  656. MILOSEVIC R, Milovic N, Aleksic P, Lazic M, et al
    Difference in recurrence frequencies of non-muscle-invasive-bladder tumors depending on optimal usage of intravesical immunotherapy of bacillus Calmette-Guerin.
    Vojnosanit Pregl. 2015;72:241-6.
    Abstract     Related articles   

  657. BANCEVIC V, Aleksic P, Milovic N, Spasic A, et al
    Radical cystectomy in eldery.
    Vojnosanit Pregl. 2015;72:136-9.
    Abstract     Related articles   

  658. DE SOUZA D, Mariano DO, Nedel F, Schultze E, et al
    New organochalcogen multitarget drug: synthesis and antioxidant and antitumoral activities of chalcogenozidovudine derivatives.
    J Med Chem. 2015;58:3329-39.
    Abstract     Related articles   

  659. OJERHOLM E, Stripp D, Mamtani R, Van Arsdalen K, et al
    Angiosarcoma of the bladder following prostate radiotherapy.
    Am J Med. 2015;128:e11-2.
    Abstract     Related articles   

  660. WANG H, Zhang W, Zuo Y, Ding M, et al
    miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   


  661. Bladder cancer: Metformin reduces recurrence after radical cystectomy.
    Nat Rev Urol. 2015 Jul 7. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  662. SABBINENI H, Alwhaibi A, Goc A, Gao F, et al
    Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion.
    Eur J Pharmacol. 2015 Jul 3. pii: S0014-2999(15)30124.
    Abstract     Related articles   

  663. JEONG JW, Lee WS, Go SI, Nagappan A, et al
    Pachymic Acid Induces Apoptosis of EJ Bladder Cancer Cells by DR5 Up-Regulation, ROS Generation, Modulation of Bcl-2 and IAP Family Members.
    Phytother Res. 2015 Jul 7. doi: 10.1002/ptr.5402.
    Abstract     Related articles   

  664. EAPEN L
    A review of the 2014 English Language publications pertinent to the treatment of invasive bladder cancer by radiotherapy.
    Curr Opin Support Palliat Care. 2015.
    Abstract     Related articles   

  665. SHERIF A, Hasan MN, Radecka E, Rodriguez AL, et al
    Pilot study of adoptive immunotherapy with sentinel node-derived T cells in muscle-invasive urinary bladder cancer.
    Scand J Urol. 2015.
    Abstract     Related articles   

  666. LI C, Wu S, Wang H, Bi X, et al
    The C228T mutation of TERT promoter frequently occurs in bladder cancer stem cells and contributes to tumorigenesis of bladder cancer.
    Oncotarget. 2015.
    Abstract     Related articles   

  667. EISSA S, Matboli M, Essawy NO, Kotb YM, et al
    Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
    Tumour Biol. 2015.
    Abstract     Related articles   

  668. GUO LS, Li HX, Li CY, Zhang SY, et al
    Vitamin D3 enhances antitumor activity of metformin in human bladder carcinoma SW-780 cells.
    Pharmazie. 2015;70:123-8.
    Abstract     Related articles   

  669. KANG M, Jeong CW, Kwak C, Kim HH, et al
    The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
    Yonsei Med J. 2015;56:375-81.
    Abstract     Related articles   

  670. SCHULZ WA, Koutsogiannouli EA, Niegisch G, Hoffmann MJ, et al
    Epigenetics of urothelial carcinoma.
    Methods Mol Biol. 2015;1238:183-215.
    Abstract     Related articles   

  671. MOORE JH
    Epistasis analysis using ReliefF.
    Methods Mol Biol. 2015;1253:315-25.
    Abstract     Related articles   

  672. MOORE JH, Andrews PC
    Epistasis analysis using multifactor dimensionality reduction.
    Methods Mol Biol. 2015;1253:301-14.
    Abstract     Related articles   

  673. MOORE JH, Hu T
    Epistasis analysis using information theory.
    Methods Mol Biol. 2015;1253:257-68.
    Abstract     Related articles   

  674. KIM HS, Piao S, Moon KC, Jeong CW, et al
    Adjuvant Chemotherapy Correlates with Improved Survival after Radical Cystectomy in Patients with pT3b (Macroscopic Perivesical Tissue Invasion) Bladder Cancer.
    J Cancer. 2015;6:750-758.
    Abstract     Related articles   

  675. YUGE K, Kikuchi E, Hagiwara M, Yasumizu Y, et al
    Nicotine induces tumor growth and chemoresistance through activation of PI3K/Akt/mTOR pathway in bladder cancer.
    Mol Cancer Ther. 2015 Jul 16. pii: molcanther.0140.2015.
    Abstract     Related articles   

  676. VAN DE PUTTE EE, Mertens LS, Meijer RP, van der Heijden MS, et al
    Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin.
    World J Urol. 2015.
    Abstract     Related articles   

  677. MORALES A, Kamat A, Steinberg G, Given R, et al
    Re: Herr et al.: BCG-refractory vs. BCG-relapsing non-muscle-invasive bladder cancer: A prospective cohort outcomes study (Urol Oncol 2015; 33: 108.el-108.e4).
    Urol Oncol. 2015;33:335-336.
    Abstract     Related articles   

  678. BOOTH CM, Tannock IF
    Benefits of Adjuvant Chemotherapy for Bladder Cancer.
    JAMA Oncol. 2015 Jun 25. doi: 10.1001/jamaoncol.2015.1210.
    Abstract     Related articles   

  679. MIN X, Zhuang Y, Zhang Z, Jia Y, et al
    Lab in a Tube: Sensitive Detection of MicroRNAs in Urine Samples from Bladder Cancer Patients Using a Single-label DNA Probe with AIEgens.
    ACS Appl Mater Interfaces. 2015.
    Abstract     Related articles   

  680. VASEKAR M, Degraff D, Joshi M
    Immunotherapy in Bladder Cancer.
    Curr Mol Pharmacol. 2015.
    Abstract     Related articles   

  681. KONAC E, Varol N, Kiliccioglu I, Bilen CY, et al
    Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells.
    Oncol Lett. 2015;10:560-564.
    Abstract     Related articles   

  682. AI X, Jia ZM, Wang J, DI GP, et al
    Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms.
    Oncol Lett. 2015;10:543-549.
    Abstract     Related articles   

  683. LAN G, Yang L, Xie X, Peng L, et al
    MicroRNA-490-5p is a novel tumor suppressor targeting c-FOS in human bladder cancer.
    Arch Med Sci. 2015;11:561-9.
    Abstract     Related articles   

  684. LIU Y, Baker S, Jiang H, Stuart G, et al
    Correlating Bladder Cancer Risk Genes with Their Targeting MicroRNAs Using MMiRNA-Tar.
    Genomics Proteomics Bioinformatics. 2015 Jul 10. pii: S1672-0229(15)00052.
    Abstract     Related articles   

  685. BOTELHO MC, Figueiredo J, Alves H
    Bladder cancer and urinary Schistosomiasis in Angola.
    J Nephrol Res. 2015;1:22-24.
    Abstract     Related articles   

  686. LISS MA, Noguchi J, Lee HJ, Vera DR, et al
    Sentinel lymph node biopsy in bladder cancer: Systematic review and technology update.
    Indian J Urol. 2015;31:170-5.
    Abstract     Related articles   

  687. LI S, Yu Z, Chen SS, Li F, et al
    The YAP1 oncogene contributes to bladder cancer cell proliferation and migration by regulating the H19 long noncoding RNA.
    Urol Oncol. 2015 Jul 8. pii: S1078-1439(15)00291.
    Abstract     Related articles   

  688. FAMULARO G, Stasolla A, Gasbarrone L
    Pachydermoperiostosis and bladder cancer.
    Dermatol Online J. 2015;21.
    Abstract     Related articles   

  689. SHUKLA HS, Sirohi B, Behari A, Sharma A, et al
    Indian Council of Medical Research consensus document for the management of gall bladder cancer.
    Indian J Med Paediatr Oncol. 2015;36:79-84.
    Abstract     Related articles   

  690. YANG X, Ou L, Tang M, Wang Y, et al
    Knockdown of PLCepsilon inhibits inflammatory cytokine release via STAT3 phosphorylation in human bladder cancer cells.
    Tumour Biol. 2015.
    Abstract     Related articles   

  691. OUYANG Q, Duan Z, Jiao G, Lei J, et al
    A Biomimic Reconstituted High-Density-Lipoprotein-Based Drug and p53 Gene Co-delivery System for Effective Antiangiogenesis Therapy of Bladder Cancer.
    Nanoscale Res Lett. 2015;10:965.
    Abstract     Related articles   

  692. ZHUANG J, Lu Q, Shen B, Huang X, et al
    TGFbeta1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT.
    Sci Rep. 2015;5:11924.
    Abstract     Related articles   

  693. KAO HL, Lai CR, Ho HL, Pan CC, et al
    Molecular Typing for Detection of High-Risk HPV is a Useful Tool to Distinguish Primary Bladder Cancer from Secondary Involvement of Uterine Cervical Cancer in the Urinary Bladder.
    Histopathology. 2015 Jul 7. doi: 10.1111/his.12769.
    Abstract     Related articles   

  694. KESSLER ER, Amini A, Wilson SS, Anp-C KB, et al
    Lymphoepithelioma-Like Carcinoma of the Urinary Bladder.
    Oncology (Williston Park). 2015;29:462.
    Abstract     Related articles   

  695. SOLOMON JP, Hansel DE
    Prognostic factors in urothelial carcinoma of the bladder: histologic and molecular correlates.
    Adv Anat Pathol. 2015;22:102-12.
    Abstract     Related articles   

  696. MAGRATH GN, Proctor CM, Reardon WA, Patel KG, et al
    Esophageal adenocarcinoma and urothelial carcinoma orbital metastases masquerading as infection.
    Orbit. 2015;34:51-5.
    Abstract     Related articles   

  697. SAWICKA E, Lisowska A, Kowal P, Dlugosz A, et al
    The role of oxidative stress in bladder cancer.
    Postepy Hig Med Dosw (Online). 2015;69:744-52.
    Abstract     Related articles   

  698. HADJIISKI L, Weizer AZ, Alva A, Caoili EM, et al
    Treatment Response Assessment for Bladder Cancer on CT Based on Computerized Volume Analysis, World Health Organization Criteria, and RECIST.
    AJR Am J Roentgenol. 2015;205:348-52.
    Abstract     Related articles   

  699. JANCKE G, Rosell J, Jahnson S
    Tumour location adjacent to the ureteric orifice in primary Ta/T1 bladder cancer is predictive of recurrence.
    Scand J Urol. 2015.
    Abstract     Related articles   

  700. WISE J
    No strong association is found between pioglitazone and bladder cancer.
    BMJ. 2015;351:h3934.
    Abstract     Related articles   

  701. IZARD JP, Siemens DR, Mackillop WJ, Wei X, et al
    Outcomes of squamous histology in bladder cancer: A population-based study.
    Urol Oncol. 2015 Jul 18. pii: S1078-1439(15)00299.
    Abstract     Related articles   

  702. SIEMENS DR, Mackillop WJ, Peng Y, Wei X, et al
    Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: A population-based study.
    Urol Oncol. 2015 Jul 18. pii: S1078-1439(15)00293.
    Abstract     Related articles   

  703. KONSTANTAKOU EG, Voutsinas GE, Velentzas AD, Basogianni AS, et al
    3-BrPA eliminates human bladder cancer cells with highly oncogenic signatures via engagement of specific death programs and perturbation of multiple signaling and metabolic determinants.
    Mol Cancer. 2015;14:135.
    Abstract     Related articles   

  704. LIU C, Chen Z, Fang J, Xu A, et al
    H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation.
    Tumour Biol. 2015.
    Abstract     Related articles   

  705. TIAN F, Xing X, Xu F, Cheng W, et al
    Downregulation of SKA1 Gene Expression Inhibits Cell Growth in Human Bladder Cancer.
    Cancer Biother Radiopharm. 2015.
    Abstract     Related articles   

  706. LEWIS JD, Habel LA, Quesenberry CP, Strom BL, et al
    Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.
    JAMA. 2015;314:265-77.
    Abstract     Related articles   

  707. WIECZOREK E, Jablonowski Z, Tomasik B, Konecki T, et al
    MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer.
    Clin Biochem. 2015 Jul 18. pii: S0009-9120(15)00301.
    Abstract     Related articles   

  708. AZEVEDO R, Ferreira JA, Peixoto A, Neves M, et al
    Emerging antibody-based therapeutic strategies for bladder cancer: A systematic review.
    J Control Release. 2015 Jul 18. pii: S0168-3659(15)30016.
    Abstract     Related articles   

  709. STONE L
    Bladder cancer: Cancer cell sampling and storage-new filtration device aids collection from urine.
    Nat Rev Urol. 2015 Jul 21. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  710. ZHANG MN, Ding Z, Long YT
    Sensing cisplatin-induced permeation of single live human bladder cancer cells by scanning electrochemical microscopy.
    Analyst. 2015.
    Abstract     Related articles   

  711. DU HF, Ou LP, Lv CK, Yang X, et al
    Expression of hepaCAM inhibits bladder cancer cell proliferation via a Wnt/beta-catenin -dependent pathway in vitro and in vivo.
    Cancer Biol Ther. 2015.
    Abstract     Related articles   

  712. MILOWICH D, Le Mercier M, De Neve N, Sandras F, et al
    Diagnostic value of the UCA1 test for bladder cancer detection: a clinical study.
    Springerplus. 2015;4:349.
    Abstract     Related articles   

  713. TANG K, Wang C, Chen Z, Xu H, et al
    Clinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.
    Int J Clin Exp Pathol. 2015;8:4999-5007.
    Abstract     Related articles   

  714. GARCIA PV, Apolinario LM, Bockelmann PK, Nunes Ida S, et al
    Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer.
    Int J Clin Exp Pathol. 2015;8:4427-43.
    Abstract     Related articles   

  715. MILOJEVIC B, Dzamic Z, Kajmakovic B, Milenkovic Petronic D, et al
    Urothelial carcinoma: Recurrence and risk factors.
    J BUON. 2015;20:391-8.
    Abstract     Related articles   

  716. BOSMAN FT
    In this issue.
    Virchows Arch. 2015;466:483.
    Abstract     Related articles   

  717. MATA DA, Groshen S, Von Rundstedt FC, Skinner DG, et al
    Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.
    J Surg Oncol. 2015;111:923-8.
    Abstract     Related articles   

  718. DELL'ATTI L
    Relevance of prostate cancer in patients with synchronous invasive bladder urothelial carcinoma: a monocentric retrospective analysis.
    Arch Ital Urol Androl. 2015;87:76-9.
    Abstract     Related articles   

  719. FONSEKA T, Ahmed K, Froghi S, Khan SA, et al
    Comparing robotic, laparoscopic and open cystectomy: a systematic review and meta-analysis.
    Arch Ital Urol Androl. 2015;87:41-8.
    Abstract     Related articles   

  720. ZAKARIA AS, Santos F, Tanguay S, Kassouf W, et al
    Radical cystectomy in patients over 80 years old in Quebec: A population-based study of outcomes.
    J Surg Oncol. 2015;111:917-22.
    Abstract     Related articles   

  721. DI CARLO D, Ferrari A, Perruccio K, D'Angelo P, et al
    Management and follow-up of urothelial neoplasms of the bladder in children: a report from the TREP project.
    Pediatr Blood Cancer. 2015;62:1000-3.
    Abstract     Related articles   

  722. WARRICK JI, Hovelson DH, Amin A, Liu CJ, et al
    Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma.
    Virchows Arch. 2015;466:297-311.
    Abstract     Related articles   

  723. SINGH PK, Srivastava AK, Dalela D, Rath SK, et al
    Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.
    Immunobiology. 2015;220:68-73.
    Abstract     Related articles   

  724. SINGH PK, Srivastava AK, Rath SK, Dalela D, et al
    Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma.
    Immunobiology. 2015;220:103-8.
    Abstract     Related articles   

  725. ZHANG Z, Zhang C, Wu C, Yang B, et al
    Progressive ureteral dilations and retrograde placement of single-j stent guided by flexible cystoscope for management of ureteroenteral anastomotic stricture in patients after radical cystectomy and bricker urinary diversion.
    J Endourol. 2015;29:90-4.
    Abstract     Related articles   

  726. MAKAMBI KH, Seung H
    A non-iterative extension of the multivariate random effects meta-analysis.
    J Biopharm Stat. 2015;25:109-23.
    Abstract     Related articles   

  727. DE CASTRO ABREU AL, Azhar RA, Berger AK, Chopra S, et al
    Robotic implantation of biodegradable regenerative urinary conduit: experimental study.
    J Endourol. 2015;29:52-7.
    Abstract     Related articles   

  728. STOKKEVAG CH, Engeseth GM, Hysing LB, Ytre-Hauge KS, et al
    Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer.
    Acta Oncol. 2015.
    Abstract     Related articles   

  729. LEI M, Xie W, Sun E, Sun Y, et al
    microRNA-21 Regulates Cell Proliferation and Migration and Cross Talk with PTEN and p53 in Bladder Cancer.
    DNA Cell Biol. 2015.
    Abstract     Related articles   

  730. LOMBARD AP, Mudryj M
    The emerging role of the androgen receptor in bladder cancer.
    Endocr Relat Cancer. 2015 Jul 30. pii: ERC-15-0209.
    Abstract     Related articles   

  731. DE PAOLI M, Perco P, Muhlberger I, Lukas A, et al
    Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic.
    Biomarkers. 2015.
    Abstract     Related articles   

  732. NAKAI Y, Tatsumi Y, Miyake M, Anai S, et al
    Expression of ferrochelatase has a strong correlation in protoporphyrin IX accumulation with photodynamic detection of bladder cancer.
    Photodiagnosis Photodyn Ther. 2015 Jul 27. pii: S1572-1000(15)30012.
    Abstract     Related articles   

  733. KAPOOR VK
    Is gall bladder cancer a bad cancer per se?
    World J Gastrointest Surg. 2015;7:107-9.
    Abstract     Related articles   

  734. SUN E, Zhang W, Wang L, Wang A, et al
    Down-regulation of Sphk2 suppresses bladder cancer progression.
    Tumour Biol. 2015.
    Abstract     Related articles   

  735. ALIRAMAJI A, Kaseean A, Yousefnia Pasha YR, Shafi H, et al
    Age distribution types of bladder cancers and their relationship with opium consumption and smoking.
    Caspian J Intern Med. 2015;6:82-6.
    Abstract     Related articles   

  736. COMPLOJ E, Trenti E, Palermo S, Pycha A, et al
    Urinary cytology in bladder cancer: why is it still relevant?
    Urologia. 2015;0:0.
    Abstract     Related articles   

  737. KRPINA K, Babarovic E, Jonjic N
    Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma.
    Virchows Arch. 2015.
    Abstract     Related articles   

  738. XIE XF, Ding Q, Hou JG, Chen G, et al
    Inhibitory effects of a dendritic cell vaccine loaded with radiation-induced apoptotic tumor cells on tumor cell antigens in mouse bladder cancer.
    Genet Mol Res. 2015;14:7548-55.
    Abstract     Related articles   

  739. FU X, Pang X, Qi H, Chen S, et al
    XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro.
    Clin Transl Oncol. 2015.
    Abstract     Related articles   

  740. OZTURK H
    Comparing RECIST with EORTC criteria in metastatic bladder cancer.
    J Cancer Res Clin Oncol. 2015.
    Abstract     Related articles   

  741. PACELLA E, Ricci F, Colecchia M, Boccardo F, et al
    Prostatic and urothelial metastasis in the same lymph node: a case report.
    Anal Quant Cytopathol Histpathol. 2015;37:139-43.
    Abstract     Related articles   

  742. BRACARDA S, Altavilla A, Hamzaj A, Sisani M, et al
    Immunologic checkpoints blockade in renal cell, prostate, and urothelial malignancies.
    Semin Oncol. 2015;42:495-505.
    Abstract     Related articles   

  743. PAPADOPOULOS EI, Yousef GM, Scorilas A
    Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes.
    Tumour Biol. 2015;36:3197-207.
    Abstract     Related articles   

  744. LI X, Liu S, Yao S, Wang M, et al
    A Rare Case of Urachal Mucinous Adenocarcinoma Detected by 18F-FDG PET/CT.
    Clin Nucl Med. 2015.
    Abstract     Related articles   

  745. ZAGOURI F, Peroukidis S, Tzannis K, Kouloulias V, et al
    Current clinical practice guidelines on chemotherapy and radiotherapy for the treatment of non-metastatic muscle-invasive urothelial cancer: a systematic review and critical evaluation by the Hellenic Genito-Urinary Cancer Group (HGUCG).
    Crit Rev Oncol Hematol. 2015;93:36-49.
    Abstract     Related articles   

  746. GRONBORG C, Vestergaard A, Hoyer M, Sohn M, et al
    Intra-fractional bladder motion and margins in adaptive radiotherapy for urinary bladder cancer.
    Acta Oncol. 2015.
    Abstract     Related articles   

  747. POYET C, Buser L, Roudnicky F, Detmar M, et al
    Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer.
    J Clin Pathol. 2015 Aug 6. pii: jclinpath-2015-202898.
    Abstract     Related articles   

  748. JEONG P, Ha YS, Yun SJ, Yoon HY, et al
    Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis.
    BMC Urol. 2015;15:80.
    Abstract     Related articles   

  749. MASIOR L, Krasnodebski M, Kobryn K, Grat M, et al
    Surgical treatment of gall-bladder cancer.
    Pol Przegl Chir. 2015;87:324-30.
    Abstract     Related articles   

  750. KIM GY, Park SY, Jo A, Kim M, et al
    Gecko proteins induce the apoptosis of bladder cancer 5637 cell by inhibiting Akt and activating intrinsic caspase cascade.
    BMB Rep. 2015 Aug 7. pii: 3261.
    Abstract     Related articles   

  751. PANG X, Fu X, Chen S, Zhu X, et al
    Overexpression of CIP2A promotes bladder cancer progression by regulating EMT.
    Clin Transl Oncol. 2015.
    Abstract     Related articles   

  752. NOSOV AK, Reva SA, Dzhalilov IB, Petrov SB, et al
    [LAPAROSCOPIC AND OPEN RADICAL CYSTECTOMY FOR BLADDER CANCER].
    Vopr Onkol. 2015;61:352-61.
    Abstract     Related articles   

  753. BENOIT T, Keller EX, Wolfsgruber P, Hermanns T, et al
    High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer.
    Med Sci Monit. 2015;21:2266-74.
    Abstract     Related articles   

  754. KIM SH, Seo HK, Shin HC, Chang SJ, et al
    Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea.
    J Korean Med Sci. 2015;30:1150-6.
    Abstract     Related articles   

  755. CHEN Z, Li Q, Wang S, Zhang J, et al
    miR4855p inhibits bladder cancer metastasis by targeting HMGA2.
    Int J Mol Med. 2015 Aug 3. doi: 10.3892/ijmm.2015.2302.
    Abstract     Related articles   

  756. HUANG J, Wu Z, Wang G, Cai Y, et al
    NMyc downstreamregulated gene 2 suppresses the proliferation of T24 human bladder cancer cells via induction of oncosis.
    Mol Med Rep. 2015 Aug 3. doi: 10.3892/mmr.2015.4169.
    Abstract     Related articles   

  757. SANTOS F, Dragomir A, Zakaria AS, Kassouf W, et al
    Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada.
    BMC Health Serv Res. 2015;15:308.
    Abstract     Related articles   

  758. WANG S, Qi X, Liu F, Zheng M, et al
    An improved technique for bladder cancer: Pure laparoscopic radical cystectomy with orthotopic U-shape ileal neobladder using titanium staples.
    Eur J Surg Oncol. 2015 Jul 26. pii: S0748-7983(15)00524.
    Abstract     Related articles   

  759. ZUBKOV AJ, Sitdykov JN, Nuriev LR, Sitdykova MJ, et al
    [INTRAOPERATIVE CONTROL OF THE EFFECTIVENESS OF TRANSURETHRAL RESECTION OF NON-MUSCLE-INVASIVE BLADDER CANCER].
    Urologiia. 2015;:65-7.
    Abstract     Related articles   

  760. SHEN HM, D'Souza AM, Green IF, Pohar KS, et al
    Do amount of variant differentiation and mitotic rate in bladder cancer change with neoadjuvant chemotherapy?
    Hum Pathol. 2015 Jun 4. pii: S0046-8177(15)00196.
    Abstract     Related articles   

  761. RAUSCH S, Hennenlotter J, Teepe K, Kuehs U, et al
    Muscle-invasive bladder cancer is characterized by overexpression of thymidine kinase 1.
    Urol Oncol. 2015 Jul 28. pii: S1078-1439(15)00295.
    Abstract     Related articles   

  762. FARRAG HA, A-Karam El-Din A, Mohamed El-Sayed ZG, Abdel-Latifissa S, et al
    Microbial colonization of irradiated pathogenic yeast to catheter surfaces: Relationship between adherence, cell surface hydrophobicity, biofilm formation and antifungal susceptibility. A scanning electron microscope analysis.
    Int J Radiat Biol. 2015;91:519-27.
    Abstract     Related articles   

  763. VAROL N, Konac E, Bilen CY
    Does Wnt/beta-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
    Exp Biol Med (Maywood). 2015;240:624-30.
    Abstract     Related articles   

  764. PICKENS RB, Bajo A, Simaan N, Herrell D, et al
    A pilot ex vivo evaluation of a telerobotic system for transurethral intervention and surveillance.
    J Endourol. 2015;29:231-4.
    Abstract     Related articles   

  765. PUSZTASZERI M
    Cellular swirls and cellular swirl-like structures are not restricted to papillary thyroid carcinoma.
    Diagn Cytopathol. 2014 Feb 18. doi: 10.1002/dc.23108.
    Abstract     Related articles   

  766. CHOU R, Selph S, Buckley D, Gustafson K, et al
    Different patterns in the prognostic value of age for bladder cancer-specific survival depending on tumor stages.
    Am J Cancer Res. 2015;5:2090-7.
    Abstract     Related articles   

  767. QIE Y, Hu H, Tian D, Xie L, et al
    [The value of taking surgical margin specimens during transurethral resection of bladder tumor in the diagnosis and treatment of non-muscle invasive bladder cancer].
    Zhonghua Wai Ke Za Zhi. 2015;53:202-205.
    Abstract     Related articles   

  768. WEISS BE, Pietzak EJ, Wein AJ, Malkowicz SB, et al
    Single instillation of mitomycin C plus bacillus Calmette-Guerin (BCG) versus BCG alone in high grade non-muscle invasive bladder cancer.
    Can J Urol. 2015;22:7876-81.
    Abstract     Related articles   

  769. KRABBE LM, Westerman ME, Margulis V, Raj GV, et al
    Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Can J Urol. 2015;22:7865-75.
    Abstract     Related articles   

  770. FAHMY O, Asri K, Schwentner C, Stenzl A, et al
    Current status of robotic assisted radical cystectomy with intracorporeal ileal neobladder for bladder cancer.
    J Surg Oncol. 2015 Aug 11. doi: 10.1002/jso.24007.
    Abstract     Related articles   

  771. SHANG Z, Li Y, Zhang M, Tian J, et al
    Anti-androgen therapy with Hydroxyflutamide or androgen receptor degradation enhancer ASC-J9(R) enhances BCG efficacy to better suppress bladder cancer progression.
    Mol Cancer Ther. 2015 Aug 11. pii: molcanther.1055.2014.
    Abstract     Related articles   

  772. NESI G, Nobili S, Cai T, Caini S, et al
    Chronic inflammation in urothelial bladder cancer.
    Virchows Arch. 2015.
    Abstract     Related articles   

  773. HAYAKAWA N, Kikuno N, Ishihara H, Ryoji O, et al
    Anterior urethra sparing cystoprostatectomy for bladder cancer: a 10-year, single center experience.
    Springerplus. 2015;4:401.
    Abstract     Related articles   

  774. SUNDARARAJAN S, Vogelzang NJ
    Anti-PD-1 and PD-L1 therapy for bladder cancer: what is on the horizon?
    Future Oncol. 2015;11:2299-306.
    Abstract     Related articles   

  775. SCHMID SC, Zahel T, Haller B, Horn T, et al
    Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival.
    World J Urol. 2015.
    Abstract     Related articles   

  776. SAAD F
    Progress in bladder cancer: is there light at the end of the tunnel?
    Curr Opin Support Palliat Care. 2015;9:244.
    Abstract     Related articles   

  777. PARAFITA-FERNANDEZ A, Parafita MA
    Bilateral Iritis after Vaccine for Bladder Cancer.
    Optom Vis Sci. 2015.
    Abstract     Related articles   

  778. GOOSSENS ME, Buntinx F, Zeegers MP, Driessen JH, et al
    Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients.
    Br J Clin Pharmacol. 2015 Aug 10. doi: 10.1111/bcp.12740.
    Abstract     Related articles   

  779. SEASTEDT KP, Ahmad U, Lau C, Ruggeri-Weigel P, et al
    Mycotic Thoracic Aortic Aneurysm After Intravesical Bacillus Calmette-Guerin Treatment.
    Ann Thorac Surg. 2015;99:2210-2.
    Abstract     Related articles   

  780. KAZI TG, Wadhwa SK, Afridi HI, Talpur FN, et al
    Comparison of essential and toxic elements in esophagus, lung, mouth and urinary bladder male cancer patients with related to controls.
    Environ Sci Pollut Res Int. 2015;22:7705-15.
    Abstract     Related articles   

  781. CONDE VR, Alves MG, Oliveira PF, Silva BM, et al
    Tea (Camellia sinensis (L.)): a putative anticancer agent in bladder carcinoma?
    Anticancer Agents Med Chem. 2015;15:26-36.
    Abstract     Related articles   

  782. LU B, Liang Y
    Pagetoid spread of bladder urothelial carcinoma to the vagina and vulva.
    J Low Genit Tract Dis. 2015;19:e13-6.
    Abstract     Related articles   

  783. YAO K, He L, Gan Y, Zeng Q, et al
    MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1.
    Diagn Pathol. 2015;10:146.
    Abstract     Related articles   

  784. CHEN YZ, Li J, Zhao YX, Liu D, et al
    Retraction Note to: Genetic polymorphisms in the CYP1A1 and CYP1B1 genes and susceptibility to bladder cancer: a meta-analysis.
    Mol Biol Rep. 2015.
    Abstract     Related articles   

  785. HERR HW
    Role of Repeat Resection in Non-Muscle-Invasive Bladder Cancer.
    J Natl Compr Canc Netw. 2015;13:1041-6.
    Abstract     Related articles   

  786. POLI G, Brancorsini S, Cochetti G, Barillaro F, et al
    Expression of inflammasome-related genes in bladder cancer and their association with cytokeratin 20 messenger RNA.
    Urol Oncol. 2015 Aug 14. pii: S1078-1439(15)00355.
    Abstract     Related articles   

  787. FRANZEN CA, Blackwell RH, Todorovic V, Greco KA, et al
    Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes.
    Oncogenesis. 2015;4:e163.
    Abstract     Related articles   

  788. ZHAI N, Wang YH, Zhu LM, Wang JH, et al
    Sensitivity and Specificity of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Bladder Cancers.
    Clin Invest Med. 2015;38:E173-84.
    Abstract     Related articles   

  789. LIU NW, Shatagopam K, Monn MF, Kaimakliotis HZ, et al
    Risk for Clostridium difficile infection after radical cystectomy for bladder cancer: Analysis of a contemporary series.
    Urol Oncol. 2015 Aug 13. pii: S1078-1439(15)00350.
    Abstract     Related articles   

  790. QU H, Ma B, Yuan HF, Wang ZY, et al
    Effect of salinomycin on metastasis and invasion of bladder cancer cell line T24.
    Asian Pac J Trop Med. 2015;8:578-82.
    Abstract     Related articles   

  791. VEERANKI OL, Bhattacharya A, Tang L, Marshall JR, et al
    Cruciferous vegetables, isothiocyanates, and prevention of bladder cancer.
    Curr Pharmacol Rep. 2015;1:272-282.
    Abstract     Related articles   

  792. CHOU R, Selph S, Buckley D, Gustafson K, et al
    Improved Target Cell Selection and Counting Method for UroVysion Fluorescence in Situ Hybridization.
    Clin Lab. 2015;61.
    Abstract     Related articles   

  793. LOPEZ-BELTRAN A, Marques RC, Montironi R, Reymundo C, et al
    Dysplasia and carcinoma in situ of the urinary bladder.
    Anal Quant Cytopathol Histpathol. 2015;37:29-38.
    Abstract     Related articles   

  794. LOPEZ-BELTRAN A, Marques RC, Montironi R, Reymundo C, et al
    Rare entities in urinary bladder pathology.
    Anal Quant Cytopathol Histpathol. 2015;37:14-22.
    Abstract     Related articles   

  795. BOLLINENI VR, Kramer G, Liu Y, Melidis C, et al
    A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer.
    Cancer Treat Rev. 2015;41:496-502.
    Abstract     Related articles   

  796. GHORBANZADEH-MOGHADDAM A, Gholamrezaei A, Hemati S
    Vitamin D Deficiency Is Associated With the Severity of Radiation-Induced Proctitis in Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2015;92:613-8.
    Abstract     Related articles   

  797. BRETLAU T, Hansen RH, Thomsen HS
    CT urography and hematuria: a retrospective analysis of 771 patients undergoing CT urography over a 1-year period.
    Acta Radiol. 2015;56:890-6.
    Abstract     Related articles   

  798. GRONBORG C, Vestergaard A, Hoyer M, Sohn M, et al
    Intra-fractional bladder motion and margins in adaptive radiotherapy for urinary bladder cancer.
    Acta Oncol. 2015.
    Abstract     Related articles   

  799. GONG Y, Qiu W, Ning X, Yang X, et al
    CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
    Oncotarget. 2015.
    Abstract     Related articles   

  800. WANG X, Wu Q, Xu B, Wang P, et al
    MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1.
    FEBS J. 2015 Aug 27. doi: 10.1111/febs.13502.
    Abstract     Related articles   

  801. HRUDEY SE, Backer LC, Humpage AR, Krasner SW, et al
    Evaluating Evidence for Association of Human Bladder Cancer with Drinking-Water Chlorination Disinfection By-Products.
    J Toxicol Environ Health B Crit Rev. 2015.
    Abstract     Related articles   

  802. OU Z, Wang Y, Liu L, Li L, et al
    Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals.
    Oncotarget. 2015.
    Abstract     Related articles   

  803. NOGUCHI JL, Liss MA, Parsons JK
    Obesity, Physical Activity and Bladder Cancer.
    Curr Urol Rep. 2015;16:546.
    Abstract     Related articles   

  804. GRIGOR'EV EG, Frolova IG, Velichko SA
    [Lieutaud's triangle lesion and urodynamic disorders in bladder cancer according to magnetic resonance imaging data].
    Vestn Rentgenol Radiol. 2015;:31-6.
    Abstract     Related articles   

  805. TAOKA Y, Matsumoto K, Ohashi K, Minamida S, et al
    Protein expression profile related to cisplatin resistance in bladder cancer cell lines detected by two-dimensional gel electrophoresis.
    Biomed Res. 2015;36:253-61.
    Abstract     Related articles   

  806. RYK C, Koskela LR, Thiel T, Wiklund NP, et al
    Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.
    Redox Biol. 2015;6:REDOXD1500063.
    Abstract     Related articles   

  807. ALJABERY F, Lindblom G, Skoog S, Shabo I, et al
    PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer.
    BMC Urol. 2015;15:87.
    Abstract     Related articles   

  808. CHOU R, Selph S, Buckley D, Gustafson K, et al
    CLINICO-PATHOLOGICAL PATTERN, CLASSIFICATION AND STAGING OF URINARY BLADDER CARCINOMAS--A FIVE YEARS EXPERIENCE AT A TERTIARY CARE HOSPITAL IN CENTRAL PUNJAB. .
    J Ayub Med Coll Abbottabad. 2015;27:131-4.
    Abstract     Related articles   

  809. KIMURA H, Murakami K, Aoyama T, Koumoto I, et al
    [Adenocarcinoma of an augmented bladder 49 years after enterocystoplasty : a case report].
    Hinyokika Kiyo. 2015;61:167-71.
    Abstract     Related articles   

  810. FUJIKAWA S, Iguchi R, Noguchi T, Sasaki M, et al
    [Cholesterol crystal embolization following urinary diversion: a case report].
    Hinyokika Kiyo. 2015;61:99-102.
    Abstract     Related articles   

  811. MONTIRONI R, Santoni M, Goteri G, Mazzucchelli R, et al
    Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report.
    Hum Pathol. 2015 Mar 25. pii: S0046-8177(15)00088.
    Abstract     Related articles   

  812. ZENG T, Peng L, Chao H, Xi H, et al
    IRE1alpha-TRAF2-ASK1 complex-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to CXC195-induced apoptosis in human bladder carcinoma T24 cells.
    Biochem Biophys Res Commun. 2015;460:530-6.
    Abstract     Related articles   

  813. KAWADA H, Kanematsu M, Goshima S, Kondo H, et al
    Multiphase contrast-enhanced magnetic resonance imaging features of Bacillus Calmette-Guerin-induced granulomatous prostatitis in five patients.
    Korean J Radiol. 2015;16:342-8.
    Abstract     Related articles   

  814. WEI S, Bing Z, Yao Y, Master SR, et al
    Higher Expression of miR-182 in Cytology Specimens of High-Grade Urothelial Cell Carcinoma: A Potential Diagnostic Marker.
    Acta Cytol. 2015;59:109-12.
    Abstract     Related articles   

  815. FOGAZZI GB, Pallotti F, Garigali G
    Atypical/malignant urothelial cells in routine urinary sediment: worth knowing and reporting.
    Clin Chim Acta. 2015;439:107-11.
    Abstract     Related articles   

  816. JUNQUEIRA-NETO S, Vieira FQ, Montezuma D, Costa NR, et al
    Phenotypic impact of deregulated expression of class I histone deacetylases in urothelial cell carcinoma of the bladder.
    Mol Carcinog. 2015;54:523-31.
    Abstract     Related articles   

  817. KAWAHARA T, Shareef HK, Aljarah AK, Ide H, et al
    ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
    Oncotarget. 2015.
    Abstract     Related articles   

  818. KIM BW, Ha Y, Lee JN, Kim HT, et al
    Effects of Previous or Synchronous Non-Muscle Invasive Bladder Cancer on Clinical Results after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multi-Institutional Study.
    Urol J. 2015;12:2233-9.
    Abstract     Related articles   

  819. HAN B, Cui D, Jing Y, Hong Y, et al
    Erratum to: Estrogen receptor beta (ERbeta) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch.
    World J Urol. 2015.
    Abstract     Related articles   

  820. FENNER A
    Bladder cancer: Patient-derived murine xenografts.
    Nat Rev Urol. 2015 Sep 1. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  821. DE PAOLI M, Perco P, Muhlberger I, Lukas A, et al
    Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic.
    Biomarkers. 2015;20:328-37.
    Abstract     Related articles   

  822. SCHMIDT J, Propping C, Siow WY, Lohse-Fischer A, et al
    Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.
    J Cancer Res Clin Oncol. 2015.
    Abstract     Related articles   

  823. GARG M
    Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer.
    Cancer Metastasis Rev. 2015.
    Abstract     Related articles   

  824. BAUMANN BC, Noa K, Wileyto EP, Bekelman JE, et al
    Adjuvant radiation therapy for bladder cancer: A dosimetric comparison of techniques.
    Med Dosim. 2015 Aug 28. pii: S0958-3947(15)00068.
    Abstract     Related articles   

  825. PTASZYNSKA A, Cohen SM, Messing EM, Reilly TP, et al
    Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a 'Case Study'.
    Diabetes Ther. 2015.
    Abstract     Related articles   

  826. ZHENG Y, Ishiguro H, Ide H, Inoue S, et al
    Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.
    Mol Endocrinol. 2015 Aug 31:me20151128.
    Abstract     Related articles   

  827. COLE AP, Dalela D, Hanske J, Mullane SA, et al
    Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010.
    Urol Oncol. 2015 Aug 25. pii: S1078-1439(15)00358.
    Abstract     Related articles   

  828. MISHRA K, Behari A, Kapoor VK, Khan MS, et al
    Platelet Derived Growth Factor-B and Human Epidermal Growth Factor Receptor-2 Polymorphisms in Gall Bladder Cancer.
    Asian Pac J Cancer Prev. 2015;16:5647-54.
    Abstract     Related articles   

  829. TAN J, Qiu K, Li M, Liang Y, et al
    Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.
    FEBS Lett. 2015 Aug 28. pii: S0014-5793(15)00720.
    Abstract     Related articles   

  830. AKBARI M, Naghibzadeh-Tahami A, Khanjani N, Baneshi MR, et al
    Opium as a Risk Factor for Bladder Cancer: A Population-based Case-control Study in Iran.
    Arch Iran Med. 2015;18:567-71.
    Abstract     Related articles   

  831. PATAFIO FM, Robert Siemens D, Wei X, Booth CM, et al
    Is there a gender effect in bladder cancer? A population-based study of practice and outcomes.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  832. GOTTO GT, Shea-Budgell MA, Rose MS, Ruether JD, et al
    Predictors of referral for neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer and changes in practice over time.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  833. CHENG Y, Deng X, Yang X, Li P, et al
    Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis.
    Onco Targets Ther. 2015;8:2089-96.
    Abstract     Related articles   

  834. REN L, Yang X, Zhao L, Zhang H, et al
    Evaluation of Su Fu'ning Lotion's Inhibitory Effects on Bladder Cancer Cells In Vitro and In Vivo by Intravesical Instillation.
    Integr Cancer Ther. 2015 Aug 27. pii: 1534735415596569.
    Abstract     Related articles   

  835. SHOSTKA KG, Pavlenko AN, Fedchenko AV, Fokina AV, et al
    [OUTCOME OF PELVIC EXENTERATION FOR LOCALLY ADVANCED CANCER OF THE PELVIC ORGANS].
    Vopr Onkol. 2015;61:448-51.
    Abstract     Related articles   

  836. PASQUIER D, Barney B, Sundar S, Poortmans P, et al
    Small Cell Carcinoma of the Urinary Bladder: A Retrospective, Multicenter Rare Cancer Network Study of 107 Patients.
    Int J Radiat Oncol Biol Phys. 2015;92:904-10.
    Abstract     Related articles   

  837. GEAVLETE B, Bulai C, Ene C, Checherita I, et al
    The Influence of NBI Vision Over the First Follow-up Cystoscopy Outcomes in Newly Diagnosed NMIBC Patients.
    Chirurgia (Bucur). 2015;110:157-60.
    Abstract     Related articles   

  838. SHARMA P, Kini H, Pai RR, Sahu KK, et al
    Study of the reproducibility of the 2004 World Health Organization classification of urothelial neoplasms.
    Indian J Pathol Microbiol. 2015;58:59-61.
    Abstract     Related articles   

  839. CHATTERJEE D, Das A, Radotra BD
    Invasive micropapillary carcinoma of urinary bladder: a clinicopathological study.
    Indian J Pathol Microbiol. 2015;58:2-6.
    Abstract     Related articles   

  840. YU B, Zhou J, Cai H, Xu T, et al
    Neoadjuvant chemotherapy for primary adenocarcinomas of the urinary bladder: a single-site experience.
    BMC Urol. 2015;15:3.
    Abstract     Related articles   

  841. RALEIGH DR, Hsu IC, Braunstein S, Chang AJ, et al
    Bladder wall recurrence of prostate cancer after high-dose-rate brachytherapy.
    Brachytherapy. 2015;14:185-8.
    Abstract     Related articles   

  842. WAKUI S, Mutou T, Takahashi H, Ikegami M, et al
    Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
    J Appl Toxicol. 2015;35:181-90.
    Abstract     Related articles   

  843. LIN Z, Shengnan L, Fei W, Yingli S, et al
    Dimethylarsinic acid (DMA(V) ) changed the expressions of proliferative related factors and secretion of inflammatory cytokines in rat bladder.
    J Appl Toxicol. 2015;35:133-41.
    Abstract     Related articles   

  844. DHULL VS, Karunanithi S, Arora S, Jain TK, et al
    Diuretic 68Ga DOTANOC PET/CT in Imaging of Bladder Paraganglioma.
    Clin Nucl Med. 2014.
    Abstract     Related articles   

  845. ATTALLAH AM, El-Far M, Abdallah SO, El-Waseef AM, et al
    Combined use of epithelial membrane antigen and nuclear matrix protein 52 as sensitive biomarkers for detection of bladder cancer.
    Int J Biol Markers. 2015 Aug 26:0. doi: 10.5301/jbm.5000164.
    Abstract     Related articles   

  846. GRUBMUELLER B, Roupret M, Briganti A, Shariat SF, et al
    The use of biomarkers for bladder cancer diagnosis and surveillance.
    Mini Rev Med Chem. 2015.
    Abstract     Related articles   

  847. SPRADLING K, Youssef RF
    Controversies Related to Diabetes and Risk of Bladder Cancer.
    Mini Rev Med Chem. 2015.
    Abstract     Related articles   

  848. MCBETH L, Grabnar M, Selman S, Hinds TD Jr, et al
    Involvement of the Androgen and Glucocorticoid Receptors in Bladder Cancer.
    Int J Endocrinol. 2015;2015:384860.
    Abstract     Related articles   

  849. KOSTAKOPOULOS N, Protogerou V, Skolarikos A, Varkarakis I, et al
    VIP neobladder (Padovana) reconstruction following radical cystectomy for bladder cancer Complications, functional outcome and quality of life evaluation in 95 cases.
    Ann Ital Chir. 2015;86:362-7.
    Abstract     Related articles   

  850. SHIN DH, Dier U, Melendez JA, Hempel N, et al
    Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells.
    Biochim Biophys Acta. 2015 Sep 5. pii: S0925-4439(15)00265.
    Abstract     Related articles   

  851. FEUERSTEIN MA, Goenka A
    Quality of Life Outcomes for Bladder Cancer Patients Undergoing Bladder Preservation with Radiotherapy.
    Curr Urol Rep. 2015;16:547.
    Abstract     Related articles   

  852. KUWADA M, Chihara Y, Luo Y, Li X, et al
    Pro-chemotherapeutic effects of antibody against extracellular domain of claudin-4 in bladder cancer.
    Cancer Lett. 2015 Sep 2. pii: S0304-3835(15)00559.
    Abstract     Related articles   

  853. SANGWATANAROJ S, Khovinthasate D, Pathomyok L, Santingamkun A, et al
    Bladder Paraganglioma.
    Am J Med Sci. 2015;350:63.
    Abstract     Related articles   

  854. GUIMARAES MD, Bitencourt AG, Lima EN, Marchiori E, et al
    18FDG PET/CT Findings in the Unusual Urachal Adenocarcinoma.
    Clin Nucl Med. 2014.
    Abstract     Related articles   

  855. KOLLMEIER MA
    Point/Counterpoint: Is Cystectomy Needed for Small-Cell Bladder Cancer? NO.
    Oncology (Williston Park). 2015;29.
    Abstract     Related articles   

  856. FASCO DR
    Point/Counterpoint: Is Cystectomy Needed for Small-Cell Bladder Cancer? YES.
    Oncology (Williston Park). 2015;29.
    Abstract     Related articles   

  857. JAHNSON S, Hosseini Aliabad A, Holmang S, Jancke G, et al
    Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment.
    Scand J Urol. 2015.
    Abstract     Related articles   

  858. MOSCHINI M, Karnes RJ, Suardi N, Bianchi M, et al
    Potential Effect of Antiplatelet and Anticoagulant Therapy on the Timing of the Diagnosis of Bladder Cancer.
    Clin Genitourin Cancer. 2015 Aug 18. pii: S1558-7673(15)00199.
    Abstract     Related articles   

  859. WEI S, Fukuhara H, Kawada C, Kurabayashi A, et al
    Silencing of ATPase Inhibitory Factor 1 Inhibits Cell Growth via Cell Cycle Arrest in Bladder Cancer.
    Pathobiology. 2015;82:224-232.
    Abstract     Related articles   

  860. SCARPATO KR, Morgans AK, Moses KA
    Optimal management of muscle-invasive bladder cancer - a review.
    Res Rep Urol. 2015;7:143-51.
    Abstract     Related articles   

  861. LI P, Zhang X, Deng X, Tao J, et al
    Pharmacogenetic association between XRCC1 polymorphisms and improved outcomes in bladder cancer patients following intravesical instillation of epirubicin.
    Int J Clin Exp Med. 2015;8:11167-73.
    Abstract     Related articles   

  862. CHENG Y, Yang X, Deng X, Zhang X, et al
    Metabolomics in bladder cancer: a systematic review.
    Int J Clin Exp Med. 2015;8:11052-63.
    Abstract     Related articles   

  863. ROUANNE M, Alhammadi A, Vilain D, Radulescu C, et al
    Value of positron emission tomography in diagnosing synchronous penile metastasis from urothelial bladder cancer.
    World J Surg Oncol. 2015;13:276.
    Abstract     Related articles   

  864. ZHANG Q, Zhuang J, Deng Y, Zhao X, et al
    GOLPH3 is a potential therapeutic target and a prognostic indicatior of poor survival in bladder cancer treated by cystectomy.
    Oncotarget. 2015.
    Abstract     Related articles   

  865. FIGUEROA JD, Koutros S, Colt JS, Kogevinas M, et al
    Modification of Occupational Exposures on Bladder Cancer Risk by Common Genetic Polymorphisms.
    J Natl Cancer Inst. 2015;107.
    Abstract     Related articles   

  866. LI HJ, Li X, Pang H, Pan JJ, et al
    Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer.
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  867. TAN M, Gong H, Wang J, Tao L, et al
    SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1.
    Sci Rep. 2015;5:13996.
    Abstract     Related articles   

  868. MILOSEVIC R, Milovic N, Aleksic P, Lazic M, et al
    The clinical course of non-muscle invasive bladder cancer after transurethral resection of the tumor with or without subsequent intravesical application of bacillus Calmette-Guerin: The influence of patients gender and age.
    Vojnosanit Pregl. 2015;72:596-601.
    Abstract     Related articles   

  869. SALAMA A, Abdelmaksoud AM, Shawki A, Abdelbary A, et al
    Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
    Clin Genitourin Cancer. 2015 Aug 6. pii: S1558-7673(15)00180.
    Abstract     Related articles   

  870. HAHN NM, Knudsen BS, Daneshmand S, Koch MO, et al
    Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.
    Urol Oncol. 2015 Sep 8. pii: S1078-1439(15)00402.
    Abstract     Related articles   

  871. DUMAS G, Rousseau B, Rodrigues MJ, Tlemsani C, et al
    Acquired Type II von Willebrand Syndrome in Locally Advanced Bladder Cancer Successfully Treated With Intravenous Immunoglobulin and Chemotherapy.
    Clin Genitourin Cancer. 2015 Aug 6. pii: S1558-7673(15)00186.
    Abstract     Related articles   

  872. FANTONY JJ, Inman BA
    It May Be Time to Abandon Urine Tests for Bladder Cancer.
    J Natl Compr Canc Netw. 2015;13:1163-6.
    Abstract     Related articles   

  873. PAPADOPOULOS EI, Scorilas A
    Cisplatin and Paclitaxel Alter the Expression Pattern of miR-143/145 and miR-183/96/182 Clusters in T24 Bladder Cancer Cells.
    Clin Transl Sci. 2015 Sep 10. doi: 10.1111/cts.12323.
    Abstract     Related articles   

  874. DENG X, Yang X, Cheng Y, Liu X, et al
    GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy.
    Sci Rep. 2015;5:14000.
    Abstract     Related articles   

  875. CHAN ES, Yee CH, Chiu PK, Chan CK, et al
    Robot-assisted radical cystectomy using a side-docking technique.
    J Laparoendosc Adv Surg Tech A. 2015;25:207-11.
    Abstract     Related articles   

  876. NAKSHATRI H, Appaiah HN, Anjanappa M, Gilley D, et al
    NF-kappaB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.
    Cell Death Dis. 2015;6:e1608.
    Abstract     Related articles   

  877. PYUN JH, Kim HK, Kim JY, Kim SB, et al
    Standardized analysis of complications after robot-assisted radical cystectomy: Korea University Hospital experience.
    Korean J Urol. 2015;56:48-55.
    Abstract     Related articles   

  878. MAKBOUL R, Refaiy AE, Badary FA, Abdelkawi IF, et al
    Expression of survivin in squamous cell carcinoma and transitional cell carcinoma of the urinary bladder: a comparative immunohistochemical study.
    Korean J Urol. 2015;56:31-40.
    Abstract     Related articles   

  879. BUTI S, Ciccarese C, Zanoni D, Santoni M, et al
    Prognostic and predictive factors in patients treated with chemotherapy for advanced urothelial cancer: where do we stand?
    Future Oncol. 2015;11:107-19.
    Abstract     Related articles   

  880. CHUNG KT
    Occurrence, uses, and carcinogenicity of arylamines.
    Front Biosci (Elite Ed). 2015;7:322-45.
    Abstract     Related articles   

  881. RICHTER E
    Biomonitoring of human exposure to arylamines.
    Front Biosci (Elite Ed). 2015;7:193-207.
    Abstract     Related articles   

  882. MCDONALD F, Waters R, Gulliford S, Hall E, et al
    Defining bowel dose volume constraints for bladder radiotherapy treatment planning.
    Clin Oncol (R Coll Radiol). 2015;27:22-9.
    Abstract     Related articles   

  883. VAL-BERNAL JF, Azueta A, Ballestero R, Fuentes J, et al
    Incidental bladder lipoma: a case report and review of the literature.
    Turk Patoloji Derg. 2015;31:64-7.
    Abstract     Related articles   

  884. DI MARTINO E, Kelly G, Roulson JA, Knowles MA, et al
    Alteration of cell-cell and cell-matrix adhesion in urothelial cells: an oncogenic mechanism for mutant FGFR3.
    Mol Cancer Res. 2015;13:138-48.
    Abstract     Related articles   

  885. MILLIS SZ, Bryant D, Basu G, Bender R, et al
    Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin.
    Clin Genitourin Cancer. 2015;13:e37-49.
    Abstract     Related articles   

  886. MUNARI E, Chaux A, Maldonado L, Comperat E, et al
    Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection.
    Histopathology. 2015;66:262-9.
    Abstract     Related articles   

  887. ZHANG XR, Feng C, Zhu WD, Si JM, et al
    Two Micrometer Continuous-Wave Thulium Laser Treating Primary Non-Muscle-Invasive Bladder Cancer: Is It Feasible? A Randomized Prospective Study.
    Photomed Laser Surg. 2015.
    Abstract     Related articles   

  888. WILZ SW, Liu D, Liu C, Yang J, et al
    Development of a test to identify bladder cancer in the urine of patients using mass spectroscopy and subcellular localization of the detected proteins.
    Am J Transl Res. 2015;7:1458-66.
    Abstract     Related articles   

  889. ZHAO X, Li J, Huang S, Wan X, et al
    MiRNA-29c regulates cell growth and invasion by targeting CDK6 in bladder cancer.
    Am J Transl Res. 2015;7:1382-9.
    Abstract     Related articles   

  890. SCHMID SC, Thumer L, Schuster T, Horn T, et al
    Human papilloma virus is not detectable in samples of urothelial bladder cancer in a central European population: a prospective translational study.
    Infect Agent Cancer. 2015;10:31.
    Abstract     Related articles   

  891. LEE J, Jeon H, Yoo SM, Park J, et al
    The role of Kaposi's sarcoma-associated herpesvirus infection in the proliferation of human bladder cancer cells.
    Tumour Biol. 2015.
    Abstract     Related articles   

  892. VAN KESSEL KE, Zuiverloon TC, Alberts AR, Boormans JL, et al
    Targeted therapies in bladder cancer: an overview of in vivo research.
    Nat Rev Urol. 2015 Sep 22. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  893. BJORNSSON O, Gudmundsson EO, Marteinsson VT, Jonsson E, et al
    Radical cystectomy in the treatment of bladder cancer in Iceland: A population-based study.
    Scand J Urol. 2015.
    Abstract     Related articles   

  894. JAIN M, Robinson BD, Shevchuk MM, Aggarwal A, et al
    Multiphoton microscopy: a potential intraoperative tool for the detection of carcinoma in situ in human bladder.
    Arch Pathol Lab Med. 2015;139:796-804.
    Abstract     Related articles   

  895. GUPTA S, Gupta K, Ravi R, Mehta V, et al
    Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study.
    Indian J Endocrinol Metab. 2015;19:639-43.
    Abstract     Related articles   

  896. SHINOTSUKA M, Shirai S, Tokuda Y
    Deep Vein Thrombosis due to Metastatic Bladder Cancer.
    Intern Med. 2015;54:2527-8.
    Abstract     Related articles   

  897. YOSHIDA T, Kinoshita H, Yoshida K, Yanishi M, et al
    A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy.
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  898. CHEN SP, Kirsch S, Zlatev DV, Chang T, et al
    Optical Biopsy of Bladder Cancer Using Crowd-Sourced Assessment.
    JAMA Surg. 2015 Sep 30:1-3. doi: 10.1001/jamasurg.2015.3121.
    Abstract     Related articles   

  899. HO PL, Willis DL, Patil J, Xiao L, et al
    Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience.
    Urol Oncol. 2015 Sep 25. pii: S1078-1439(15)00411.
    Abstract     Related articles   

  900. PISTAMALTZIAN N, Tzannis K, Pissanidou V, Peroukidis S, et al
    Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group.
    Anticancer Drugs. 2015.
    Abstract     Related articles   

  901. SCHUBERT T, Todenhofer T, Mischinger J, Schwentner C, et al
    The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  902. LOKE YK, Mattishent K
    Bladder cancer: Pioglitazone-when is a prescription drug safe?
    Nat Rev Urol. 2015 Sep 29. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  903. TSUZUKI S, Miki J, Moritake J, Kimura S, et al
    [CLINICAL CHARACTERISTICS OF T1 HIGH GRADE BLADDER CANCER].
    Nihon Hinyokika Gakkai Zasshi. 2015;106:71-8.
    Abstract     Related articles   

  904. ZHAO C, Tang K, Yang H, Xia D, et al
    Bipolar versus Monopolar Transurethral Resection of Non-muscle Invasive Bladder CancerA Meta-analysis.
    J Endourol. 2015.
    Abstract     Related articles   

  905. HEGAZY R, Kamel M, Salem EA, Salem NA, et al
    The prognostic significance of p53, p63 and her2 expression in non-muscle-invasive bladder cancer in relation to treatment with bacille Calmette-Guerin.
    Arab J Urol. 2015;13:225-30.
    Abstract     Related articles   

  906. KOUTROS S, Silverman DT, Alavanja MC, Andreotti G, et al
    Occupational exposure to pesticides and bladder cancer risk.
    Int J Epidemiol. 2015.
    Abstract     Related articles   

  907. WU K, Wang B, Chen Y, Zhou J, et al
    DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling.
    Cell Signal. 2015 Sep 25. pii: S0898-6568(15)00276.
    Abstract     Related articles   

  908. BAO L, Wang Y, Ma R, Ren X, et al
    Apoptosis-inducing effects of lentinan on the proliferation of human bladder cancer T24 cells.
    Pak J Pharm Sci. 2015;28:1595-600.
    Abstract     Related articles   

  909. WHALLEY D, Caine H, McCloud P, Guo L, et al
    Promising results with image guided intensity modulated radiotherapy for muscle invasive bladder cancer.
    Radiat Oncol. 2015;10:205.
    Abstract     Related articles   

  910. NAKASHIMA M, Matsui Y, Kobayashi T, Saito R, et al
    Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer.
    Cancer Biomark. 2015;15:357-64.
    Abstract     Related articles   

  911. VTORENKO VI, Trushkin RN, Lubennikov AE, Podkorytova OL, et al
    [BILATERAL NEPHROURETERECTOMY WITH CYSTOPROSTATECTOMY AD BLOC AND LYMPHADENECTOMY IN A PATIENT WITH END-STAGE RENAL FAILURE AND CANCER OF THE URINARY BLADDER T2BN0M0].
    Urologiia. 2015;:126-9.
    Abstract     Related articles   

  912. YU G, Xu K, Xu S, Zhang X, et al
    [MicroRNA-34a regulates cell cycle by targeting CD44 in human bladder carcinoma cells].
    Nan Fang Yi Ke Da Xue Xue Bao. 2015;35:935-40.
    Abstract     Related articles   

  913. LU XL, Shen YJ, Ye DW
    [Penile rehabilitation after radical pelvic surgery].
    Zhonghua Nan Ke Xue. 2015;21:463-6.
    Abstract     Related articles   

  914. CASTILLO JJ, Olszewski AJ, Kanan S, Meid K, et al
    Survival outcomes of secondary cancers in patients with Waldenstrom macroglobulinemia: An analysis of the SEER database.
    Am J Hematol. 2015;90:696-701.
    Abstract     Related articles   

  915. BOTELHO MC, Alves H, Barros A, Rinaldi G, et al
    The role of estrogens and estrogen receptor signaling pathways in cancer and infertility: the case of schistosomes.
    Trends Parasitol. 2015;31:246-50.
    Abstract     Related articles   

  916. CHAKIBA C, Cornelis F, Descat E, Gross-Goupil M, et al
    Dynamic contrast enhanced MRI-derived parameters are potential biomarkers of therapeutic response in bladder carcinoma.
    Eur J Radiol. 2015 Mar 6. pii: S0720-048X(15)00118.
    Abstract     Related articles   

  917. GABALLAH HH, Shafik NM, Wasfy RE, Abou Farha MO, et al
    Significance of suppressor of cytokine signaling-3 expression in bladder urothelial carcinoma in relation to proinflammatory cytokines and tumor histopathological grading.
    Asian Pac J Cancer Prev. 2015;16:307-14.
    Abstract     Related articles   

  918. RASHID ALI MR, Kannan KK
    Endobronchial glomus tumor.
    J Bronchology Interv Pulmonol. 2015;22:66-8.
    Abstract     Related articles   

  919. CALADO BN, Maron PE, Vedovato BC, Barrese TZ, et al
    Small cell carcinoma of the bladder.
    Einstein (Sao Paulo). 2015;13:114-6.
    Abstract     Related articles   

  920. HAN YJ, Ock SY, Kim EJ, Shin HS, et al
    Thunderclap-like headache triggered by micturition and angina as an initial manifestation of bladder pheochromocytoma. A case report.
    Sao Paulo Med J. 2015;133:154-9.
    Abstract     Related articles   

  921. CUMBERBATCH MG, Cox A, Teare D, Catto JW, et al
    Contemporary Occupational Carcinogen Exposure and Bladder Cancer: A Systematic Review and Meta-analysis.
    JAMA Oncol. 2015 Oct 8:1-9. doi: 10.1001/jamaoncol.2015.3209.
    Abstract     Related articles   

  922. WEIDERPASS E, Vainio H
    The Need for Further Preventive Measures for Occupational Bladder Cancer.
    JAMA Oncol. 2015 Oct 8:1-2. doi: 10.1001/jamaoncol.2015.3270.
    Abstract     Related articles   

  923. BUSATO JUNIOR WF, Almeida GL, Ribas CA, Ribas Filho JM, et al
    EORTC Risk Model to Predict Progression in Patients With Non-Muscle-Invasive Bladder Cancer: Is It Safe to Use in Clinical Practice?
    Clin Genitourin Cancer. 2015 Sep 25. pii: S1558-7673(15)00246.
    Abstract     Related articles   

  924. KWON T, Jeong IG, Lee C, You D, et al
    Acute Kidney Injury After Radical Cystectomy for Bladder Cancer is Associated with Chronic Kidney Disease and Mortality.
    Ann Surg Oncol. 2015.
    Abstract     Related articles   

  925. ERTURHAN S, Sen H, Demirbag A, Bayrak O, et al
    Thermochemotherapy in adjuvant treatment of primary high risk non muscle invasive bladder cancers: Single center results.
    Arch Esp Urol. 2015;68:666-671.
    Abstract     Related articles   

  926. YEH HC, Huang CN, Li CC, Chang LL, et al
    Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  927. HARB-DE LA ROSA A, Acker M, Kumar RA, Manoharan M, et al
    Epigenetics application in the diagnosis and treatment of bladder cancer.
    Can J Urol. 2015;22:7947-51.
    Abstract     Related articles   

  928. GUNARATNE DA, Krieger LE, Maclean F, Vaux KJ, et al
    Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Plasmacytoid Urothelial Bladder Cancer: A Case Report and Review of the Literature.
    Clin Genitourin Cancer. 2015 Sep 3. pii: S1558-7673(15)00223.
    Abstract     Related articles   

  929. LEE MS, Lee J, Kim JH, Kim WT, et al
    Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
    Oncotarget. 2015.
    Abstract     Related articles   

  930. WU M, Chen J, Wang Y, Hu J, et al
    URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-kappaB signaling.
    Oncotarget. 2015.
    Abstract     Related articles   

  931. FENG YH, Shen KH, Huang KH, Tzeng WS, et al
    An Effective and Well Tolerated Strategy of Bladder Preservation Therapy in Cisplatin-Ineligible Patients With Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2015 Aug 29. pii: S1558-7673(15)00219.
    Abstract     Related articles   

  932. RAIS-BAHRAMI S, Pietryga JA, Nix JW
    Contemporary role of advanced imaging for bladder cancer staging.
    Urol Oncol. 2015 Sep 28. pii: S1078-1439(15)00441.
    Abstract     Related articles   

  933. LIN J, Liu Y, Zhan Y, Zhuang C, et al
    Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.
    Tumour Biol. 2015.
    Abstract     Related articles   

  934. CHEN L, Cui Z, Liu Y, Bai Y, et al
    MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
    Clin Lab. 2015;61:1101-8.
    Abstract     Related articles   

  935. TAKEUCHI M, Sasaguri K, Naiki T, Mitsumori A, et al
    MRI Findings of Inverted Urothelial Papilloma of the Bladder.
    AJR Am J Roentgenol. 2015;205:311-6.
    Abstract     Related articles   

  936. FONTANAROSA PB, Bauchner H, Golub RM
    Evaluating Research on the Safety of Medical Therapies: The Responsibility of Journals to the Health of the Public.
    JAMA. 2015;314:235-6.
    Abstract     Related articles   

  937. SHARFSTEIN JM, Kesselheim AS
    The Safety of Prescription Drugs.
    JAMA. 2015;314:233-4.
    Abstract     Related articles   

  938. CASTIGLIONI S, Cazzaniga A, Perrotta C, Maier JA, et al
    Silver nanoparticles-induced cytotoxicity requires ERK activation in human bladder carcinoma cells.
    Toxicol Lett. 2015;237:237-43.
    Abstract     Related articles   

  939. CALATRONI M, Buzio C, Vaglio A
    The evolving paradigm of cancer risk related to cyclophosphamide therapy in granulomatosis with polyangiitis.
    Rheumatology (Oxford). 2015;54:1339-41.
    Abstract     Related articles   

  940. ZHANG GW, Qin GF, Han B, Li CX, et al
    Efficacy of Zhuling polyporus polysaccharide with BCG to inhibit bladder carcinoma.
    Carbohydr Polym. 2015;118:30-5.
    Abstract     Related articles   

  941. MATTES MD, Kan CC, Dalbagni G, Zelefsky MJ, et al
    External beam radiation therapy for small cell carcinoma of the urinary bladder.
    Pract Radiat Oncol. 2015;5:e17-22.
    Abstract     Related articles   

  942. FAURSCHOU M, Mellemkjaer L, Voss A, Keller KK, et al
    Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.
    Rheumatology (Oxford). 2015;54:1345-50.
    Abstract     Related articles   

  943. SUN X, Du P, Yuan W, Du Z, et al
    Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer.
    Cell Death Dis. 2015;6:e1907.
    Abstract     Related articles   

  944. DEMBOWSKI J, Hackemer P, Winkler A, Otlewska A, et al
    Prostate and Bladder Cancer Coexistence in Patients Undergoing Radical Cystoprostatectomy.
    Adv Clin Exp Med. 2015;24:657-662.
    Abstract     Related articles   

  945. CERBONE L, Sternberg CN, Sengelov L, Agerbaek M, et al
    Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061.
    Oncology. 2015.
    Abstract     Related articles   

  946. LERUT E, Van Poppel H, Joniau S, Gruselle O, et al
    Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.
    Int J Clin Exp Pathol. 2015;8:9522-32.
    Abstract     Related articles   

  947. SUER E, Hamidi N, Gokce MI, Gulpinar O, et al
    Significance of second transurethral resection on patient outcomes in muscle-invasive bladder cancer patients treated with bladder-preserving multimodal therapy.
    World J Urol. 2015.
    Abstract     Related articles   

  948. LIU PF, Cao YW, Zhang SD, Zhao Y, et al
    A bladder cancer microenvironment simulation system based on a microfluidic co-culture model.
    Oncotarget. 2015 Oct 10. doi: 10.18632/oncotarget.6070.
    Abstract     Related articles   

  949. CAI Q, Wu Y, Guo Z, Gong R, et al
    Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
    Oncotarget. 2015.
    Abstract     Related articles   

  950. JIANG L, Wen J, Luo W
    Rhoassociated kinase inhibitor, Y27632, inhibits the invasion and proliferation of T24 and 5367 bladder cancer cells.
    Mol Med Rep. 2015 Sep 30. doi: 10.3892/mmr.2015.4404.
    Abstract     Related articles   

  951. DENG S, Wang W, Li X, Zhang P, et al
    Common genetic polymorphisms in pre-microRNAs and risk of bladder cancer.
    World J Surg Oncol. 2015;13:297.
    Abstract     Related articles   

  952. QIU M, Chen L, Tan G, Ke L, et al
    A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells.
    Sci Rep. 2015;5:15104.
    Abstract     Related articles   

  953. MARTINEZ-FERNANDEZ M, Feber A, Duenas M, Segovia C, et al
    Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer.
    Clin Epigenetics. 2015;7:109.
    Abstract     Related articles   

  954. ARNOLD SA, Loomans HA, Ketova T, Andl CD, et al
    Urinary oncofetal ED-A fibronectin correlates with poor prognosis in patients with bladder cancer.
    Clin Exp Metastasis. 2015.
    Abstract     Related articles   

  955. DENG Y, Yi L, Lin X, Lin L, et al
    A non-invasive genomic diagnostic method for bladder cancer using size-based filtration and microchip electrophoresis.
    Talanta. 2015;144:136-44.
    Abstract     Related articles   

  956. LIU C, Ren H, Li J, Li X, et al
    Predictors for quality of life of bladder cancer patients with ileal conduit: A cross-sectional survey.
    Eur J Oncol Nurs. 2015 Oct 6. pii: S1462-3889(15)30031.
    Abstract     Related articles   

  957. FERREIRA-TEIXEIRA M, Parada B, Rodrigues-Santos P, Alves V, et al
    Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors.
    Oncotarget. 2015.
    Abstract     Related articles   

  958. NIINO M, Matsuda T
    Morphological distribution of bladder cancer from Cancer Incidence in Five Continents Vol. X.
    Jpn J Clin Oncol. 2015;45:999.
    Abstract     Related articles   

  959. ZHU H, Li X, Song Y, Zhang P, et al
    Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway.
    Biochem Biophys Res Commun. 2015 Oct 7. pii: S0006-291X(15)30702.
    Abstract     Related articles   

  960. KAUFMANN S, Amend B, Kruck S, Gakis G, et al
    [Imaging findings in BCGitis--Bacillus-Calmette-Guerin-Infektion (BCGitis) after intravesical BCG instillation therapy in urothelial carcinoma of the urinary bladder].
    Rofo. 2015;187:623-7.
    Abstract     Related articles   

  961. STOJADINOVIC MM, Prelevic RI
    External validation of existing nomograms predicting lymph node metastases in cystectomized patients.
    Int J Clin Oncol. 2015;20:164-70.
    Abstract     Related articles   

  962. ZEPEDA CM, Coffey KH
    Schistosoma haematobium Infection That Mimics Bladder Cancer in a 66-Year-Old Ethnic Egyptian Man.
    Lab Med. 2015;46:338-42.
    Abstract     Related articles   

  963. LUO HB, Li B, Yuan WG, Xu CR, et al
    Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
    J Huazhong Univ Sci Technolog Med Sci. 2015;35:730-5.
    Abstract     Related articles   

  964. TIAN YF, Zhou H, Yu G, Wang J, et al
    Prognostic significance of lymphovascular invasion in bladder cancer after surgical resection: A meta-analysis.
    J Huazhong Univ Sci Technolog Med Sci. 2015;35:646-55.
    Abstract     Related articles   

  965. REGLI S, Chen J, Messner M, Elovitz MS, et al
    Estimating Potential Increased Bladder Cancer Risk Due to Increased Bromide Concentrations in Sources of Disinfected Drinking Waters.
    Environ Sci Technol. 2015.
    Abstract     Related articles   

  966. GONG Z, Xu H, Su Y, Wu W, et al
    Establishment of a Novel Bladder Cancer Xenograft Model in Humanized Immunodeficient Mice.
    Cell Physiol Biochem. 2015;37:1355-1368.
    Abstract     Related articles   

  967. KATES M, Sopko NA, Matsui H, Drake CG, et al
    Immune checkpoint inhibitors: a new frontier in bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  968. SMITH ZL, Soloway MS
    Expectant Management of Low-Risk Bladder Cancer.
    Curr Urol Rep. 2015;16:82.
    Abstract     Related articles   

  969. CHEN X, Gu P, Li K, Xie W, et al
    Gene expression profiling of WDR5 regulated genes in bladder cancer.
    Genom Data. 2015;5:27-9.
    Abstract     Related articles   

  970. SERRETTA V, Scalici Gesolfo C
    Clinical pitfalls in diagnosis of nonmuscle-invasive bladder cancer.
    Urologia. 2015;0:0.
    Abstract     Related articles   

  971. NASELLI A, Puppo P
    Narrow band imaging and bladder cancer: when and how.
    Urologia. 2015;0:0.
    Abstract     Related articles   

  972. BOADA LD, Henriquez-Hernandez LA, Zumbado M, Almeida-Gonzalez M, et al
    Organochlorine pesticides exposure and bladder cancer: evaluation from a gene-environment perspective in a hospital-based case-control study in the Canary Islands (Spain).
    J Agromedicine. 2015.
    Abstract     Related articles   

  973. LERNER SP
    Update on The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2015;1:94-95.
    Abstract     Related articles   

  974. JAISWAL MK, Pradhan L, Vasavada S, De M, et al
    Magneto-thermally responsive hydrogels for bladder cancer treatment: Therapeutic efficacy and in vivo biodistribution.
    Colloids Surf B Biointerfaces. 2015;136:625-633.
    Abstract     Related articles   

  975. ZHAO Y, Wang D, Xu T, Liu P, et al
    Bladder cancer cells re-educate TAMs through lactate shuttling in the microfluidic cancer microenvironment.
    Oncotarget. 2015 Oct 13. doi: 10.18632/oncotarget.5538.
    Abstract     Related articles   

  976. ZHANG X, Liu D, Hayashida Y, Okazoe H, et al
    G Protein-Coupled Receptor 87 (GPR87) Promotes Cell Proliferation in Human Bladder Cancer Cells.
    Int J Mol Sci. 2015;16:24319-31.
    Abstract     Related articles   

  977. ABBOSH PH, McConkey DJ, Plimack ER
    Targeting Signaling Transduction Pathways in Bladder Cancer.
    Curr Oncol Rep. 2015;17:58.
    Abstract     Related articles   

  978. RASSHUPKINAL EV, Teodorovich OV, Kochiev DG, Andreeva JJ, et al
    [EXPERIMENTAL VALIDATION OF ND:YAG LASER COAGULATION OF THE BLADDER TISSUE].
    Urologiia. 2015;:55-9.
    Abstract     Related articles   

  979. UMBAS R, Safriadi F, Mochtar CA, Djatisoesanto W, et al
    Urologic cancer in Indonesia.
    Jpn J Clin Oncol. 2015;45:708-12.
    Abstract     Related articles   

  980. GUPTA M, Su LM
    Current and evolving uses of optical coherence tomography in the genitourinary tract.
    Curr Urol Rep. 2015;16:15.
    Abstract     Related articles   

  981. KATES M, Singh A, Matsui H, Steinberg GD, et al
    Tissue-engineered urinary conduits.
    Curr Urol Rep. 2015;16:8.
    Abstract     Related articles   

  982. KALRA S, Manikandan R, Dorairajan LN, Badhe B, et al
    Synchronously detected secondary signet ring cell urinary bladder malignancy from the stomach masquerading as genitourinary tuberculosis.
    BMJ Case Rep. 2015;2015.
    Abstract     Related articles   

  983. HO CH, Sung KC, Lim SW, Liao CH, et al
    Chronic Indwelling Urinary Catheter Increase the Risk of Bladder Cancer, Even in Patients Without Spinal Cord Injury.
    Medicine (Baltimore). 2015;94:e1736.
    Abstract     Related articles   

  984. LATIFOVIC L, Villeneuve PJ, Parent ME, Johnson KC, et al
    Bladder cancer and occupational exposure to diesel and gasoline engine emissions among Canadian men.
    Cancer Med. 2015 Oct 28. doi: 10.1002.
    Abstract     Related articles   

  985. AY SENYIGIT Z, Karavana SY, Ilem-Ozdemir D, Caliskan C, et al
    Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
    Int J Nanomedicine. 2015;10:6493-507.
    Abstract     Related articles   

  986. ISMAIL MF, El Boghdady NA, Shabayek MI, Awida HA, et al
    Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt.
    Tumour Biol. 2015.
    Abstract     Related articles   

  987. KALINSKI P, Gingrich JR
    Toward improved effectiveness of bladder cancer immunotherapy.
    Immunotherapy. 2015.
    Abstract     Related articles   

  988. WISE J
    Urinary biomarkers are unreliable for diagnosing bladder cancer, study finds.
    BMJ. 2015;351:h5652.
    Abstract     Related articles   

  989. ZHU X, Qiao Y, Liu W, Wang W, et al
    CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.
    Tumour Biol. 2015.
    Abstract     Related articles   

  990. CHOU R, Gore JL, Buckley D, Fu R, et al
    Urinary Biomarkers for Diagnosis of Bladder Cancer: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2015 Oct 27. doi: 10.7326/M15-0997.
    Abstract     Related articles   

  991. JOZWICKI W, Brozyna AA, Siekiera J, Slominski AT, et al
    Expression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients.
    Int J Mol Sci. 2015;16:24369-86.
    Abstract     Related articles   

  992. AYKAN S, Yuruk E, Tuken M, Temiz MZ, et al
    Rare but Lethal Disease of Childhood: Metastatic, Muscle Invasive Bladder Cancer.
    Pediatr Rep. 2015;7:5928.
    Abstract     Related articles   

  993. VANDERWALDE NA, Chi MT, Hurria A, Galsky MD, et al
    Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit.
    World J Urol. 2015.
    Abstract     Related articles   

  994. FERRO M, De Cobelli O, Buonerba C, Di Lorenzo G, et al
    Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience.
    Medicine (Baltimore). 2015;94:e1861.
    Abstract     Related articles   

  995. YANG J, Yuan D, Li J, Zheng S, et al
    miR-186 downregulates protein phosphatase PPM1B in bladder cancer and mediates G1-S phase transition.
    Tumour Biol. 2015.
    Abstract     Related articles   

  996. CHEN Y, Zhu G, Wu K, Gao Y, et al
    FGF2-mediated reciprocal tumor cell-endothelial cell interplay contributes to the growth of chemoresistant cells: a potential mechanism for superficial bladder cancer recurrence.
    Tumour Biol. 2015.
    Abstract     Related articles   

  997. IMAJO Y, Komasawa N, Ishio J, Miyazakl Y, et al
    [A Case of Severe Bradycardia Associated with Bladder Perforation during Spinal Anesthesia].
    Masui. 2015;64:552-4.
    Abstract     Related articles   

  998. VENTOSA-FERNANDEZ G, Milisenda JC, Pereda D, Mestres CA, et al
    Infected False Aneurysm of the Aortic Arch After Endoscopic Transurethral Instillation of Bacillus Calmette-Guerin.
    Ann Thorac Surg. 2015;100:717-20.
    Abstract     Related articles   

  999. CHANG IW, Liang PI, Li CC, Wu WJ, et al
    HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladder.
    Tumour Biol. 2015;36:5441-50.
    Abstract     Related articles   

  1000. ZHANG Z, Zhang G, Kong C, Bi J, et al
    EIF2C, Dicer, and Drosha are up-regulated along tumor progression and associated with poor prognosis in bladder carcinoma.
    Tumour Biol. 2015;36:5071-9.
    Abstract     Related articles   

  1001. XIE D, Shang C, Zhang H, Guo Y, et al
    Up-regulation of miR-9 target CBX7 to regulate invasion ability of bladder transitional cell carcinoma.
    Med Sci Monit. 2015;21:225-30.
    Abstract     Related articles   

  1002. BHATTACHARYA A, Klaene JJ, Li Y, Paonessa JD, et al
    The inverse relationship between bladder and liver in 4-aminobiphenyl-induced DNA damage.
    Oncotarget. 2015;6:836-45.
    Abstract     Related articles   

  1003. LI T, Huang H, Liao D, Ling H, et al
    Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
    Mol Genet Genomics. 2015;290:1235-45.
    Abstract     Related articles   

  1004. QUIST EE, Javadzadeh BM, Johannesen E, Johansson SL, et al
    Malignant paraganglioma of the bladder: a case report and review of the literature.
    Pathol Res Pract. 2015;211:183-8.
    Abstract     Related articles   

  1005. ROUMEGUERE T, Broeders N, Jayaswal A, Rorive S, et al
    Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy.
    Transpl Int. 2014 Nov 6. doi: 10.1111/tri.12484.
    Abstract     Related articles   

  1006. ALBANY C, Sonpavde G
    Docetaxel for the treatment of bladder cancer.
    Expert Opin Investig Drugs. 2015.
    Abstract     Related articles   

  1007. BARTLEY K, DeBusk K, Duff S
    Health-Related Quality Of Life In Bladder Cancer: A Systematic Literature Review.
    Value Health. 2015;18:A474-5.
    Abstract     Related articles   

  1008. CLARK M, Harris NI, Martin S, Bartley K, et al
    The Impact Of Non-Muscle Invasive Bladder Cancer: Qualitative Research With Patients.
    Value Health. 2015;18:A471.
    Abstract     Related articles   

  1009. JABLONOWSKI Z, Konecki T, Ziobro M, Haldas M, et al
    Cost-Utility of Hexaminolevulinate Blue Light Cystoscopy (Hal) Assisted Transurethral Resection of The Bladder Tumour (Turb) Compared to Turb With White Light Cystoscopy (Wlc) Alone In Patients With Non-Muscle Invasive Bladder Cancer (Nimbc) In Poland
    Value Health. 2015;18:A360.
    Abstract     Related articles   

  1010. DANSK V, Malmstrom P, Blackberg M, Malmenas M, et al
    Hexaminolevulinate Blue-Light Flexible Cystoscopy In Addition To Standard White-Light Cystoscopy In The Follow-Up Of Non-Muscle Invasive Bladder Cancer: Cost-Consequences During Outpatient Surveillance In Sweden.
    Value Health. 2015;18:A354.
    Abstract     Related articles   

  1011. ECKE TH
    Biomarker in Cisplatin-Based Chemotherapy for Urinary Bladder Cancer.
    Adv Exp Med Biol. 2015;867:293-316.
    Abstract     Related articles   

  1012. RAZMARIA AA
    JAMA PATIENT PAGE. Bladder Cancer.
    JAMA. 2015;314:1886.
    Abstract     Related articles   

  1013. JIN D, Chen H, Cao M, Yang G, et al
    SERS measurement of the bladder cancer cells with the nanoparticles.
    Pak J Pharm Sci. 2015;28.
    Abstract     Related articles   

  1014. CASTILLO-MARTIN M, Collazo Lorduy A, Gladoun N, Hyun G, et al
    H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    J Pediatr Urol. 2015 Oct 22. pii: S1477-5131(15)00368.
    Abstract     Related articles   

  1015. ZHANG ZW, Xiao J, Luo W, Wang BH, et al
    Caffeine Suppresses Apoptosis of Bladder Cancer RT4 Cells in Response to Ionizing Radiation by Inhibiting Ataxia Telangiectasia Mutated-Chk2-p53 Axis.
    Chin Med J (Engl). 2015;128:2938-45.
    Abstract     Related articles   

  1016. DI LORENZO G, Federico P, De Placido S, Buonerba C, et al
    Increased risk of bladder cancer in critical areas at high pressure of pollution of the Campania region in Italy: A systematic review.
    Crit Rev Oncol Hematol. 2015 Jul 20. pii: S1040-8428(15)30004.
    Abstract     Related articles   

  1017. VON SCHOEN-ANGERER T, Wilkens J, Kienle GS, Kiene H, et al
    High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series.
    Perm J. 2015;19:76-83.
    Abstract     Related articles   

  1018. LIN C, Lin W, Yeh S, Li L, et al
    Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals.
    Oncotarget. 2015 Oct 16. doi: 10.18632/oncotarget.5638.
    Abstract     Related articles   

  1019. ZHUANG C, Li J, Liu Y, Chen M, et al
    Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells.
    Oncotarget. 2015 Oct 15. doi: 10.18632/oncotarget.5880.
    Abstract     Related articles   

  1020. MARTINEZ-FERNANDEZ M, Duenas M, Feber A, Segovia C, et al
    A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
    Oncotarget. 2015 Oct 17. doi: 10.18632/oncotarget.5546.
    Abstract     Related articles   

  1021. PAKZAD R, Mohammadian-Hafshejani A, Mohammadian M, Pakzad I, et al
    Incidence and Mortality of Bladder Cancer and their Relationship with Development in Asia.
    Asian Pac J Cancer Prev. 2015;16:7365-74.
    Abstract     Related articles   

  1022. ZENG Y, Jiang HY, Wei L, Xu WD, et al
    Association between the CYP1A2 rs762551 Polymorphism and Bladder Cancer Susceptibility: a Meta-Analysis Based on Case-Control Studies.
    Asian Pac J Cancer Prev. 2015;16:7249-54.
    Abstract     Related articles   

  1023. TAN J, Sun C, Xu K, Wang C, et al
    Immobilization of ALA-Zn Coordination Polymer Pro-photosensitizers on Magnetite Colloidal Supraparticles for Target Photodynamic Therapy of Bladder Cancer.
    Small. 2015 Oct 30. doi: 10.1002/smll.201502131.
    Abstract     Related articles   

  1024. ZOLOTAREVA EV, Andreeva YY, Frank GA
    [Lymphoepithelioma-like tumors: A review of literature and a clinical case of bladder carcinoma].
    Arkh Patol. 2015;77:55-62.
    Abstract     Related articles   

  1025. JAYARAM A, Zafeiriou Z, de Bono JS
    Cabozantinib-Getting Under the Skin of Cutaneous Toxicity.
    JAMA Oncol. 2015;1:535-6.
    Abstract     Related articles   

  1026. GIERTH M, Mayr R, Aziz A, Krieger S, et al
    Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy.
    J Cancer Res Clin Oncol. 2015;141:1819-26.
    Abstract     Related articles   

  1027. BALCI U, Dogantekin E, Ozer K, Gorgel SN, et al
    Patterns, risks and outcomes of urethral recurrence after radical cystectomy for urothelial cancer; over 20 year single center experience.
    Int J Surg. 2015;13:148-51.
    Abstract     Related articles   

  1028. HUAN T, Li L
    Counting missing values in a metabolite-intensity data set for measuring the analytical performance of a metabolomics platform.
    Anal Chem. 2015;87:1306-13.
    Abstract     Related articles   

  1029. KOSHIKAWA N
    A novel biomarker for diagnosis of bladder cancer.
    Nihon Yakurigaku Zasshi. 2015;146:248-51.
    Abstract     Related articles   

  1030. RAO Q, Chen Y, Yeh CR, Jie D, et al
    Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERbeta/CCL2/CCR2 EMT/MMP9 signals.
    Oncotarget. 2015 Nov 5. doi: 10.18632/oncotarget.5467.
    Abstract     Related articles   

  1031. CAVANAUGH A, Juengst B, Sheridan K, Danella JF, et al
    Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer.
    Oncotarget. 2015 Nov 4. doi: 10.18632/oncotarget.5496.
    Abstract     Related articles   

  1032. HIGASHIOKA K, Miyake N, Nishida R, Chong Y, et al
    [Bilateral Granulomatous Renal Masses after Intravesical BCG Therapy for Non-muscle-invasive Bladder Cancer and Carcinoma in Situ of the Upper Urinary Tract: A Case Study].
    Kansenshogaku Zasshi. 2015;89:481-4.
    Abstract     Related articles   

  1033. STONE L
    Bladder cancer: In the driving seat - AGL loss drives tumour growth.
    Nat Rev Urol. 2015 Nov 10. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  1034. CHEN T, Xie W, Xie L, Sun Y, et al
    Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
    Biochem Biophys Res Commun. 2015 Nov 6. pii: S0006-291X(15)30881.
    Abstract     Related articles   

  1035. LI M, Yu X, Cheng L, Huang Y, et al
    Prostate stem cell antigen variation rs2294008 associated with the risk of bladder cancer.
    Int J Clin Exp Med. 2015;8:13259-66.
    Abstract     Related articles   

  1036. ZENG J, Liao Y, Zhou J, Yang G, et al
    Role of WISP3 siRNA in proliferation, apoptosis and invasion of bladder cancer cells.
    Int J Clin Exp Med. 2015;8:12792-800.
    Abstract     Related articles   

  1037. XU XD, Shao SX, Cao YW, Yang XC, et al
    The study of energy metabolism in bladder cancer cells in co-culture conditions using a microfluidic chip.
    Int J Clin Exp Med. 2015;8:12327-36.
    Abstract     Related articles   

  1038. CORREA AF, Theisen K, Ferroni M, Maranchie JK, et al
    The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer.
    Adv Urol. 2015;2015:656918.
    Abstract     Related articles   

  1039. APPEL JH, Ren H, Sin ML, Liao JC, et al
    Rapid bladder cancer cell detection from clinical urine samples using an ultra-thin silicone membrane.
    Analyst. 2015.
    Abstract     Related articles   

  1040. DEMIRER Z, Uslu AU
    Predictive value of neutrophil-lymphocyte ratio in non-muscle-invasive bladder cancer.
    Urol Oncol. 2015 Nov 5. pii: S1078-1439(15)00449.
    Abstract     Related articles   

  1041. ZHANG Z, Zhang G, Kong C, Gong D, et al
    PP242 suppresses bladder cancer cell proliferation and migration through deactivating the mammalian target of rapamycin complex 2/AKT1 signaling pathway.
    Mol Med Rep. 2015 Nov 6. doi: 10.3892/mmr.2015.4528.
    Abstract     Related articles   

  1042. LANTTO J, Isokangas OP, Saily M
    [Peripheral ischemia and heart failure as complications of neoadjuvant therapy of bladder cancer].
    Duodecim. 2015;131:1605-7.
    Abstract     Related articles   

  1043. ZHANG S, Li J, Zhou G, Mu D, et al
    Increased expression of ESCO1 is correlated with poor patient survival and its role in human bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  1044. MURTHY V, Masodkar R, Kalyani N, Mahantshetty U, et al
    Clinical Outcomes With Dose-Escalated Adaptive Radiation Therapy for Urinary Bladder Cancer: A Prospective Study.
    Int J Radiat Oncol Biol Phys. 2015 Sep 16. pii: S0360-3016(15)03321.
    Abstract     Related articles   

  1045. GAO Y, Wu K, Chen Y, Zhou J, et al
    Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription.
    Oncotarget. 2015 Oct 27. doi: 10.18632/oncotarget.6101.
    Abstract     Related articles   

  1046. XUE M, Pang H, Li X, Li H, et al
    Long noncoding RNA UCA1 promotes bladder cancer cell migration and invasion via hsa-miR-145/ ZEB1/2 /FSCN1 pathway.
    Cancer Sci. 2015 Nov 6. doi: 10.1111/cas.12844.
    Abstract     Related articles   

  1047. SHELLEY M, Court JB, Kynaston HG, Wilt TJ, et al
    WITHDRAWN: Intravesical Bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Cochrane Database Syst Rev. 2015;11:CD003231.
    Abstract     Related articles   

  1048. BURNIER A, Shimizu Y, Dai Y, Nakashima M, et al
    CXCL1 is elevated in the urine of bladder cancer patients.
    Springerplus. 2015;4:610.
    Abstract     Related articles   

  1049. WETTSTEIN MS, Buser L, Hermanns T, Roudnicky F, et al
    CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer.
    Dis Markers. 2015;2015:785461.
    Abstract     Related articles   

  1050. WANG QY, Zhao Y, Zhang R
    The role of mutations and overexpression of the fibroblast growth factor receptor-3 in bladder cancer.
    Minerva Med. 2015.
    Abstract     Related articles   

  1051. ZHAN Y, Liu Y, Lin J, Fu X, et al
    Synthetic Tet-inducible artificial microRNAs targeting beta-catenin or HIF-1alpha inhibit malignant phenotypes of bladder cancer cells T24 and 5637.
    Sci Rep. 2015;5:16177.
    Abstract     Related articles   

  1052. APOZNANSKI W, Rysiakiewicz J, Polok M, Rysiakiewicz K, et al
    Transurethral Resection of the Bladder Tumour as a Treatment Method in Children with Transitional Cell Carcinoma of the Bladder--Analysis of Our Material and Literature Review.
    Adv Clin Exp Med. 2015;24:505-9.
    Abstract     Related articles   

  1053. KOO KC, Lee KS, Chung BH
    Urologic cancers in Korea.
    Jpn J Clin Oncol. 2015;45:805-11.
    Abstract     Related articles   

  1054. ICHIOKA D, Miyazaki J, Inoue T, Kageyama S, et al
    Impact of renal function of patients with advanced urothelial cancer on eligibility for first-line chemotherapy and treatment outcomes.
    Jpn J Clin Oncol. 2015;45:867-73.
    Abstract     Related articles   

  1055. SHATAGOPAM K, Kaimakliotis HZ, Cheng L, Koch MO, et al
    Genitourinary small cell malignancies: prostate and bladder.
    Future Oncol. 2015;11:479-88.
    Abstract     Related articles   

  1056. MARSH GM, Zimmerman SD
    Mortality among chemical plant workers exposed to acrylonitrile: 2011 follow-up.
    J Occup Environ Med. 2015;57:134-45.
    Abstract     Related articles   

  1057. GASPERI V, Evangelista D, Oddi S, Florenzano F, et al
    Regulation of inflammation and proliferation of human bladder carcinoma cells by type-1 and type-2 cannabinoid receptors.
    Life Sci. 2015;138:41-51.
    Abstract     Related articles   

  1058. YAMAMOTO T, Takahashi S, Ichihara K, Hiyama Y, et al
    How do we understand the disagreement in the frequency of surgical site infection between the CDC and Clavien-Dindo classifications?
    J Infect Chemother. 2015;21:130-3.
    Abstract     Related articles   

  1059. LEVI F, Randimbison L, Rafael BM, Manuela MC, et al
    Second primary cancers in the Vaud and Neuchatel Cancer Registries.
    Eur J Cancer Prev. 2015;24:150-4.
    Abstract     Related articles   

  1060. TSAI SC, Ou YC, Cheng CL, Li JR, et al
    Reduction of bladder activity on FDG PET/CT scan in patients with urinary bladder carcinoma. A prospective study with a patient-friendly protocol.
    Nuklearmedizin. 2014;54.
    Abstract     Related articles   

  1061. SALVATORI R, Dackiw AP, Bishop J, Fishman EK, et al
    Bladder pheochromocytoma.
    Endocrine. 2015;48:349-50.
    Abstract     Related articles   

  1062. KAGOTANI A, Ishida M, Yoshida K, Iwai M, et al
    High-grade urothelial carcinoma of the bladder with rhabdoid features: cytological and histological report of two cases.
    Cytopathology. 2015;26:54-6.
    Abstract     Related articles   

  1063. WU Z, Liu K, Wang Y, Xu Z, et al
    Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer.
    Cancer Cell Int. 2015;15:107.
    Abstract     Related articles   

  1064. MARTINEZ-FERNANDEZ M, Rubio C, Segovia C, Lopez-Calderon FF, et al
    EZH2 in Bladder Cancer, a Promising Therapeutic Target.
    Int J Mol Sci. 2015;16:27107-27132.
    Abstract     Related articles   

  1065. JOSEPH N, Dovedi SJ, Thompson C, Lyons J, et al
    Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer.
    Ann Oncol. 2015.
    Abstract     Related articles   

  1066. MADKA V, Mohammed A, Li Q, Zhang Y, et al
    Targeting mTOR and p53 signaling inhibits muscle invasive bladder cancer in vivo.
    Cancer Prev Res (Phila). 2015 Nov 17. pii: canprevres.0199.2015.
    Abstract     Related articles   

  1067. TUOMIKOSKI L, Valli A, Tenhunen M, Muren L, et al
    A comparison between two clinically applied plan library strategies in adaptive radiotherapy of bladder cancer.
    Radiother Oncol. 2015 Nov 11. pii: S0167-8140(15)00554.
    Abstract     Related articles   

  1068. ARMSTRONG DA, Green BB, Seigne JD, Schned AR, et al
    MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer.
    Mol Cancer. 2015;14:194.
    Abstract     Related articles   

  1069. RANZI AD, da Silva JN, Graziottin TM, Annels N, et al
    Immunohistochemistry Biomarkers in Nonmuscle Invasive Bladder Cancer.
    Appl Immunohistochem Mol Morphol. 2015.
    Abstract     Related articles   

  1070. ZHU YT, Pang SY, Lei CY, Luo Y, et al
    Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine.
    Stem Cell Res Ther. 2015;6:224.
    Abstract     Related articles   

  1071. SHARMA P, Zargar-Shoshtari K, Sexton WJ
    Valrubicin in refractory non-muscle invasive bladder cancer.
    Expert Rev Anticancer Ther. 2015.
    Abstract     Related articles   

  1072. OZER K, Horsanali MO, Gorgel SN, Ozbek E, et al
    Bladder injury secondary to obturator reflex is more common with plasmakinetic transurethral resection than monopolar transurethral resection of bladder cancer.
    Cent European J Urol. 2015;68:284-8.
    Abstract     Related articles   

  1073. HONG Y, Esuvaranathan K, Pasikanti KK, Yong Chan EC, et al
    Metabonomic diagnosis of bladder cancer: what are the advantages and considerations?
    Bioanalysis. 2015.
    Abstract     Related articles   

  1074. BEOTHE T, Zubakov D, Kovacs G
    Homozygous losses detected by array comparative genomic hybridization in multiplex urothelial carcinomas of the bladder.
    Cancer Genet. 2015;208:434-40.
    Abstract     Related articles   

  1075. VIRSEDA-RODRIGUEZ AJ, Padilla-Fernandez B, Lopez-Parra M, Santos-Antunes MT, et al
    Influence of antiplatelet-anticoagulant drugs on the need of blood components transfusion after vesical transurethral resection.
    Arch Ital Urol Androl. 2015;87:136-40.
    Abstract     Related articles   

  1076. YUKSEL OH, Verit A, Urkmez A
    What is the correct staging and treatment strategy for locally advanced prostate cancer extending to the bladder?
    Arch Ital Urol Androl. 2015;87:130-5.
    Abstract     Related articles   

  1077. GUGLIERI-LOPEZ B, Perez-Pitarch A, Porta-Oltra B, Ferriols-Lisart F, et al
    Effectiveness, toxicity, and economic evaluation of vinflunine for the treatment of patients with transitional cell carcinoma in the Spanish outpatient setting.
    Anticancer Drugs. 2015;26:860-5.
    Abstract     Related articles   

  1078. PAQUET ER, Hovington H, Brisson H, Lacombe C, et al
    Low level of the X-linked ribosomal protein S4 in human urothelial carcinomas is associated with a poor prognosis.
    Biomark Med. 2015;9:187-97.
    Abstract     Related articles   

  1079. HUPE MC, Kramer MW, Merseburger AS
    Preoperative and modifiable factors to lower postoperative complications after radical cystectomy.
    Curr Urol Rep. 2015;16:19.
    Abstract     Related articles   

  1080. SIM A, Todenhofer T, Mischinger J, Halalsheh O, et al
    Y pouch neobladder-a simplified method of intracorporeal neobladder after robotic cystectomy.
    J Endourol. 2015;29:387-9.
    Abstract     Related articles   

  1081. NOUR HH, Gobashy SE, Kamal AM, Elbaz AG, et al
    Low-dose bacille Calmette-Guerin for non-muscle-invasive bladder cancer: Results of a prospective study.
    Arab J Urol. 2015;13:238-243.
    Abstract     Related articles   

  1082. KANDEEL W, Abdelal A, Elmohamady BN, Sebaey A, et al
    A comparative study between full-dose and half-dose intravesical immune bacille Calmette-Guerin injection in the management of superficial bladder cancer.
    Arab J Urol. 2015;13:233-237.
    Abstract     Related articles   

  1083. CHEN K, Li BK, Xu K, Xu AB, et al
    [Effect of stable DNA methyltransferase 3bknockdown on proliferation and apoptosis in bladder cancer cells in vitro].
    Nan Fang Yi Ke Da Xue Xue Bao. 2015;35:1524-1529.
    Abstract     Related articles   

  1084. GAUTAM KA, Muktanand T, Sankhwar SN, Goel A, et al
    Functional polymorphisms in the IL6 gene promoter and the risk of urinary bladder cancer in India.
    Cytokine. 2015;77:152-156.
    Abstract     Related articles   

  1085. GREGG JR, Dahm P, Chang SS
    Guideline-based management of non-muscle invasive bladder cancer.
    Indian J Urol. 2015;31:320-326.
    Abstract     Related articles   

  1086. BROOKS NA, O'Donnell MA
    Treatment options in non-muscle-invasive bladder cancer after BCG failure.
    Indian J Urol. 2015;31:312-319.
    Abstract     Related articles   

  1087. JOKISCH JF, Karl A, Stief C
    Intravesical immunotherapy in nonmuscle invasive bladder cancer.
    Indian J Urol. 2015;31:304-311.
    Abstract     Related articles   

  1088. PORTEN SP, Leapman MS, Greene KL
    Intravesical chemotherapy in non-muscle-invasive bladder cancer.
    Indian J Urol. 2015;31:297-303.
    Abstract     Related articles   

  1089. ISHARWAL S, Konety B
    Non-muscle invasive bladder cancer risk stratification.
    Indian J Urol. 2015;31:289-296.
    Abstract     Related articles   

  1090. SOUBRA A, Risk MC
    Diagnostics techniques in nonmuscle invasive bladder cancer.
    Indian J Urol. 2015;31:283-288.
    Abstract     Related articles   

  1091. DARWICHE F, Parekh DJ, Gonzalgo ML
    Biomarkers for non-muscle invasive bladder cancer: Current tests and future promise.
    Indian J Urol. 2015;31:273-282.
    Abstract     Related articles   

  1092. KONETY BR
    Advances in nonmuscle invasive bladder cancer.
    Indian J Urol. 2015;31:272.
    Abstract     Related articles   

  1093. DODAGOUDAR C, Doval DC, Mahanta A, Goel V, et al
    FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients.
    Jpn J Clin Oncol. 2015.
    Abstract     Related articles   

  1094. OZCAN C, Telli O, Ozturk E, Suer E, et al
    The prognostic significance of preoperative leukocytosis and neutrophil-to-lymphocyte ratio in patients who underwent radical cystectomy for bladder cancer.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  1095. ABROL S, Jairath A, Ganpule S, Ganpule A, et al
    Can CT Virtual Cystoscopy Replace Conventional Cystoscopy in Early Detection of Bladder Cancer?
    Adv Urol. 2015;2015:926590.
    Abstract     Related articles   

  1096. ZHAO Y, Qi JG, Yang N, Lin YL, et al
    Association between MYC rs9642880[T] allele and bladder cancer risk: a meta-analysis.
    Genet Mol Res. 2015;14:14745-51.
    Abstract     Related articles   

  1097. ZHAO T, Wu X, Liu J
    Association between interleukin-22 genetic polymorphisms and bladder cancer risk.
    Clinics (Sao Paulo). 2015;70:686-90.
    Abstract     Related articles   

  1098. TRABOULSI SL, Kassouf W
    Bladder cancer: A step closer to individualized treatment for bladder cancer.
    Nat Rev Urol. 2015 Nov 24. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  1099. WITJES JA
    Bladder cancer in 2015: Improving indication, technique and outcome of radical cystectomy.
    Nat Rev Urol. 2015 Nov 24. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  1100. LEVERIDGE MJ
    The state and potential of social media in bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  1101. KISS B, Burkhard FC, Thalmann GN
    Open radical cystectomy: still the gold standard for muscle invasive bladder cancer.
    World J Urol. 2015.
    Abstract     Related articles   

  1102. WU H, Wang X, Zhang L, Mo N, et al
    Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
    Clin Genitourin Cancer. 2015 Oct 26. pii: S1558-7673(15)00263.
    Abstract     Related articles   

  1103. CROZIER J, Papa N, Sengupta S, Bolton DM, et al
    Changing practice of pelvic lymph node dissection in management of primary bladder cancer.
    Minerva Urol Nefrol. 2015.
    Abstract     Related articles   

  1104. CHOU R, Buckley D, Fu R, Gore JL, et al
    The potential of MRI-guided online adaptive re-optimisation in radiotherapy of urinary bladder cancer.
    Radiother Oncol. 2015 Nov 26. pii: S0167-8140(15)00594.
    Abstract     Related articles   

  1105. FENG C, Wang L, Ding G, Jiang H, et al
    BLCA1 expression is associated with angiogenesis of bladder cancer and is correlated with common pro-angiogenic factors.
    Int J Clin Exp Med. 2015;8:16259-16265.
    Abstract     Related articles   

  1106. DING M, Li Y, Wang H, Lv Y, et al
    Diagnostic value of urinary microRNAs as non-invasive biomarkers for bladder cancer: a meta-analysis.
    Int J Clin Exp Med. 2015;8:15432-15440.
    Abstract     Related articles   

  1107. MESSINA C, Zanardi E, Dellepiane C, Tomasello L, et al
    A Case of Plasmacytoid Variant of Bladder Cancer With a Single Penile Metastasis and a Complete Response to Carboplatin-Based Chemotherapy and Review of the Literature.
    Clin Genitourin Cancer. 2015 Oct 28. pii: S1558-7673(15)00268.
    Abstract     Related articles   

  1108. WU S, Yang Z, Ye R, An D, et al
    Novel variants in MLL confer to bladder cancer recurrence identified by whole-exome sequencing.
    Oncotarget. 2015 Nov 25. doi: 10.18632/oncotarget.6380.
    Abstract     Related articles   

  1109. AZUMA T, Nagase Y, Oshi M
    Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guerin.
    Mol Clin Oncol. 2015;3:1113-1116.
    Abstract     Related articles   

  1110. ZHANG HH, Qi F, Cao YH, Zu XB, et al
    Expression and clinical significance of microRNA-21, maspin and vascular endothelial growth factor-C in bladder cancer.
    Oncol Lett. 2015;10:2610-2616.
    Abstract     Related articles   

  1111. CAI T, Mondaini N, Tiscione D, Dal Canto M, et al
    Loss of heterozygosis on chromosome 18q21-23 and muscle-invasive bladder cancer natural history.
    Oncol Lett. 2015;10:2569-2573.
    Abstract     Related articles   

  1112. RICCI S, Bruzzese D, DI Carlo A
    Evaluation of MMP-2, MMP-9, TIMP-1, TIMP-2, NGAL and MMP-9/NGAL complex in urine and sera from patients with bladder cancer.
    Oncol Lett. 2015;10:2527-2532.
    Abstract     Related articles   

  1113. SONG YH, Liao R, Li PC, Ge BO, et al
    Effects of siRNA Livin on EJ human bladder cancer cells treated with mitomycin-C.
    Oncol Lett. 2015;10:2422-2426.
    Abstract     Related articles   

  1114. KOBATAKE K, Mita K, Ohara S, Kato M, et al
    Advantage of transurethral resection with narrow band imaging for non-muscle invasive bladder cancer.
    Oncol Lett. 2015;10:1097-1102.
    Abstract     Related articles   

  1115. LIN YL, Gui SL, Ma JG
    Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
    Oncol Lett. 2015;10:647-652.
    Abstract     Related articles   

  1116. ZHAO C, Qi L, Chen M, Liu L, et al
    microRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling.
    Exp Ther Med. 2015;10:1103-1108.
    Abstract     Related articles   

  1117. KNOLLMAN H, Godwin JL, Jain R, Wong YN, et al
    Muscle-invasive urothelial bladder cancer: an update on systemic therapy.
    Ther Adv Urol. 2015;7:312-330.
    Abstract     Related articles   

  1118. PAGLIARULO V, Ancona P, Martines I, Spadavecchia R, et al
    Celecoxib for the prevention of nonmuscle invasive bladder cancer: results from a matched control study.
    Ther Adv Urol. 2015;7:303-311.
    Abstract     Related articles   

  1119. EARL J, Rico D, Carrillo-de-Santa-Pau E, Rodriguez-Santiago B, et al
    Erratum to: The UBC-40 Urothelial Bladder Cancer Cell Line Index: a genomic resource for functional studies.
    BMC Genomics. 2015;16:1019.
    Abstract     Related articles   

  1120. BAHOUTH Z, Halachmi S, Moskovitz B, Nativ O, et al
    The role of hyperthermia as a treatment for non-muscle invasive bladder cancer.
    Expert Rev Anticancer Ther. 2015.
    Abstract     Related articles   

  1121. ZHANG Q, Hao C, Cheng G, Wang L, et al
    High CD4(+) T cell density is associated with poor prognosis in patients with non-muscle-invasive bladder cancer.
    Int J Clin Exp Pathol. 2015;8:11510-6.
    Abstract     Related articles   

  1122. ZHANG Z, Xu Q, Huang X, Yang J, et al
    The effects of early versus delayed castration targeting androgen on prolonging survival in a mouse model of bladder cancer.
    Int J Clin Exp Pathol. 2015;8:10283-93.
    Abstract     Related articles   

  1123. LI Y, Cheng H, Xu W, Tian X, et al
    Expression of Robo protein in bladder cancer tissues and its effect on the growth of cancer cells by blocking Robo protein.
    Int J Clin Exp Pathol. 2015;8:9932-40.
    Abstract     Related articles   

  1124. FAILLIE JL, Hillaire-Buys D
    Examples of how the pharmaceutical industries distort the evidence of drug safety: the case of pioglitazone and the bladder cancer issue.
    Pharmacoepidemiol Drug Saf. 2015 Nov 30. doi: 10.1002/pds.3925.
    Abstract     Related articles   

  1125. ZHANG S, Pei X, Hu H, Zhang W, et al
    Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  1126. BEN FRADJ MK, Kallel A, Gargouri MM, Chehida MA, et al
    Association of FokI polymorphism of vitamin D receptor with urothelial bladder cancer in Tunisians: role of tobacco smoking and plasma vitamin D concentration.
    Tumour Biol. 2015.
    Abstract     Related articles   

  1127. JONES RT, Felsenstein KM, Theodorescu D
    Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer.
    Urol Clin North Am. 2016;43:77-86.
    Abstract     Related articles   

  1128. NETTO GJ, Tafe LJ
    Emerging Bladder Cancer Biomarkers and Targets of Therapy.
    Urol Clin North Am. 2016;43:63-76.
    Abstract     Related articles   

  1129. MBEUTCHA A, Lucca I, Mathieu R, Lotan Y, et al
    Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer.
    Urol Clin North Am. 2016;43:47-62.
    Abstract     Related articles   

  1130. KIM GY, Park SY, Jo A, Kim M, et al
    Erratum to: Gecko proteins induce the apoptosis of bladder cancer 5637 cells by inhibiting Akt and activating the intrinsic caspase cascade.
    BMB Rep. 2015;48:642.
    Abstract     Related articles   

  1131. SOLOMON JP, Hansel DE
    Morphologic and Molecular Characteristics of Bladder Cancer.
    Surg Pathol Clin. 2015;8:663-76.
    Abstract     Related articles   

  1132. SAVINA NV, Nikitchenko NV, Kuzhir TD, Rolevich AI, et al
    The Cellular Response to Oxidatively Induced DNA Damage and Polymorphism of Some DNA Repair Genes Associated with Clinicopathological Features of Bladder Cancer.
    Oxid Med Cell Longev. 2016;2016:5710403.
    Abstract     Related articles   

  1133. SUN DK, Wang JM, Zhang P, Wang YQ, et al
    MicroRNA-138 Regulates Metastatic Potential of Bladder Cancer Through ZEB2.
    Cell Physiol Biochem. 2015;37:2366-2374.
    Abstract     Related articles   

  1134. LACOMBE L, Fradet V, Levesque E, Pouliot F, et al
    Phase II drug metabolizing polymorphisms and smoking status predict recurrence of non-muscle invasive bladder cancer: a gene-smoking interaction.
    Cancer Prev Res (Phila). 2015 Dec 8. pii: canprevres.0069.2015.
    Abstract     Related articles   

  1135. WANG C, Ge Q, Chen Z, Hu J, et al
    Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 expression.
    Tumour Biol. 2015.
    Abstract     Related articles   

  1136. JURI H, Tsuboyama T, Kumano S, Inada Y, et al
    Detection of Bladder Cancer: Comparison of Low-Dose Scans with AIDR 3D and Routine-Dose Scans with FBP on the Excretory Phase in CT Urography.
    Br J Radiol. 2015 Dec 7:20150495.
    Abstract     Related articles   

  1137. KONG D, Chen F, Sima NI
    Inhibition of focal adhesion kinase induces apoptosis in bladder cancer cells via Src and the phosphatidylinositol 3-kinase/Akt pathway.
    Exp Ther Med. 2015;10:1725-1731.
    Abstract     Related articles   

  1138. HEYES SM, Bond MJ, Harrington A, Belan I, et al
    The relative contributions of function, perceived psychological burden and partner support to cognitive distress in bladder cancer.
    Psychooncology. 2015 Dec 7. doi: 10.1002/pon.4054.
    Abstract     Related articles   

  1139. NARAYAN V, Mamtani R, Keefe S, Guzzo T, et al
    Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer.
    Cancer Res Treat. 2015 Dec 2. doi: 10.4143/crt.2015.
    Abstract     Related articles   

  1140. HU H, Zhao J, Zhang M
    Expression of Annexin A2 and Its Correlation With Drug Resistance and Recurrence of Bladder Cancer.
    Technol Cancer Res Treat. 2015 Dec 4. pii: 1533034615617078.
    Abstract     Related articles   

  1141. AFONSO J, Santos LL, Morais A, Amaro T, et al
    Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumour aggressiveness.
    Cell Cycle. 2015.
    Abstract     Related articles   

  1142. ETHUG H, Jagodic S, Ahmetovic-Ethug J, Selimovic Z, et al
    Predicting recurrence of non-muscle-invasive bladder cancer after transurethral resection.
    Med Glas (Zenica). 2016;13.
    Abstract     Related articles   

  1143. WAN B, Tan J, Zeng Q, He LY, et al
    729G/C polymorphism in Toll-like receptor 4 results in increased susceptibility to bladder cancer.
    Genet Mol Res. 2015;14:15482-7.
    Abstract     Related articles   

  1144. SHEN B, Tan M, Mu X, Qin Y, et al
    Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy.
    Tumour Biol. 2015.
    Abstract     Related articles   

  1145. KISELYOV A, Bunimovich-Mendrazitsky S, Startsev V
    Treatment of non-muscle invasive bladder cancer with Bacillus Calmette-Guerin (BCG): Biological markers and simulation studies.
    BBA Clin. 2015;4:27-34.
    Abstract     Related articles   

  1146. XIE L, Sun Y, Chen T, Tian D, et al
    Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis.
    Onco Targets Ther. 2015;8:3679-3690.
    Abstract     Related articles   

  1147. HIRAIWA T, Mori T, Ohashi T, Hanami Y, et al
    Eosinophilic fasciitis with severe joint contracture in a patient with bladder cancer and B-cell lymphoma.
    J Dermatol. 2015 Dec 15. doi: 10.1111/1346-8138.13233.
    Abstract     Related articles   

  1148. OGIHARA K, Kikuchi E, Yuge K, Ito Y, et al
    Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients.
    Ann Surg Oncol. 2015.
    Abstract     Related articles   

  1149. FERRARA A, Lewis JD, Habel LA
    Pioglitazone Use and Risk of Bladder Cancer-Reply.
    JAMA. 2015;314:2568-2569.
    Abstract     Related articles   

  1150. DAVIES BJ
    Pioglitazone Use and Risk of Bladder Cancer.
    JAMA. 2015;314:2568.
    Abstract     Related articles   

  1151. SINGH S, Suchard MA
    Pioglitazone Use and Risk of Bladder Cancer.
    JAMA. 2015;314:2567-2568.
    Abstract     Related articles   

  1152. LIU CAI-SHU, Cai S, Zhang YP, Yan HY, et al
    [Present Situation and Prospect of Urinary Biomarkers For Bladder Cancer].
    Sheng Li Ke Xue Jin Zhan. 2015;46:255-8.
    Abstract     Related articles   

  1153. ALFANO M, Canducci F, Nebuloni M, Clementi M, et al
    The interplay of extracellular matrix and microbiome in urothelial bladder cancer.
    Nat Rev Urol. 2015 Dec 15. doi: 10.1038/nrurol.2015.
    Abstract     Related articles   

  1154. GUNLUSOY B, Ceylan Y, Degirmenci T, Kozacioglu Z, et al
    Urothelial bladder cancer in young adults: Diagnosis, treatment and clinical behaviour.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  1155. KASSOUF W, Traboulsi SL, Kulkarni GS, Breau RH, et al
    CUA guidelines on the management of non-muscle invasive bladder cancer.
    Can Urol Assoc J. 2015;9.
    Abstract     Related articles   

  1156. KARKOULIS PK, Stravopodis DJ, Voutsinas GE
    17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy.
    Tumour Biol. 2015.
    Abstract     Related articles   

  1157. CAO YH, Zhang HH, Xu HF, Duan YJ, et al
    Prognostic role of microRNA-100 in patients with bladder cancer.
    Genet Mol Res. 2015;14:15948-15954.
    Abstract     Related articles   

  1158. KRPINA K, Babarovic E, Spanjol J, Dordevic G, et al
    Correlation of tumor-associated macrophages and NK cells with bladder cancer size and T stage in patients with solitary low-grade urothelial carcinoma.
    Wien Klin Wochenschr. 2015.
    Abstract     Related articles   

  1159. ZHANG X, Zhang Y, Liu X, Fang A, et al
    Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
    Oncotarget. 2015 Dec 7. doi: 10.18632/oncotarget.6487.
    Abstract     Related articles   

  1160. LI CC, Yang JC, Lu MC, Lee CL, et al
    ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer.
    Oncotarget. 2015 Dec 5. doi: 10.18632/oncotarget.6482.
    Abstract     Related articles   

  1161. CLARK PE
    Toward Personalized Guidelines in Bladder Cancer.
    J Natl Compr Canc Netw. 2015;13:1458-60.
    Abstract     Related articles   

  1162. ZENG S, Yu X, Ma C, Zhang Z, et al
    Low-Dose Versus Standard Dose of Bacillus Calmette-Guerin in the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Medicine (Baltimore). 2015;94:e2176.
    Abstract     Related articles   

  1163. PENG XC, Gong FM, Chen Y, Qiu M, et al
    Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer.
    J Proteomics. 2015 Dec 3. pii: S1874-3919(15)30177.
    Abstract     Related articles   

  1164. SAKR SA, Mahran HA, Fahmy AM, El-Kholy MA, et al
    Expression of c-erb-B2 gene in bladder cancer of Egyptian patients and its correlation with p53 and bcl-2.
    Biomed Pharmacother. 2015;76:73-81.
    Abstract     Related articles   

  1165. DABROWSKA M, Drabarek T, Muraszko-Klaudel A, Slawek J, et al
    A thoracic tuberculous spondylodisctis after intravesical BCG immunotherapy of bladder cancer - Case report and literature review.
    Neurol Neurochir Pol. 2015;49:460-466.
    Abstract     Related articles   

  1166. CHOU R, Buckley D, Fu R, Gore JL, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 37-2015. A 76-Year-Old Man with Fevers, Leukopenia, and Pulmonary Infiltrates.
    N Engl J Med. 2015;373:2162-72.
    Abstract     Related articles   

  1167. DRAGOVIC T, Marinkovic D, Kuzmic-Jankovic S, Prelevic R, et al
    Unrecognised adrenergic symptoms and the delayed diagnosis of urinary bladder paraganglioma.
    Vojnosanit Pregl. 2015;72:831-6.
    Abstract     Related articles   

  1168. KAMAL AM, Wishahi M, Nour HH, Elganzoury H, et al
    AMBULANT FLEXIBLE CYSTOSCOPY FOR FOLLOW-UP OF Ta-TI UROTHELIAL CARCINOMA OF THE URINARY BLADDER: PAIN PERCEPTION AND COST EFFECTIVE.
    J Egypt Soc Parasitol. 2015;45:429-33.
    Abstract     Related articles   

  1169. MINA SN, Antonios SN
    LYMPHOEPITHELIOMA-LIKE CARCINOMA OF THE URINARY BLADDER ASSOCIATED WITH SCHISTOSOMIASIS: A CASE REPORT AND REVIEW OF LITERATURE.
    J Egypt Soc Parasitol. 2015;45:385-8.
    Abstract     Related articles   

  1170. HASEGAWA Y, Komasawa N, Matsunami S, Kido H, et al
    [Rapid Sequence Intubation with the McGRATH MAC Videolaryngoscope in the Sitting Position for a Patient with Restricted Mouth Opening].
    Masui. 2015;64:632-4.
    Abstract     Related articles   

  1171. BANNO E, Nishino A, Nagai Y, Yasuda M, et al
    [A CASE OF UROTHELIAL CARCINOMA OF THE URINARY BLADDER WITH SQUAMOUS DIFFERENTIATION RESPONDING TO PACLITAXEL AND CARBOPLATIN NEOADJUVANT CHEMOTHERAPY].
    Nihon Hinyokika Gakkai Zasshi. 2015;106:206-10.
    Abstract     Related articles   

  1172. MENG YS, Su Y, Fan Y, Yu W, et al
    [Risk factors for the development of postoperative paralytic ileus after radical cystectomy: a report of 740 cases].
    Beijing Da Xue Xue Bao. 2015;47:628-33.
    Abstract     Related articles   

  1173. LIU YQ, Lu J, Zhao L, Hou XF, et al
    [Prognostic factors for intravesical recurrence after surgery for upper tract urothelial carcinoma in renal transplant recipients].
    Beijing Da Xue Xue Bao. 2015;47:605-10.
    Abstract     Related articles   

  1174. BRIMO F, Dauphin-Pierre S, Aprikian A, Kassouf W, et al
    Inverted urothelial carcinoma: a series of 12 cases with a wide morphologic spectrum overlapping with the large nested variant.
    Hum Pathol. 2015;46:1506-13.
    Abstract     Related articles   

  1175. KIM K, Sung CO, Park BH, Ku JY, et al
    Immunoprofile-based subgrouping of urothelial bladder carcinomas for survival prediction.
    Hum Pathol. 2015;46:1464-70.
    Abstract     Related articles   

  1176. BOUCHER M, Bryan S, Dukes S
    Deficiency or dementia? Exploring B12 deficiency after urostomy.
    Br J Nurs. 2015;24:594-7.
    Abstract     Related articles   

  1177. MATOSO A, Epstein JI
    Epithelioid Angiosarcoma of the Bladder: A Series of 9 Cases.
    Am J Surg Pathol. 2015;39:1377-82.
    Abstract     Related articles   

  1178. ADDING C, Collins JW, Laurin O, Hosseini A, et al
    Enhanced recovery protocols (ERP) in robotic cystectomy surgery. Review of current status and trends.
    Curr Urol Rep. 2015;16:32.
    Abstract     Related articles   

  1179. SUKHA A, Smyth N
    Fistula formation between the external iliac artery and ileal conduit following a radical cystoprostatectomy: a rare complication with prewarning signs of haemorrhage.
    BMJ Case Rep. 2015;2015.
    Abstract     Related articles   

  1180. LIN YH, Peng PY
    Semiconductor sensor embedded microfluidic chip for protein biomarker detection using a bead-based immunoassay combined with deoxyribonucleic acid strand labeling.
    Anal Chim Acta. 2015;869:34-42.
    Abstract     Related articles   

  1181. FERNANDEZ-PINEDA I, McCarville MB, Brennan RC, Spunt SL, et al
    Bilateral internal hemipelvectomy for osteosarcoma in a pediatric patient previously treated for rhabdomyosarcoma.
    Orthop Traumatol Surg Res. 2015;101:395-7.
    Abstract     Related articles   

  1182. ZYCZKOWSKI M, Muskala B, Kaletka Z, Bryniarski P, et al
    Sacrocolpopexy with polypropylene tape as valuable surgical modification during cystectomy with orthotopic ileal bladder: functional results.
    Biomed Res Int. 2015;2015:306191.
    Abstract     Related articles   

  1183. TOMASZEWSKI JJ, Smaldone MC
    Perioperative strategies to reduce postoperative complications after radical cystectomy.
    Curr Urol Rep. 2015;16:26.
    Abstract     Related articles   

  1184. TYSON MD, Wisenbaugh ES, Patton M, Salevitz D, et al
    Postoperative changes in serum CO2 as an indicator of postoperative complications after radical cystectomy.
    Curr Urol Rep. 2015;16:25.
    Abstract     Related articles   

  1185. OH KJ, Choi YD, Chung HS, Hwang EC, et al
    A novel transurethral resection technique for superficial flat bladder tumor: grasp and bite technique.
    Korean J Urol. 2015;56:227-32.
    Abstract     Related articles   

  1186. KOJIMA Y, Takahi Y, Ichimaru N, Okumi M, et al
    Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report.
    BMC Res Notes. 2015;8:25.
    Abstract     Related articles   

  1187. BUNIMOVICH-MENDRAZITSKY S, Pisarev V, Kashdan E
    Modeling and simulation of a low-grade urinary bladder carcinoma.
    Comput Biol Med. 2015;58:118-29.
    Abstract     Related articles   

  1188. CHANG CH, Chan PC, Li JR, Chen CJ, et al
    Gab1 is essential for membrane translocation, activity and integrity of mTORCs after EGF stimulation in urothelial cell carcinoma.
    Oncotarget. 2015;6:1478-89.
    Abstract     Related articles   

  1189. MICHAILIDI C, Hayashi M, Datta S, Sen T, et al
    Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use.
    Cancer Prev Res (Phila). 2015;8:208-21.
    Abstract     Related articles   

  1190. BAGLO Y, Peng Q, Hagen L, Berg K, et al
    Studies of the photosensitizer disulfonated meso-tetraphenyl chlorin in an orthotopic rat bladder tumor model.
    Photodiagnosis Photodyn Ther. 2015;12:58-66.
    Abstract     Related articles   

  1191. ABOUMARZOUK O, Valentine R, Buist R, Ahmad S, et al
    Laser-induced autofluorescence spectroscopy: can it be of importance in detection of bladder lesions?
    Photodiagnosis Photodyn Ther. 2015;12:76-83.
    Abstract     Related articles   

  1192. NOWAK JM, Klimaszewska-Wisniewska A, Izdebska M, Gagat M, et al
    Gelsolin is a potential cellular target for cotinine to regulate the migration and apoptosis of A549 and T24 cancer cells.
    Tissue Cell. 2015;47:105-14.
    Abstract     Related articles   

  1193. CHOO MS, Jeong CW, Kwak C, Kim HH, et al
    Effect of sex on prognosis of urothelial carcinoma: propensity score matching analysis.
    Clin Genitourin Cancer. 2015;13:e113-21.
    Abstract     Related articles   

  1194. NECCHI A, Pond GR, Giannatempo P, Di Lorenzo G, et al
    Cisplatin-based first-line therapy for advanced urothelial carcinoma after previous perioperative cisplatin-based therapy.
    Clin Genitourin Cancer. 2015;13:178-84.
    Abstract     Related articles   

  1195. BIGUM LH, Spielmann ME, Juhl G, Rasmussen A, et al
    A qualitative study exploring male cancer patients' experiences with percutaneous nephrostomy.
    Scand J Urol. 2015;49:162-8.
    Abstract     Related articles   

  1196. BOUAZIZ O, Guilloux A
    A penalized algorithm for event-specific rate models for recurrent events.
    Biostatistics. 2015;16:281-94.
    Abstract     Related articles   

  1197. MONTGOMERY JS
    Editorial comment for Sim et al.
    J Endourol. 2015;29:390.
    Abstract     Related articles   

  1198. YANG YH, Zhu Y, Zhu XW, Tang HJ, et al
    Unusual presentation of urachal adenocarcinoma with genitourinary cutaneous metastasis.
    Asian J Androl. 2015;17:339-40.
    Abstract     Related articles   

  1199. JENSEN BT, Petersen AK, Jensen JB, Laustsen S, et al
    Efficacy of a multiprofessional rehabilitation programme in radical cystectomy pathways: a prospective randomized controlled trial.
    Scand J Urol. 2015;49:133-41.
    Abstract     Related articles   

  1200. NECCHI A, Giannatempo P, Paolini B, Lo Vullo S, et al
    Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy.
    Clin Genitourin Cancer. 2015;13:171-7.
    Abstract     Related articles   

  1201. PIANA S, Bernardi C, Zoino JL
    Itchy erythroderma in a neoplastic patient-mind the mite!
    Eur J Intern Med. 2015;26:139-40.
    Abstract     Related articles   

  1202. RICHARDS KA, Cohn JA, Large MC, Bales GT, et al
    The effect of length of ureteral resection on benign ureterointestinal stricture rate in ileal conduit or ileal neobladder urinary diversion following radical cystectomy.
    Urol Oncol. 2015;33:65.
    Abstract     Related articles   

  1203. MITIN T, George A, Zietman AL, Heney NM, et al
    Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233.
    Int J Radiat Oncol Biol Phys. 2016;94:67-74.
    Abstract     Related articles   

  1204. MA L, Xu Z, Xu C, Jiang X, et al
    MicroRNA-148a represents an independent prognostic marker in bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  1205. BEN BAHRIA-SEDIKI I, Sampaio C, Chebil M, Cherif M, et al
    Akt activation correlates with the tumor aggressiveness in Tunisian patients with bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  1206. WANG Y, Yu Y, Ye R, Zhang D, et al
    An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese.
    Oncotarget. 2015 Dec 19. doi: 10.18632/oncotarget.6666.
    Abstract     Related articles   

  1207. SANTOS F, Dragomir A, Zakaria AS, Kassouf W, et al
    Predictors of costs associated with radical cystectomy for bladder cancer: A population-based retrospective cohort study in the province of Quebec, Canada.
    J Surg Oncol. 2015 Dec 22. doi: 10.1002/jso.24132.
    Abstract     Related articles   

  1208. ZHONG J, Chen Y, Liao X, Li J, et al
    Testis expressed 19 is a novel cancer-testis antigen expressed in bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  1209. KAWAHARA T, Ide H, Kashiwagi E, Patterson JD, et al
    Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation.
    Am J Cancer Res. 2015;5:2959-68.
    Abstract     Related articles   

  1210. RORBACH-DOLATA A, Marchewka Z, Piwowar A
    [The biochemical carcinogenesis of selected heavy metals in bladder cancer].
    Postepy Biochem. 2015;61:176-82.
    Abstract     Related articles   

  1211. HERNANDEZ V, Llorente C, de la Pena E, Perez-Fernandez E, et al
    Long-term oncological outcomes of an active surveillance program in recurrent low grade Ta bladder cancer.
    Urol Oncol. 2015 Dec 10. pii: S1078-1439(15)00557.
    Abstract     Related articles   

  1212. ABRO S, Clark M, Barkan G, Hoppensteadt D, et al
    Inflammation and Hemostatic Activation may Contribute to Postsurgical Thrombosis in Patients With Bladder Cancer.
    Clin Appl Thromb Hemost. 2015 Dec 17. pii: 1076029615622000.
    Abstract     Related articles   

  1213. SHI Z, Li X, Wu D, Tang R, et al
    Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
    Tumour Biol. 2015.
    Abstract     Related articles   

  1214. CROZIER J, Demkiw S, Lawrentschuk N
    Utility of lymphadenectomy following cystectomy for non-urothelial bladder cancer.
    Minerva Urol Nefrol. 2015.
    Abstract     Related articles   

  1215. SALMINEN AP, Jambor I, Syvanen KT, Bostrom PJ, et al
    Lymph node imaging in bladder cancer.
    Minerva Urol Nefrol. 2015.
    Abstract     Related articles   

  1216. SHEN H, Blijlevens M, Yang N, Frangou C, et al
    Sox4 Expression Confers Bladder Cancer Stem Cell Properties and Predicts for Poor Patient Outcome.
    Int J Biol Sci. 2015;11:1363-75.
    Abstract     Related articles   

  1217. MIYATA Y, Sakai H
    Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy.
    Dis Markers. 2015;2015:857416.
    Abstract     Related articles   

  1218. AN Y, Li H, Wang KJ, Liu XH, et al
    Meta-analysis of the relationship between slow acetylation of N-acetyl transferase 2 and the risk of bladder cancer.
    Genet Mol Res. 2015;14:16896-904.
    Abstract     Related articles   

  1219. KLAASSEN Z, DiBianco JM, Jen RP, Harper B, et al
    The Impact of Radical Cystectomy and Urinary Diversion on Suicidal Death in Patients With Bladder Cancer.
    J Wound Ostomy Continence Nurs. 2015.
    Abstract     Related articles   

  1220. CHIU KY, Wu CC, Chia CH, Hsu SL, et al
    Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms.
    Cancer Lett. 2015 Dec 8. pii: S0304-3835(15)00736.
    Abstract     Related articles   

  1221. CHOU R, Buckley D, Fu R, Gore JL, et al
    Risk of Malignant Neoplasms of Kidney and Bladder in a Cohort Study of the Diabetic Population in Taiwan With Age, Sex, and Geographic Area Stratifications.
    Medicine (Baltimore). 2015;94:e1494.
    Abstract     Related articles   

  1222. LUO Y, She DL, Xiong H, Fu SJ, et al
    The Prognostic Effect of Statin Use on Urologic Cancers: An Updated Meta-Analysis of 35 Observational Studies.
    Medicine (Baltimore). 2015;94:e1523.
    Abstract     Related articles   

  1223. AHMAD I
    The role of WNT signalling in urothelial cell carcinoma.
    Ann R Coll Surg Engl. 2015;97:481-6.
    Abstract     Related articles   

  1224. WANG X, Xu S, Tang D, Gu W, et al
    Malignant Inflammatory Myofibroblastic Tumor of the Urinary Bladder in a 14-Year-Old Boy.
    J Pediatr Hematol Oncol. 2015;37:e402-4.
    Abstract     Related articles   

  1225. KOYUNCUER A
    Histopathological evaluation of urothelial carcinomas in transurethral resection urinary bladder tumor specimens: eight years of single center experience.
    Asian Pac J Cancer Prev. 2015;16:2871-7.
    Abstract     Related articles   

  1226. CATHOMAS R, De Santis M, Galsky MD
    First-line treatment of metastatic disease: cisplatin-ineligible patients.
    Hematol Oncol Clin North Am. 2015;29:329-40.
    Abstract     Related articles   

  1227. JANI AB, Efstathiou JA, Shipley WU
    Bladder preservation strategies.
    Hematol Oncol Clin North Am. 2015;29:289-300.
    Abstract     Related articles   

  1228. WEIJERS Y, Arentsen HC, Arends TJ, Witjes JA, et al
    Management of low-risk and intermediate-risk non-muscle-invasive bladder carcinoma.
    Hematol Oncol Clin North Am. 2015;29:219-25.
    Abstract     Related articles   

  1229. CHI BH, Kim SJ, Seo HK, Seo HH, et al
    P70S6K and Elf4E dual inhibition is essential to control bladder tumor growth and progression in orthotopic mouse non-muscle invasive bladder tumor model.
    J Korean Med Sci. 2015;30:308-16.
    Abstract     Related articles   

  1230. ROSSI L, Santoni M, Crabb SJ, Scarpi E, et al
    High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.
    Ann Surg Oncol. 2015;22:1377-84.
    Abstract     Related articles   

  1231. BEANE FREEMAN LE, Karagas MR, Baris D, Schwenn M, et al
    Is the Inverse Association Between Selenium and Bladder Cancer Due to Confounding by Smoking?
    Am J Epidemiol. 2015.
    Abstract     Related articles   


  1232. Re: "Is the Inverse Association Between Selenium and Bladder Cancer Due to Confounding by Smoking?".
    Am J Epidemiol. 2015;182:280.
    Abstract     Related articles   

  1233. GOOSSENS ME, Brinkman M, Zeegers MP, Buntinx F, et al
    RE: "IS THE INVERSE ASSOCIATION BETWEEN SELENIUM AND BLADDER CANCER DUE TO CONFOUNDING BY SMOKING?"
    Am J Epidemiol. 2015.
    Abstract     Related articles   

  1234. KLOPFER K, Delahunt B, Adamson M, Samaratunga H, et al
    Value of uroplakin III in distinguishing variants of primary bladder urothelial carcinoma from malignancy metastatic to the urinary bladder.
    Anticancer Res. 2014;34:6779-84.
    Abstract     Related articles   

  1235. KUO JH, Shih TY, Lin JP, Lai KC, et al
    Cantharidin Induces DNA Damage and Inhibits DNA Repair-associated Protein Expressions in TSGH8301 Human Bladder Cancer Cell.
    Anticancer Res. 2015;35:795-804.
    Abstract     Related articles   

  1236. ECKE TH, Arndt C, Stephan C, Hallmann S, et al
    Preliminary Results of a Multicentre Study of the UBC Rapid Test for Detection of Urinary Bladder Cancer.
    Anticancer Res. 2015;35:2651-5.
    Abstract     Related articles   

  1237. SULE N, Xu BO, El Zein D, Szigeti K, et al
    Radiation-induced Chondrosarcoma of the Bladder. Case Report and Review of Literature.
    Anticancer Res. 2015;35:2857-60.
    Abstract     Related articles   

  1238. NOEL N, Couteau J, Maillet G, Gobet F, et al
    TP53 and FGFR3 Gene Mutation Assessment in Urine: Pilot Study for Bladder Cancer Diagnosis.
    Anticancer Res. 2015;35:4915-21.
    Abstract     Related articles   

  1239. LEA MA, Altayyar M, desBORDES C
    Inhibition of Growth of Bladder Cancer Cells by 3-(3-Pyridinyl)-1-(4-pyridinyl)-2-propen-1-one in Combination with Other Compounds Affecting Glucose Metabolism.
    Anticancer Res. 2015;35:5889-99.
    Abstract     Related articles   

  1240. MCINNES MD, Siemens DR, Mackillop WJ, Peng Y, et al
    Utilization of pre-operative imaging for muscle-invasive bladder cancer: a population-based study.
    BJU Int. 2015 Jan 5. doi: 10.1111/bju.13034.
    Abstract     Related articles   

  1241. COCKERILL PA, Knoedler JJ, Frank I, Tarrell R, et al
    Intravesical Gemcitabine in combination with Mitomycin C as salvage treatment in recurrent non-muscle invasive bladder cancer.
    BJU Int. 2015 Feb 13. doi: 10.1111/bju.13088.
    Abstract     Related articles   

  1242. BALTACI S, Bozlu M, Yildirim A, Gokce MI, et al
    Significance of time interval between first and second transurethral resection on recurrence and progression rates in patients with high risk non muscle invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guerin.
    BJU Int. 2015 Feb 24. doi: 10.1111/bju.13102.
    Abstract     Related articles   

  1243. HARRAZ AM, Osman Y, El-Halwagy S, Laymon M, et al
    Risk factors of hospital readmission after radical cystectomy and urinary diversion: analysis of a large contemporary series.
    BJU Int. 2015;115:94-100.
    Abstract     Related articles   

  1244. PIGNOT G, Salomon L, Lebacle C, Neuzillet Y, et al
    Prostate cancer incidence on cystoprostatectomy specimens are directly linked to age: results from a multicenter study.
    BJU Int. 2014 May 13. doi: 10.1111/bju.12803.
    Abstract     Related articles   

  1245. PELLUCCHI F, Freschi M, Moschini M, Rocchini L, et al
    Oncological predictive value of the 2004 World Health Organisation grading classification in primary T1 non-muscle-invasive bladder cancer. A step forward or back?
    BJU Int. 2015;115:267-73.
    Abstract     Related articles   

  1246. ELSEN S, Lerut E, Van Cleynenbreugel B, Van der Aa F, et al
    Biodistribution of Evans blue in an orthotopic AY-27 rat bladder urothelial cell carcinoma model: implication for the improved diagnosis of non-muscle-invasive bladder cancer (NMIBC) using dye-guided white-light cystoscopy.
    BJU Int. 2015 Mar 6. doi: 10.1111/bju.13113.
    Abstract     Related articles   

  1247. HANSKE J, Roghmann F, Noldus J, Trinh QD, et al
    Robotic and conventional open radical cystectomy lead to similar postoperative health-related quality of life.
    BJU Int. 2014;114:793-4.
    Abstract     Related articles   

  1248. MESSER JC, Punnen S, Fitzgerald J, Svatek R, et al
    Health-related quality of life from a prospective randomised clinical trial of robot-assisted laparoscopic vs open radical cystectomy.
    BJU Int. 2014;114:896-902.
    Abstract     Related articles   

  1249. SMITH ND, Castle EP, Gonzalgo ML, Svatek RS, et al
    The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial update.
    BJU Int. 2015;115:198-205.
    Abstract     Related articles   

  1250. MOSCHINI M, Sharma V, Dell'oglio P, Cucchiara V, et al
    Comparing long-term outcomes between primary versus progressive muscle invasive bladder cancer after radical cystectomy.
    BJU Int. 2015 Apr 7. doi: 10.1111/bju.13146.
    Abstract     Related articles   

  1251. STARKE N, Singla N, Haddad A, Lotan Y, et al
    Long-term outcomes of high risk bladder cancer screening cohort.
    BJU Int. 2015 Apr 18. doi: 10.1111/bju.13154.
    Abstract     Related articles   

  1252. MCLATCHIE LM
    Could a dye offer a cheap and simple approach to detect bladder cancer using white-light cystoscopy?
    BJU Int. 2015 May 8. doi: 10.1111/bju.13177.
    Abstract     Related articles   

  1253. BAACK KUKREJA JE, Scosyrev E, Brasacchio RA, Toy EP, et al
    Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer.
    BJU Int. 2014;114:844-51.
    Abstract     Related articles   

  1254. TOLCHARD S, Angell J, Pyke M, Lewis S, et al
    Cardiopulmonary reserve as determined by cardiopulmonary exercise testing correlates with length of stay and predicts complications after radical cystectomy.
    BJU Int. 2015;115:554-61.
    Abstract     Related articles   

  1255. LUCCA I, Roupret M, Kluth L, Rink M, et al
    Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
    BJU Int. 2015;115:722-7.
    Abstract     Related articles   

  1256. LEOW JJ, Reese S, Trinh QD, Bellmunt J, et al
    Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis.
    BJU Int. 2015;115:713-21.
    Abstract     Related articles   

  1257. ISHIOKA J, Saito K, Kijima T, Nakanishi Y, et al
    Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    BJU Int. 2015;115:705-12.
    Abstract     Related articles   

  1258. PHE V, Roupret M, Cussenot O, Chartier-Kastler E, et al
    Forkhead box protein P3 (Foxp3) expression serves as an early chronic inflammation marker of squamous cell differentiation and aggressive pathology of urothelial carcinomas in neurological patients.
    BJU Int. 2015;115 Suppl 6:28-32.
    Abstract     Related articles   

  1259. GAKIS G, Stenzl A
    Can we rely on lymphovascular invasion for determining the need for adjuvant chemotherapy in organ-confined bladder cancer?
    BJU Int. 2015;116:3-4.
    Abstract     Related articles   

  1260. O'REGAN T, Tatton M, Lyon M, Masters J, et al
    The effectiveness of BCG and interferon against non-muscle invasive bladder cancer: A New Zealand Perspective.
    BJU Int. 2015 Jul 14. doi: 10.1111/bju.13211.
    Abstract     Related articles   

  1261. ROSE JB, Armstrong S, Hermann GG, Kjellberg J, et al
    Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue- light cystoscopy in trans-urethral bladder tumour resection for non-muscle invasive bladder cancer patients in Sweden.
    BJU Int. 2015 Aug 25. doi: 10.1111/bju.13261.
    Abstract     Related articles   

  1262. PATEL MI, Bang A, Gillatt D, Smith DP, et al
    Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study.
    BJU Int. 2015 Sep 2. doi: 10.1111/bju.13152.
    Abstract     Related articles   

  1263. WITJES JA
    Fluorescence cystoscopy: the end of biopsies for carcinoma in situ detection?
    BJU Int. 2015;116:2-3.
    Abstract     Related articles   

  1264. VON RUNDSTEDT FC, Mata DA, Groshen S, Stein JP, et al
    Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
    BJU Int. 2015;116:44-9.
    Abstract     Related articles   

  1265. ALBISINNI S, Rassweiler J, Abbou CC, Cathelineau X, et al
    Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology.
    BJU Int. 2015;115:937-45.
    Abstract     Related articles   

  1266. VOSKOBOYNIK M, Rudman S, Arkenau HT, Hughes S, et al
    Immunotherapy for Bladder Cancer: Rediscovering an Old Friend.
    BJU Int. 2015 Sep 21. doi: 10.1111/bju.13330.
    Abstract     Related articles   

  1267. RAMIREZ D, Gupta A, Canter D, Harrow B, et al
    Microscopic hematuria at time of diagnosis is associated with lower disease stage in patients with newly diagnosed bladder cancer.
    BJU Int. 2015 Oct 5. doi: 10.1111/bju.13345.
    Abstract     Related articles   

  1268. WARREN H, Raison N, Dasgupta P
    Pioglitazone and Bladder Cancer.
    BJU Int. 2015 Oct 15. doi: 10.1111/bju.13352.
    Abstract     Related articles   

  1269. MULLER J, Grosclaude P, Lapotre-Ledoux B, Woronoff AS, et al
    Trends of the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10,047 patients.
    BJU Int. 2015 Oct 15. doi: 10.1111/bju.13351.
    Abstract     Related articles   

  1270. LOEB S, Ribal MJ
    Controversies in management of high-risk prostate and bladder cancer.
    BJU Int. 2015;116:675.
    Abstract     Related articles   

  1271. GENDY R, Delprado W, Brenner P, Brooks A, et al
    Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
    BJU Int. 2015 Oct 21. doi: 10.1111/bju.13265.
    Abstract     Related articles   

  1272. WILLIAMS SB, Kamat AM, Lamm DL
    Pelvic recurrence after radical cystectomy: a call to arms.
    BJU Int. 2015;116:172-3.
    Abstract     Related articles   

  1273. SATHE A, Guerth F, Cronauer MV, Heck MM, et al
    Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapy.
    Br J Cancer. 2014;111:2103-13.
    Abstract     Related articles   

  1274. BRYAN RT, Regan HL, Pirrie SJ, Devall AJ, et al
    Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM.
    Br J Cancer. 2015 Feb 26. doi: 10.1038/bjc.2015.
    Abstract     Related articles   

  1275. CHOI YJ, Lee SH, Lee JL, Ahn JH, et al
    Phase II study of pemetrexed in combination with cisplatin in patients with advanced urothelial cancer: the PECULIAR study (KCSG 10-17).
    Br J Cancer. 2015;112:260-5.
    Abstract     Related articles   

  1276. TURATI F, Polesel J, Di Maso M, Montella M, et al
    Diabetes mellitus and the risk of bladder cancer: an Italian case-control study.
    Br J Cancer. 2015 May 21. doi: 10.1038/bjc.2015.
    Abstract     Related articles   

  1277. MATSUSHITA R, Seki N, Chiyomaru T, Inoguchi S, et al
    Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.
    Br J Cancer. 2015 Jun 9. doi: 10.1038/bjc.2015.
    Abstract     Related articles   

  1278. KHADJAVI A, Mannu F, Destefanis P, Sacerdote C, et al
    Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins.
    Br J Cancer. 2015 Jun 30. doi: 10.1038/bjc.2015.
    Abstract     Related articles   

  1279. BLICK C, Ramachandran A, McCormick R, Wigfield S, et al
    Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis.
    Br J Cancer. 2015 Jul 21. doi: 10.1038/bjc.2015.
    Abstract     Related articles   

  1280. BHINDI B, Hermanns T, Wei Y, Yu J, et al
    Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
    Br J Cancer. 2015 Dec 10. doi: 10.1038/bjc.2015.
    Abstract     Related articles   

  1281. TOLLEFSON MK, Psutka SP
    Reply to sarcopenia is more than simply documenting low skeletal muscle mass.
    Cancer. 2015;121:159-60.
    Abstract     Related articles   

  1282. CINTOSUN U, Tasci I, Binay Safer V, Safer U, et al
    Sarcopenia is more than simply documenting low skeletal muscle mass.
    Cancer. 2015;121:159.
    Abstract     Related articles   

  1283. CHRISTODOULEAS J, Baumann B
    Reply to external validation of a model to predict local failure after radical cystectomy.
    Cancer. 2014;120:3585.
    Abstract     Related articles   

  1284. FROEHNER M, Novotny V, Wirth MP, Brookman-May S, et al
    External validation of a model to predict locoregional failure after radical cystectomy.
    Cancer. 2014;120:3584.
    Abstract     Related articles   

  1285. BALAR AV, Milowsky MI
    Cytotoxic and DNA-targeted therapy in urothelial cancer: have we squeezed the lemon enough?
    Cancer. 2015;121:179-87.
    Abstract     Related articles   

  1286. GALSKY MD, Pal SK, Chowdhury S, Harshman LC, et al
    Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
    Cancer. 2015 Apr 14. doi: 10.1002/cncr.29387.
    Abstract     Related articles   

  1287. SOHL SJ, Borowski LA, Kent EE, Smith AW, et al
    Cancer survivors' disclosure of complementary health approaches to physicians: the role of patient-centered communication.
    Cancer. 2015;121:900-7.
    Abstract     Related articles   

  1288. GILBERT SM
    Revisiting structure, process, and outcome.
    Cancer. 2015;121:328-30.
    Abstract     Related articles   

  1289. GREEN AK, Milowsky MI
    Genomic profiling of advanced bladder cancer to guide the use of targeted therapeutics.
    Cancer. 2015 Dec 9. doi: 10.1002/cncr.29825.
    Abstract     Related articles   

  1290. CEKIC C, Linden J
    Adenosine A2A receptors intrinsically regulate CD8+ T cells in the tumor microenvironment.
    Cancer Res. 2014;74:7239-49.
    Abstract     Related articles   

  1291. HE F, Melamed J, Tang MS, Huang C, et al
    Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas.
    Cancer Res. 2015;75:2017-28.
    Abstract     Related articles   

  1292. PALMBOS PL, Wang L, Yang H, Wang Y, et al
    ATDC/TRIM29 drives invasive bladder cancer formation through microRNA-mediated and epigenetic mechanisms.
    Cancer Res. 2015 Oct 15. pii: canres.0603.2015.
    Abstract     Related articles   

  1293. LI C, Du Y, Yang Z, He L, et al
    GALNT1-mediated glycosylation and activation of sonic hedgehog signaling maintains the self-renewal and tumor-initiating capacity of bladder cancer stem cells.
    Cancer Res. 2015 Dec 16. pii: canres.2309.2015.
    Abstract     Related articles   

  1294. N M, Tj H, E C, R G, et al
    To be an ally or an adversary in bladder cancer: the NF-kappaB story has not unfolded.
    Carcinogenesis. 2014.
    Abstract     Related articles   

  1295. AVGERIS M, Mavridis K, Tokas T, Stravodimos K, et al
    Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment.
    Carcinogenesis. 2015.
    Abstract     Related articles   

  1296. WANG H, Wang Y, Kota KK, Kallakury B, et al
    Strong association between long and heterogeneous telomere length in blood lymphocytes and bladder cancer risk in Egyptian.
    Carcinogenesis. 2015.
    Abstract     Related articles   

  1297. LEE SR, Roh YG, Kim SK, Lee JS, et al
    Activation of EZH2 and SUZ12 regulated by E2F1 predicts the disease progression and aggressive characteristics of bladder cancer.
    Clin Cancer Res. 2015 Aug 12. pii: clincanres.2680.2014.
    Abstract     Related articles   

  1298. SVATEK RS, Zhao XR, Morales EE, Jha MK, et al
    Sequential intravesical mitomycin plus Bacillus Calmette-Guerin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial.
    Clin Cancer Res. 2015;21:303-11.
    Abstract     Related articles   

  1299. SHAPIRO GI, Kwak E, Dezube BJ, Yule M, et al
    First-in-human phase I dose escalation study of a second-generation non-ansamycin HSP90 inhibitor, AT13387, in patients with advanced solid tumors.
    Clin Cancer Res. 2015;21:87-97.
    Abstract     Related articles   

  1300. KIM J, Akbani R, Creighton CJ, Lerner SP, et al
    Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise.
    Clin Cancer Res. 2015;21:4514-24.
    Abstract     Related articles   

  1301. KIM HS, Jeong CW, Kwak C, Kim HH, et al
    Pathological T0 following cisplatin-based neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a network meta-analysis.
    Clin Cancer Res. 2015 Oct 26. pii: clincanres.1208.2015.
    Abstract     Related articles   

  1302. NOGUCHI M, Matsumoto K, Uemura H, Arai G, et al
    An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy.
    Clin Cancer Res. 2015.
    Abstract     Related articles   

  1303. GHASEMZADEH A, Bivalacqua TJ, Hahn NM, Drake CG, et al
    New Strategies in Bladder Cancer: A Second Coming for Immunotherapy.
    Clin Cancer Res. 2015 Dec 18. pii: clincanres.1135.2015.
    Abstract     Related articles   

  1304. ROSE TL, Milowsky MI
    Management of muscle-invasive bladder cancer in the elderly.
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  1305. MATHIEU R, Lucca I, Klatte T, Babjuk M, et al
    Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  1306. DIBIANCO JM, George AK, Su D, Agarwal PK, et al
    Managing noninvasive recurrences after definitive treatment for muscle-invasive bladder cancer or high-grade upper tract urothelial carcinoma.
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  1307. WOLFF I, Brookman-May S, May M
    Sex difference in presentation and outcomes of bladder cancer: biological reality or statistical fluke?
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  1308. APOLO AB, Burger M
    A precision, personalized approach to the management of bladder cancer.
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  1309. MCCONKEY DJ, Choi W, Dinney CP
    Genetic subtypes of invasive bladder cancer.
    Curr Opin Urol. 2015;25:449-58.
    Abstract     Related articles   

  1310. FAKHREJAHANI F, Tomita Y, Maj-Hes A, Trepel JB, et al
    Immunotherapies for bladder cancer: a new hope.
    Curr Opin Urol. 2015.
    Abstract     Related articles   

  1311. NIVER BE, Daneshmand S, Satkunasivam R
    Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes.
    Curr Opin Urol. 2015;25:105-10.
    Abstract     Related articles   

  1312. KNOEDLER J, Frank I
    Organ-sparing surgery in urology: partial cystectomy.
    Curr Opin Urol. 2015;25:111-5.
    Abstract     Related articles   

  1313. GO H, Kim PJ, Jeon YK, Cho YM, et al
    Sphingosine-1-phosphate receptor 1 (S1PR1) expression in non-muscle invasive urothelial carcinoma: Association with poor clinical outcome and potential therapeutic target.
    Eur J Cancer. 2015;51:1937-45.
    Abstract     Related articles   

  1314. GROENENDIJK FH, de Jong J, Fransen van de Putte EE, Michaut M, et al
    ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy.
    Eur Urol. 2015 Jan 27. pii: S0302-2838(15)00037.
    Abstract     Related articles   

  1315. REAL FX, Boutros PC, Malats N
    Next-generation sequencing of urologic cancers: next is now.
    Eur Urol. 2014;66:4-7.
    Abstract     Related articles   

  1316. KLUTH LA, Black PC, Bochner BH, Catto J, et al
    Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature.
    Eur Urol. 2015 Feb 20. pii: S0302-2838(15)00075.
    Abstract     Related articles   

  1317. NGUYEN DP, Al Hussein Al Awamlh B, Wu X, O'Malley P, et al
    Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer.
    Eur Urol. 2015 Feb 20. pii: S0302-2838(15)00157.
    Abstract     Related articles   

  1318. SULTMANN H, Diederichs S
    Long noncoding RNA: "LNCs" to cancer.
    Eur Urol. 2014;65:1152-3.
    Abstract     Related articles   

  1319. MARTENS-UZUNOVA ES, Bottcher R, Croce CM, Jenster G, et al
    Long noncoding RNA in prostate, bladder, and kidney cancer.
    Eur Urol. 2014;65:1140-51.
    Abstract     Related articles   

  1320. LOTAN Y
    Words of wisdom. Re: prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guerin: results of a retrospective multicenter study of 2451 patients.
    Eur Urol. 2014;66:968-9.
    Abstract     Related articles   

  1321. BRYAN RT, Ward DG
    Bladder Cancers Arise from Distinct Urothelial Sub-populations.
    Eur Urol. 2015;67:590-1.
    Abstract     Related articles   

  1322. BID HK
    Re: bacillus calmette-guerin strain differences have an impact on clinical outcome in bladder cancer immunotherapy.
    Eur Urol. 2015;67:351.
    Abstract     Related articles   

  1323. CHA EK, Bochner BH
    Re: Whole-genome and Whole-exome Sequencing of Bladder Cancer Identifies Frequent Alterations in Genes Involved in Sister Chromatid Cohesion and Segregation.
    Eur Urol. 2015;67:350-1.
    Abstract     Related articles   

  1324. GROENENDIJK FH, Fransen van de Putte EE, van Rhijn BW, Bernards R, et al
    Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Ca
    Eur Urol. 2015 Mar 13. pii: S0302-2838(15)00208.
    Abstract     Related articles   

  1325. VAN ALLEN EM, Garraway LA, Rosenberg JE
    Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/
    Eur Urol. 2015 Mar 11. pii: S0302-2838(15)00209.
    Abstract     Related articles   

  1326. CRESSWELL J, Mostafid AH
    Predicting Outcomes in Bladder Cancer: Are We Any Good and Could We Do Better?
    Eur Urol. 2015 Mar 11. pii: S0302-2838(15)00198.
    Abstract     Related articles   

  1327. BABJUK M
    Re: the effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus calmette-guerin.
    Eur Urol. 2015;67:815.
    Abstract     Related articles   

  1328. GREIFE A, Hoffmann MJ, Schulz WA
    Consequences of Disrupted Notch Signaling in Bladder Cancer.
    Eur Urol. 2015 Mar 16. pii: S0302-2838(15)00199.
    Abstract     Related articles   

  1329. BUCHWALD ZS, Efstathiou JA
    Re: MPDL3280A (Anti-PD-L1) Treatment Leads to Clinical Activity in Metastatic Bladder Cancer.
    Eur Urol. 2015;67:975.
    Abstract     Related articles   

  1330. YUH B, Chan K, Lau C, Wilson T, et al
    Variable Recurrence Patterns After Cystectomy in Bladder Cancer: Can the Robot Be Blamed?
    Eur Urol. 2015 Apr 18. pii: S0302-2838(15)00311.
    Abstract     Related articles   

  1331. NAVAI N, Matin SF
    Words of wisdom. Re: A randomized trial of robot-assisted laparoscopic radical cystectomy.
    Eur Urol. 2015;67:173-4.
    Abstract     Related articles   

  1332. GOFRIT ON
    Re: Long-Term Outcomes in Patients with Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233.
    Eur Urol. 2015;68:165-6.
    Abstract     Related articles   

  1333. GIANNARINI G, Palumbo V, Ficarra V
    Words of Wisdom. Re: robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients.
    Eur Urol. 2015;67:1191-2.
    Abstract     Related articles   

  1334. DE MARTINO M, Lucca I, Mbeutcha A, Wiener HG, et al
    Carbonic Anhydrase IX as a Diagnostic Urinary Marker for Urothelial Bladder Cancer.
    Eur Urol. 2015 Jun 29. pii: S0302-2838(15)00518.
    Abstract     Related articles   

  1335. POURMALEK F, Abdi H, Black PC
    Re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.02.003.
    Eur Urol. 2015 Jul 13. pii: S0302-2838(15)00559.
    Abstract     Related articles   

  1336. FROEHNER M, Koch R, Heberling U, Novotny V, et al
    Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis.
    Eur Urol. 2015 Jul 17. pii: S0302-2838(15)00564.
    Abstract     Related articles   

  1337. NGUYEN DP, Scherr DS
    Reply to Farshad Pourmalek, Hamidreza Abdi, and Peter C. Black's Letter to the Editor re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol.
    Eur Urol. 2015 Jul 14. pii: S0302-2838(15)00558.
    Abstract     Related articles   

  1338. AINE M, Eriksson P, Liedberg F, Hoglund M, et al
    On Molecular Classification of Bladder Cancer: Out of One, Many.
    Eur Urol. 2015 Jul 24. pii: S0302-2838(15)00666.
    Abstract     Related articles   

  1339. CAMBIER S, Sylvester RJ, Collette L, Gontero P, et al
    EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin.
    Eur Urol. 2015 Jul 22. pii: S0302-2838(15)00556.
    Abstract     Related articles   

  1340. PLIMACK ER, Dunbrack RL, Brennan TA, Andrake MD, et al
    Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based chemotherapy in Muscle-invasive Bladder Cancer.
    Eur Urol. 2015 Jul 31. pii: S0302-2838(15)00613.
    Abstract     Related articles   

  1341. BLACK PC
    Fine-tuning Risk Stratification for Non-Muscle-invasive Bladder Cancer.
    Eur Urol. 2015 Aug 6. pii: S0302-2838(15)00693.
    Abstract     Related articles   

  1342. RENTSCH CA, Stenner F, Ruiz C, Bubendorf L, et al
    Three Genes to Predict Response to Chemotherapy for Bladder Cancer: Individualised Cancer Care at the Doorstep.
    Eur Urol. 2015 Aug 13. pii: S0302-2838(15)00709.
    Abstract     Related articles   

  1343. MORALES EE, Grill S, Svatek RS, Kaushik D, et al
    Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study.
    Eur Urol. 2015 Aug 27. pii: S0302-2838(15)00772.
    Abstract     Related articles   

  1344. ROSE TL, Milowsky MI
    A Small Step Toward Improving Salvage Treatment for Metastatic Bladder Cancer - At What Cost?
    Eur Urol. 2015 Sep 4. pii: S0302-2838(15)00784.
    Abstract     Related articles   

  1345. DOBRUCH J, Daneshmand S, Fisch M, Lotan Y, et al
    Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.
    Eur Urol. 2015 Sep 4. pii: S0302-2838(15)00782.
    Abstract     Related articles   

  1346. LA VECCHIA C
    Finasteride and Bladder Cancer.
    Eur Urol. 2015 Sep 10. pii: S0302-2838(15)00858.
    Abstract     Related articles   

  1347. SONPAVDE G, Pond GR, Bellmunt J
    Reply from Authors re: Tracy L. Rose, Matthew I. Milowsky. A Small Step Toward Improving Salvage Treatment for Metastatic Bladder Cancer - At What Cost? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.08.039: Combination Chemotherapy as a
    Eur Urol. 2015 Sep 23. pii: S0302-2838(15)00909.
    Abstract     Related articles   

  1348. SONPAVDE G, Nix JW
    The Neoadjuvant Paradigm for Development of Systemic Therapy and Precision Medicine for Bladder Cancer.
    Eur Urol. 2015 Sep 20. pii: S0302-2838(15)00912.
    Abstract     Related articles   

  1349. LEAL J, Luengo-Fernandez R, Sullivan R, Witjes JA, et al
    Economic Burden of Bladder Cancer Across the European Union.
    Eur Urol. 2015 Oct 24. pii: S0302-2838(15)01005.
    Abstract     Related articles   

  1350. RESNICK MJ
    Variation in Bladder Cancer Spending: A Global Call to Action.
    Eur Urol. 2015 Nov 19. pii: S0302-2838(15)01084.
    Abstract     Related articles   

  1351. CHAN KG, Guru K, Wiklund P, Catto J, et al
    Robot-assisted radical cystectomy and urinary diversion: technical recommendations from the Pasadena Consensus Panel.
    Eur Urol. 2015;67:423-31.
    Abstract     Related articles   

  1352. ARON M, Gill IS
    Robotic radical cystectomy: so far, so good--what next?
    Eur Urol. 2015;67:361-2.
    Abstract     Related articles   

  1353. WILSON TG, Guru K, Rosen RC, Wiklund P, et al
    Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel.
    Eur Urol. 2015;67:363-75.
    Abstract     Related articles   

  1354. NOVARA G, Catto JW, Wilson T, Annerstedt M, et al
    Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy.
    Eur Urol. 2015;67:376-401.
    Abstract     Related articles   

  1355. YUH B, Wilson T, Bochner B, Chan K, et al
    Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
    Eur Urol. 2015;67:402-22.
    Abstract     Related articles   

  1356. KIM JH, Ku JH
    Re: Edwin E. Morales, Sonja Grill, Robert S. Svatek, et al. Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.08.029.
    Eur Urol. 2015 Dec 9. pii: S0302-2838(15)01174.
    Abstract     Related articles   

  1357. JONES RJ
    Making trials work in practice: please mind the gap.
    Eur Urol. 2015;67:250-1.
    Abstract     Related articles   

  1358. ANDREW AS, Marsit CJ, Schned AR, Seigne JD, et al
    Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence.
    Int J Cancer. 2014 Dec 29. doi: 10.1002/ijc.29413.
    Abstract     Related articles   

  1359. HOSEN I, Rachakonda PS, Heidenreich B, de Verdier PJ, et al
    Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
    Int J Cancer. 2015 Mar 21. doi: 10.1002/ijc.29526.
    Abstract     Related articles   

  1360. MATULLO G, Naccarati A, Pardini B
    microRNA expression profiling in bladder cancer: The challenge of Next Generation Sequencing in tissues and biofluids.
    Int J Cancer. 2015 Oct 21. doi: 10.1002/ijc.29895.
    Abstract     Related articles   

  1361. WANG M, Du M, Ma L, Chu H, et al
    A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating a miR-140-5p binding site.
    Int J Cancer. 2015 Dec 22. doi: 10.1002/ijc.29978.
    Abstract     Related articles   

  1362. FU B, Wang Y, Zhang X, Lang B, et al
    miR-221-induced PUMA silencing mediates immune evasion of bladder cancer cells.
    Int J Oncol. 2015 Jan 13. doi: 10.3892/ijo.2015.2837.
    Abstract     Related articles   

  1363. MATSUSHIMA M, Kikuchi E, Matsumoto K, Hattori S, et al
    Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model.
    Int J Oncol. 2015 May 11. doi: 10.3892/ijo.2015.2995.
    Abstract     Related articles   

  1364. GAO Y, Guan Z, Chen J, Xie H, et al
    CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9.
    Int J Oncol. 2015 Jun 9. doi: 10.3892/ijo.2015.3041.
    Abstract     Related articles   

  1365. RIEGER C, Huebner D, Temme A, Wirth MP, et al
    Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells.
    Int J Oncol. 2015 Jul 20. doi: 10.3892/ijo.2015.3096.
    Abstract     Related articles   

  1366. ZHANG S, Zhang C, Liu W, Zheng W, et al
    MicroRNA-24 upregulation inhibits proliferation, metastasis and induces apoptosis in bladder cancer cells by targeting CARMA3.
    Int J Oncol. 2015 Aug 7. doi: 10.3892/ijo.2015.3117.
    Abstract     Related articles   

  1367. HUANG YT, Cheng CC, Chiu TH, Lai PC, et al
    Therapeutic potential of thalidomide for gemcitabine-resistant bladder cancer.
    Int J Oncol. 2015 Sep 11. doi: 10.3892/ijo.2015.3155.
    Abstract     Related articles   

  1368. SUN Y, Guan Z, Liang L, Cheng Y, et al
    NF-kappaB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.
    Int J Oncol. 2015 Nov 20. doi: 10.3892/ijo.2015.3256.
    Abstract     Related articles   

  1369. FERNANDEZ-GOMEZ JM
    Editorial Comment to Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long-term follow-up experience at a single institute.
    Int J Urol. 2015 Mar 25. doi: 10.1111/iju.12762.
    Abstract     Related articles   

  1370. WINTERS B, James A, Lee J, Kho J, et al
    Chemotherapeutic effects on circulating tumor cells in bladder cancer.
    Int J Urol. 2015 Mar 31. doi: 10.1111/iju.12758.
    Abstract     Related articles   

  1371. MIYAKE M, Gotoh D, Shimada K, Tatsumi Y, et al
    Exploration of risk factors predicting outcomes for primary T1 high-grade bladder cancer and validation of the Spanish Urological Club for Oncological Treatment scoring model: Long-term follow-up experience at a single institute.
    Int J Urol. 2015 Apr 8. doi: 10.1111/iju.12749.
    Abstract     Related articles   

  1372. SATAKE N, Ohno Y, Nakashima J, Ohori M, et al
    Prognostic value of preoperative pyuria in patients with non-muscle-invasive bladder cancer.
    Int J Urol. 2015 Apr 24. doi: 10.1111/iju.12788.
    Abstract     Related articles   

  1373. SHINDO T
    Editorial Comment to Prognostic value of preoperative pyuria in patients with non-muscle-invasive bladder cancer.
    Int J Urol. 2015 May 4. doi: 10.1111/iju.12802.
    Abstract     Related articles   

  1374. ZAHRAN MH
    Response to Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:892-3.
    Abstract     Related articles   

  1375. EL-GAMAL OM
    Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:892.
    Abstract     Related articles   

  1376. ZAHRAN MH, El-Hefnawy AS, Zidan EM, El-Bilsha MA, et al
    Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
    Int J Urol. 2014;21:887-92.
    Abstract     Related articles   

  1377. OH JJ, Kang MY, Jo JK, Lee HM, et al
    Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy.
    Int J Urol. 2015 Aug 20. doi: 10.1111/iju.12901.
    Abstract     Related articles   

  1378. ROBINSON R
    Editorial Comment to Efficacy and tolerance of one-third full dose bacillus Calmette-Guerin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
    Int J Urol. 2015;22:61.
    Abstract     Related articles   

  1379. PFISTER C, Kerkeni W, Rigaud J, Le Gal S, et al
    Efficacy and tolerance of one-third full dose bacillus Calmette-Guerin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
    Int J Urol. 2015;22:53-60.
    Abstract     Related articles   

  1380. BALL MW
    Editorial Comment to Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
    Int J Urol. 2015 Oct 6. doi: 10.1111/iju.12964.
    Abstract     Related articles   

  1381. RICHARDS KA, Ham S, Cohn JA, Steinberg GD, et al
    Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
    Int J Urol. 2015 Oct 6. doi: 10.1111/iju.12959.
    Abstract     Related articles   

  1382. AKITA H, Okamura T, Nakane A, Kobayashi T, et al
    Infectious aortic aneurysms occurring 1 year after bacillus Calmette-Guerin bladder instillation therapy.
    Int J Urol. 2015;22:234-5.
    Abstract     Related articles   

  1383. GINORI A, Barone A, Santopietro R, Barbanti G, et al
    Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection.
    Int J Urol. 2015;22:222-5.
    Abstract     Related articles   

  1384. BERMAN DM, Kawashima A, Peng Y, Mackillop WJ, et al
    Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:163-70.
    Abstract     Related articles   

  1385. SHIGEHARA K, Namiki M
    Editorial comment to Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection.
    Int J Urol. 2015;22:225-6.
    Abstract     Related articles   

  1386. BERMAN DM, Kawashima A, Peng Y, Mackillop WJ, et al
    Response to editorial comments to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:172.
    Abstract     Related articles   

  1387. GONDO T
    Editorial comment from Dr Gondo to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:171.
    Abstract     Related articles   

  1388. TSUZUKI T
    Editorial comment from Dr Tsuzuki to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Int J Urol. 2015;22:170-1.
    Abstract     Related articles   

  1389. YAGISAWA T, Okumi M, Omoto K, Sawada Y, et al
    Novel approach for bladder cancer treatment using sulfoquinovosylacylpropanediol as a radiosensitizer.
    Int J Urol. 2015 Dec 21. doi: 10.1111/iju.13034.
    Abstract     Related articles   

  1390. LI Z, Hou R, Li J
    The efficacy and safety of simultaneous transurethral GreenLight photoselective vaporization of bladder tumor and prostate in patients with bladder tumor and lower urinary tract symptoms.
    Int Urol Nephrol. 2014;46:691-4.
    Abstract     Related articles   

  1391. HUNG SY, Yang WC, Luo HL, Hsu CC, et al
    Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer.
    Int Urol Nephrol. 2014;46:921-6.
    Abstract     Related articles   

  1392. BALCI M, Tuncel A, Guzel O, Aslan Y, et al
    Use of the nuclear matrix protein 22 Bladder Chek test in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer.
    Int Urol Nephrol. 2015.
    Abstract     Related articles   

  1393. HUANG W, Wang F, Wu C, Hu W, et al
    Efficacy and safety of pirarubicin combined with hyaluronic acid for non-muscle invasive bladder cancer after transurethral resection: a prospective, randomized study.
    Int Urol Nephrol. 2015.
    Abstract     Related articles   

  1394. LIU S, Yang T, Na R, Hu M, et al
    The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients.
    Int Urol Nephrol. 2015.
    Abstract     Related articles   

  1395. PEPE P, Fraggetta F, Galia A, Panella P, et al
    Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: our experience in 242 cases.
    Int Urol Nephrol. 2014;46:1325-8.
    Abstract     Related articles   

  1396. STOJADINOVIC MM, Prelevic R, Vukicevic A
    Scoring system for prediction of lymph node metastasis in radical cystectomy cohort.
    Int Urol Nephrol. 2014;46:1317-23.
    Abstract     Related articles   

  1397. HUANG TB, Guo ZF, Zhang XL, Zhang XP, et al
    Coffee consumption and urologic cancer risk: a meta-analysis of cohort studies.
    Int Urol Nephrol. 2014;46:1481-93.
    Abstract     Related articles   

  1398. SUER E, Ozcan C, Gokce I, Gulpinar O, et al
    Do blood groups have effect on prognosis of patients undergoing radical cystectomy?
    Int Urol Nephrol. 2014;46:1521-6.
    Abstract     Related articles   

  1399. YE J, Xu X, Fan M, Xue D, et al
    AFP-producing urothelial carcinoma of the bladder: a case report.
    Int Urol Nephrol. 2014;46:1527-9.
    Abstract     Related articles   

  1400. XU T, Zhu Z, Wang X, Xia L, et al
    Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer.
    Int Urol Nephrol. 2015.
    Abstract     Related articles   

  1401. KOIE T, Ohyama C, Hosogoe S, Yamamoto H, et al
    Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Int Urol Nephrol. 2015.
    Abstract     Related articles   

  1402. THOMAS C, Giesswein A, Hainz M, Stein R, et al
    Concomitant Gleason Score >/=7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.
    Int Urol Nephrol. 2015.
    Abstract     Related articles   

  1403. FLOYD MS JR, Khattak AQ
    Total urinary tract exenteration including donor nephrectomy for transitional cell carcinoma 41 years following transplantation.
    Int Urol Nephrol. 2015;47:107-8.
    Abstract     Related articles   

  1404. WILLIAMS EM, Higgins JP, Sangoi AR, McKenney JK, et al
    Androgen receptor immunohistochemistry in genitourinary neoplasms.
    Int Urol Nephrol. 2015;47:81-5.
    Abstract     Related articles   

  1405. AHMED FO, Hamdan HZ, Abdelgalil HB, Sharfi AA, et al
    A comparison between transabdominal ultrasonographic and cystourethroscopy findings in adult Sudanese patients presenting with haematuria.
    Int Urol Nephrol. 2015;47:223-8.
    Abstract     Related articles   

  1406. DJUKIC T, Simic T, Radic T, Matic M, et al
    GSTO1*C/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder.
    Int Urol Nephrol. 2015;47:625-30.
    Abstract     Related articles   

  1407. MARTIN-DOYLE W, Leow JJ, Orsola A, Chang SL, et al
    Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients.
    J Clin Oncol. 2015 Jan 5. pii: JCO.2014.57.6967.
    Abstract     Related articles   

  1408. PLIMACK ER, Hoffman-Censits J, Rosenberg JE, Wong YN, et al
    Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye.
    J Clin Oncol. 2014;32:4171-2.
    Abstract     Related articles   

  1409. STERNBERG CN, Apolo AB
    Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye.
    J Clin Oncol. 2014;32:4172-3.
    Abstract     Related articles   

  1410. SHIELS MS, Gibson T, Sampson J, Albanes D, et al
    Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers.
    J Clin Oncol. 2014;32:3989-95.
    Abstract     Related articles   

  1411. STITZENBERG KB, Chang Y, Smith AB, Nielsen ME, et al
    Exploring the burden of inpatient readmissions after major cancer surgery.
    J Clin Oncol. 2015;33:455-64.
    Abstract     Related articles   

  1412. LU K
    Depth of Invasion in High-Grade T1 Bladder Cancer: Added Value In Timely Cystectomy?
    J Clin Oncol. 2015 Jul 20. pii: JCO.2015.62.2712.
    Abstract     Related articles   

  1413. MARTIN-DOYLE W, Orsola A, Bellmunt J
    Reply to K. Lu.
    J Clin Oncol. 2015;33:2716-7.
    Abstract     Related articles   

  1414. RITCH CR, Cookson MS, Chang SS, Clark PE, et al
    Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy.
    J Urol. 2014;192:1360-4.
    Abstract     Related articles   

  1415. GEVAERT T, Vanstreels E, Daelemans D, Franken J, et al
    Identification of different phenotypes of interstitial cells in the upper and deep lamina propria of the human bladder dome.
    J Urol. 2014;192:1555-63.
    Abstract     Related articles   

  1416. SUGIHARA T, Yasunaga H, Horiguchi H, Matsui H, et al
    Comparison of perioperative outcomes including severe bladder injury between monopolar and bipolar transurethral resection of bladder tumors: a population based comparison.
    J Urol. 2014;192:1355-9.
    Abstract     Related articles   

  1417. NAHM LS, Chen Y, DeVivo MJ, Lloyd LK, et al
    Bladder Cancer Mortality after Spinal Cord Injury over 4 Decades.
    J Urol. 2015 Jan 20. pii: S0022-5347(15)00159-7. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1418. FANG CY, Tsai YD, Lin MC, Wang M, et al
    Inhibition of human bladder cancer growth by a suicide gene delivered by JC polyomavirus virus-like particles in a mouse model.
    J Urol. 2015 Jan 23. pii: S0022-5347(15)00174-3. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1419. CASEY MF, Gross T, Wisnivesky J, Stensland KD, et al
    The impact of regionalization of cystectomies on racial disparities in bladder cancer care.
    J Urol. 2015 Jan 23. pii: S0022-5347(15)00166-4. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1420. GURU KA
    Editorial comment.
    J Urol. 2014;192:1740.
    Abstract     Related articles   

  1421. DESAI MM, Gill IS, de Castro Abreu AL, Hosseini A, et al
    Robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients.
    J Urol. 2014;192:1734-40.
    Abstract     Related articles   

  1422. MCKIERNAN JM, Holder DD, Ghandour RA, Barlow LJ, et al
    Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guerin treatment failure.
    J Urol. 2014;192:1633-8.
    Abstract     Related articles   

  1423. TUDOR J, Cantley RL, Jain S
    Primary small cell carcinoma arising from a bladder diverticulum.
    J Urol. 2014;192:236-7.
    Abstract     Related articles   

  1424. KARL A
    Editorial comment.
    J Urol. 2014;192:56.
    Abstract     Related articles   

  1425. WOOD DP
    Re: prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer.
    J Urol. 2014;192:59.
    Abstract     Related articles   

  1426. LI DR, Zhang H, Peek E, Wang S, et al
    Synergy of histone-deacetylase inhibitor AR-42 with cisplatin in bladder cancer.
    J Urol. 2015 Mar 3. pii: S0022-5347(15)03244-9. doi: 10.1016/j.juro.2015.02.2918
    Abstract     Related articles   

  1427. SIEGEL C
    Re: Surveillance of Patients with Bladder Cancer following Cystectomy: Yield of CT Urography.
    J Urol. 2015;193:785.
    Abstract     Related articles   

  1428. SIEGEL C
    Re: MR Imaging of Urinary Bladder Cancer for T-Staging: A Review and a Pictorial Essay of Diffusion-Weighted Imaging.
    J Urol. 2015;193:784-5.
    Abstract     Related articles   

  1429. ELLIOTT SP
    Screening for Bladder Cancer in Individuals with Spinal Cord Injury.
    J Urol. 2015 Mar 17. pii: S0022-5347(15)03363-7. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1430. SKINNER EC, Fairey AS, Groshen S, Daneshmand S, et al
    Randomized Trial of Studer Pouch versus T-Pouch Orthotopic Ileal Neobladder in Bladder Cancer Patients.
    J Urol. 2015 Mar 27. pii: S0022-5347(15)03565-X. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1431. WOOD DP
    Re: Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy.
    J Urol. 2015;193:73.
    Abstract     Related articles   

  1432. SIEGEL C
    Re: Multiparametric MRI of the bladder: ready for clinical routine?
    J Urol. 2015;193:73-4.
    Abstract     Related articles   

  1433. THOMAS C, Roos FC, Thuroff JW
    Systematic Biopsy, Targeted Biopsy or a Combination-How Should We Detect Prostate Cancer in the Future?
    J Urol. 2014 Oct 16. pii: S0022-5347(14)04679-5. doi: 10.1016/j.juro.2014.
    Abstract     Related articles   

  1434. VON RUNDSTEDT FC, Lerner SP, Godoy G, Amiel G, et al
    Usefulness of transurethral biopsy for staging the prostatic urethra before radical cystectomy.
    J Urol. 2015;193:58-63.
    Abstract     Related articles   

  1435. ENGILBERTSSON H, Aaltonen KE, Bjornsson S, Kristmundsson T, et al
    Transurethral bladder tumor resection can cause seeding of cancer cells into the bloodstream.
    J Urol. 2015;193:53-7.
    Abstract     Related articles   

  1436. SUN S, Xu A, Chen G, Zhang X, et al
    Re: Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial: V. Venkatramani, A. Panda, R. Manojkumar and N. S. Kekre J Urol 2014; 191: 1703-1707.
    J Urol. 2015;193:371-2.
    Abstract     Related articles   

  1437. BABAYAN RK
    Re: robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years.
    J Urol. 2014;191:1732.
    Abstract     Related articles   

  1438. CHANG SS
    Re: Preventive Effects of NSAIDs, NO-NSAIDs, and NSAIDs plus Difluoromethylornithine in a Chemically Induced Urinary Bladder Cancer Model.
    J Urol. 2015;193:1727.
    Abstract     Related articles   

  1439. PENSON DF
    Re: risk of fracture after radical cystectomy and urinary diversion for bladder cancer.
    J Urol. 2015;193:1518.
    Abstract     Related articles   

  1440. CHANG SS
    Re: thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis.
    J Urol. 2015;193:1517-8.
    Abstract     Related articles   

  1441. CHANG SS
    Re: quality of diagnostic staging in patients with bladder cancer: a process-outcomes link.
    J Urol. 2015;193:1517-8.
    Abstract     Related articles   

  1442. CHENG EY
    Urinary tract management after radical cystectomy for rhabdomyosarcoma in children--what is the best option?
    J Urol. 2014;191:1650-1.
    Abstract     Related articles   

  1443. PATEL S, Steinberg G
    Editorial comment.
    J Urol. 2014;191:1763.
    Abstract     Related articles   

  1444. BALAJI KC
    Autophagy: friend or foe for progression and treatment of urothelial carcinoma.
    J Urol. 2014;191:1644-5.
    Abstract     Related articles   

  1445. BLACK P
    Bladder tumor resection: doing it right.
    J Urol. 2014;191:1646-7.
    Abstract     Related articles   

  1446. ALVA A, Friedlander T, Clark M, Huebner T, et al
    "Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer".
    J Urol. 2015 Apr 22. pii: S0022-5347(15)03852.
    Abstract     Related articles   

  1447. THUPILI CR, Chamarthi SK, Ghosh S
    Bacillus Calmette-Guerin (osis).
    J Urol. 2014;191:1876-7.
    Abstract     Related articles   

  1448. OJHA R, Singh SK, Bhattacharyya S, Dhanda RS, et al
    Inhibition of grade dependent autophagy in urothelial carcinoma increases cell death under nutritional limiting condition and potentiates the cytotoxicity of chemotherapeutic agent.
    J Urol. 2014;191:1889-98.
    Abstract     Related articles   

  1449. CASTAGNETTI M, Angelini L, Alaggio R, Scarzello G, et al
    Oncologic outcome and urinary function after radical cystectomy for rhabdomyosarcoma in children: role of the orthotopic ileal neobladder based on 15-year experience at a single center.
    J Urol. 2014;191:1850-5.
    Abstract     Related articles   

  1450. VENKATRAMANI V, Panda A, Manojkumar R, Kekre NS, et al
    Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial.
    J Urol. 2014;191:1703-7.
    Abstract     Related articles   

  1451. GOFRIT ON, Pizov G, Shapiro A, Duvdevani M, et al
    Mixed high and low grade bladder tumors--are they clinically high or low grade?
    J Urol. 2014;191:1693-6.
    Abstract     Related articles   

  1452. ROSE A, El-Leithy T, Vom Dorp F, Zakaria A, et al
    Mistletoe Plant Extract in Patients with Non Muscle-Invasive Bladder Cancer - Results from a Phase Ib/IIa Single Group Dose Escalation Study.
    J Urol. 2015 Apr 21. pii: S0022-5347(15)03849-5. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1453. ATALA A
    Re: Mutations in 3'-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb.
    J Urol. 2015;193:1061.
    Abstract     Related articles   

  1454. ROUANNE M, Lebret T, Courbebaisse M
    Re: Long-term renal function outcomes after radical cystectomy.
    J Urol. 2015;193:1066-7.
    Abstract     Related articles   

  1455. CHANG SS
    Re: Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study with Molecular Correlates of Response and Toxicit
    J Urol. 2015;193:1932.
    Abstract     Related articles   

  1456. CHANG SS
    Re: long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of radiation therapy oncology group protocols 8802, 8903, 9506, 9706, 9906, and 0233.
    J Urol. 2015;193:1931-2.
    Abstract     Related articles   

  1457. HAYASHI T, Seiler R, Oo HZ, Jager W, et al
    Targeting HER2 with T-DM1, an Antibody-cytotoxic Drug Conjugate, is effective in HER2-overexpressing bladder cancer.
    J Urol. 2015 Jun 2. pii: S0022-5347(15)04105-1. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1458. GANGKAK G, Giri V, Yadav SS
    Re: Enhanced Recovery Protocol after Radical Cystectomy for Bladder Cancer: S. Daneshmand, H. Ahmadi, A. K. Schuckman, A. P. Mitra, J. Cai, G. Miranda and H. Djaladat J Urol 2014;192:50-56.
    J Urol. 2015 Jun 1. pii: S0022-5347(15)03726-X. doi: 10.1016/j.juro.2015.02.2950
    Abstract     Related articles   

  1459. CHANG SS
    Re: Hedgehog Signaling Restrains Bladder Cancer Progression by Eliciting Stromal Production of Urothelial Differentiation Factors.
    J Urol. 2015;194:261.
    Abstract     Related articles   

  1460. ZABELL JR, Adejoro O, Konety BR, Weight CJ, et al
    Risk of End-Stage Kidney Disease after Radical Cystectomy According to Urinary Diversion Type.
    J Urol. 2014 Oct 31. pii: S0022-5347(14)04805-8. doi: 10.1016/j.juro.2014.
    Abstract     Related articles   

  1461. HEMDAN T, Malmstrom PU, Jahnson S, Segersten U, et al
    Emmprin expression predict response and survival following cisplatin-containing chemotherapy - A validation study in bladder cancer patients from two randomized studies of cystectomy with and without neoadjuvant chemotherapy.
    J Urol. 2015 Jun 25. pii: S0022-5347(15)04296-2. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1462. CHAN KG, Collins JW, Wiklund NP
    Robot-assisted radical cystectomy: extracorporeal vs intracorporeal urinary diversion.
    J Urol. 2015;193:1467-9.
    Abstract     Related articles   

  1463. FRYE TP, Sadowski DJ, Zahnd WE, Jenkins WD, et al
    Impact of county rurality and urologist density on urological cancer mortality in illinois.
    J Urol. 2015;193:1608-13.
    Abstract     Related articles   

  1464. PSUTKA SP, Boorjian SA, Moynagh MR, Schmit GD, et al
    Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting.
    J Urol. 2015;193:1507-13.
    Abstract     Related articles   

  1465. PARKER WP, Ho PL, Melquist JJ, Scott K, et al
    The effect of concomitant carcinoma in situ on neoadjuvant chemotherapy for urothelial cell carcinoma of the bladder: inferior pathological outcomes but no effect on survival.
    J Urol. 2015;193:1494-9.
    Abstract     Related articles   

  1466. SKOLARUS TA, Jacobs BL, Schroeck FR, He C, et al
    Understanding hospital readmission intensity after radical cystectomy.
    J Urol. 2015;193:1500-6.
    Abstract     Related articles   

  1467. GEIJSEN ED, de Reijke TM, Koning CC, Zum Vorde Sive Vording PJ, et al
    Combining Mitomycin C and regional 70 MHz hyperthermia in patients with non-muscle invasive bladder cancer: a pilot study.
    J Urol. 2015 Jul 1. pii: S0022-5347(15)04307-4. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1468. PIERZYNSKI JA, Hildebrandt MA, Kamat AM, Lin J, et al
    Genetic Variants within the Wnt/beta-Catenin Signaling Pathway as Indicators of Bladder Cancer Risk.
    J Urol. 2015 Jul 11. pii: S0022-5347(15)04361-X. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1469. BLUTE ML JR, Rushmer TJ, Shi F, Fuller B, et al
    Renin-Angiotensin Inhibitors Decrease Recurrence After Turbt in Non-Muscle Invasive Bladder Cancer.
    J Urol. 2015 Jul 11. pii: S0022-5347(15)04360-8. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1470. ZARGAR-SHOSHTARI K, Zargar H, Lotan Y, Shah JB, et al
    A Multi-Institutional Analysis of Outcomes in Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy.
    J Urol. 2015 Jul 20. pii: S0022-5347(15)04421-3. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1471. CHANG SS
    Re: Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer.
    J Urol. 2015;194:334-5.
    Abstract     Related articles   

  1472. SMITH ND, Prasad SM, Patel AR, Weiner AB, et al
    Bladder Cancer Mortality in the United States: A Geographic and Temporal Analysis of Socioeconomic and Environmental Factors.
    J Urol. 2015 Jul 30. pii: S0022-5347(15)04499-7. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1473. YOKOMIZO A, Kanimoto Y, Okamura T, Ozono S, et al
    Randomized Controlled Study of the Efficacy, Safety and Quality of Life of Low-Dose Bacillus Calmette-Guerin Instillation Therapy for Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2015 Aug 22. pii: S0022-5347(15)04674-1. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1474. PENSON DF
    Re: Association between Cannabis Use and the Risk of Bladder Cancer: Results from the California Men's Health Study.
    J Urol. 2015;194:667.
    Abstract     Related articles   

  1475. CHANG SS
    Re: Contemporary Cost-Effectiveness Analysis Comparing Sequential bacillus Calmette-Guerin and Electromotive Mitomycin versus bacillus Calmette-Guerin Alone for Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2015;194:666.
    Abstract     Related articles   

  1476. CHANG SS
    Re: Intermediate-Term Oncologic Outcomes of Robot-Assisted Radical Cystectomy for Urothelial Carcinoma.
    J Urol. 2015;194:44.
    Abstract     Related articles   

  1477. GUPTA A, Long JB, Chen J, Gross CP, et al
    Risk of Vascular Toxicity with Platinum-based Chemotherapy in Elderly Patients with Bladder Cancer.
    J Urol. 2015 Sep 1. pii: S0022-5347(15)04708-4. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1478. VAN KESSEL KE, Van Neste L, Lurkin I, Zwarthoff EC, et al
    Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Hematuria Patients.
    J Urol. 2015 Aug 28. pii: S0022-5347(15)04705-9. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1479. SATHE A, Koshy N, Schmid SC, Thalgott M, et al
    CDK4/6-inhibition controls proliferation of bladder cancer and transcription of RB1.
    J Urol. 2015 Aug 26. pii: S0022-5347(15)04685-6. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1480. FAN EW, Li CC, Wu WJ, Huang CN, et al
    FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
    J Urol. 2015;194:223-9.
    Abstract     Related articles   

  1481. BROOKS M, Godoy G, Sun M, Shariat SF, et al
    External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival, and Overall Survival Following Radical Cystectomy.
    J Urol. 2015 Sep 4. pii: S0022-5347(15)04716-3. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1482. ATALA A
    Re: Loss of Expression of the Tumour Suppressor Gene AIMP3 Predicts Survival following Radiotherapy in Muscle-Invasive Bladder Cancer.
    J Urol. 2015;194:1162-3.
    Abstract     Related articles   

  1483. CHANG SS
    Re: MPDL3280A (Anti-PD-L1) Treatment Leads to Clinical Activity in Metastatic Bladder Cancer.
    J Urol. 2015;194:956.
    Abstract     Related articles   

  1484. BANERJEE I, Yadav S, Priyadarshi S, Tomar V, et al
    Re: Clinical Outcomes of cT1 Micropapillary Bladder Cancer: D. L. Willis, M. I. Fernandez, R. J. Dickstein, S. Parikh, J. B. Shah, L. L. Pisters, C. C. Guo, S. Henderson, B. A. Czerniak, H. B. Grossman, C. P. Dinney and A. M. Kamat J Urol 2015;193:112
    J Urol. 2015 Sep 3. pii: S0022-5347(15)04139-7. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1485. DOWNS TM
    Reducing readmissions and mortality after radical cystectomy.
    J Urol. 2015;193:1461-2.
    Abstract     Related articles   

  1486. ODISHO AY
    Editorial comment.
    J Urol. 2015;193:1613.
    Abstract     Related articles   


  1487. Reply by author.
    J Urol. 2015;193:1613-4.
    Abstract     Related articles   

  1488. WU TF, Li CF, Chien LH, Shen KH, et al
    Galectin-1 dysregulation independently predicts disease specific survival in bladder urothelial carcinoma.
    J Urol. 2015;193:1002-8.
    Abstract     Related articles   

  1489. HAUTMANN RE
    Editorial Comment.
    J Urol. 2015;194:439.
    Abstract     Related articles   

  1490. FU LY, Adeniran AJ
    Adenocarcinoma Arising from a Bladder Diverticulum.
    J Urol. 2015;194:527-8.
    Abstract     Related articles   

  1491. GIRI V, Jha AK, Tomar V, Banerjee I, et al
    Re: Novel Bladder Preservation Therapy with Osaka Medical College Regimen: H. Azuma, T. Inamoto, K. Takahara, H. Nomi, H. Hirano, N. Ibuki, H. Uehara, K. Komura, K. Minami, T. Uchimoto, K. Saito, T. Takai, N. Tanda, K. Yamamoto, Y. Narumi and S. Kiyam
    J Urol. 2015;194:263.
    Abstract     Related articles   

  1492. WANG B, Wu S, Zeng H, Liu Z, et al
    CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
    J Urol. 2015;194:556-62.
    Abstract     Related articles   

  1493. DOWNS T
    Editorial comment.
    J Urol. 2015;193:450.
    Abstract     Related articles   

  1494. DREICER R
    Interdisciplinary management of locally advanced and metastatic genitourinary cancers: a team sport.
    J Urol. 2015;193:389-90.
    Abstract     Related articles   

  1495. LAU CS, Blackwell RH, Quek ML
    Radical cystectomy: open vs robotic approach.
    J Urol. 2015;193:400-2.
    Abstract     Related articles   

  1496. GLEASON JM, Bowlin PR, Bagli DJ, Lorenzo AJ, et al
    A comprehensive review of pediatric urachal anomalies and predictive analysis for adult urachal adenocarcinoma.
    J Urol. 2015;193:632-6.
    Abstract     Related articles   

  1497. YOUSSEF RF, von Rundstedt FC, Kapur P, Mosbah A, et al
    Utility of biomarkers in the prediction of oncologic outcome after radical cystectomy for squamous cell carcinoma.
    J Urol. 2015;193:451-6.
    Abstract     Related articles   

  1498. AZUMA H, Inamoto T, Takahara K, Nomi H, et al
    Novel Bladder Preservation Therapy, OMC-Regimen: Combined Therapy using Balloon-Occluded Arterial Infusion of Anticancer Agent and Hemodialysis with Concurrent Radiation.
    J Urol. 2014 Aug 25. pii: S0022-5347(14)04349-3. doi: 10.1016/j.juro.2014.
    Abstract     Related articles   

  1499. SUN AJ, Djaladat H, Schuckman A, Miranda G, et al
    Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events.
    J Urol. 2015;193:565-9.
    Abstract     Related articles   

  1500. HERR HW
    The Risk of Urinary Tract Infection after Flexible Cystoscopy in Bladder Tumor Patients who did not receive Prophylactic Antibiotics.
    J Urol. 2014 Jul 18. pii: S0022-5347(14)03963-9. doi: 10.1016/j.juro.2014.
    Abstract     Related articles   

  1501. LAMM DL
    Getting the Most Out of Bacillus Calmette-Guerin for Treatment of Bladder Cancer.
    J Urol. 2015 Oct 8. pii: S0022-5347(15)04960-5. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1502. SEFTEL AD
    Re: Evaluating Sexual Function in Women after Radical Cystectomy as Treatment for Bladder Cancer.
    J Urol. 2015;194:1232.
    Abstract     Related articles   

  1503. PENSON DF
    Re: Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men: Results from the Health Professionals Follow-up Study.
    J Urol. 2015;194:1231-2.
    Abstract     Related articles   

  1504. CHANG SS
    Re: Improving Selection Criteria for Early Cystectomy in High-Grade T1 Bladder Cancer: A Meta-Analysis of 15,215 Patients.
    J Urol. 2015;194:1230.
    Abstract     Related articles   

  1505. VAN OSCH FH, Jochems SH, van Schooten FJ, Bryan RT, et al
    Significant role for lifetime cigarette smoking in worsening bladder cancer and upper tract urothelial carcinoma prognosis: a meta-analysis.
    J Urol. 2015 Oct 30. pii: S0022-5347(15)05162-9. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1506. ZARGAR H, Zargar-Shoshtari K, Lotan Y, Shah JB, et al
    Final Pathologic Stage after Neoadjuvant Chemotherapy and Radical Cystectomy For Bladder Cancer: Does pT0 Predict Better Survival Than pTa/Tis/T1?
    J Urol. 2015 Oct 29. pii: S0022-5347(15)05153-8. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1507. LIN YC, Lin JF, Wen SI, Yang SC, et al
    Inhibition of High Basal Level of Autophagy Induces Apoptosis in Human Bladder Cancer Cells.
    J Urol. 2015 Oct 28. pii: S0022-5347(15)05148-4. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1508. JAMES AC, Izard JP, Holt SK, Calvert JK, et al
    Root-Causes and Modifiability of 30-day Hospital Readmissions Following Radical Cystectomy for Bladder Cancer Under 65 Years of Age.
    J Urol. 2015 Nov 7. pii: S0022-5347(15)05203-9. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1509. PARK JC, Gandhi NM, Carducci MA, Eisenberger MA, et al
    A Retrospective Analysis of the Effect of Time from Diagnosis to Cystectomy on Survival in Patients with Muscle-Invasive Bladder Cancer Receiving Neoadjuvant Chemotherapy.
    J Urol. 2015 Nov 17. pii: S0022-5347(15)05238-6. doi: 10.1016/j.juro.2015.
    Abstract     Related articles   

  1510. CHANG SS
    Re: Potential Impact of 18F-FDG PET/CT on Patients Selection for Neoadjuvant Chemotherapy before Radical Cystectomy.
    J Urol. 2015;194:955-6.
    Abstract     Related articles   

  1511. CHANG SS
    Re: Metastases in Normal-Sized Pelvic Lymph Nodes: Detection with Diffusion-Weighted MR Imaging.
    J Urol. 2015;194:954-5.
    Abstract     Related articles   

  1512. VALLOT C, Herault A, Boyle S, Bickmore WA, et al
    PRC2-independent chromatin compaction and transcriptional repression in cancer.
    Oncogene. 2015;34:741-51.
    Abstract     Related articles   

  1513. PARK SJ, Shim JW, Park HS, Eum DY, et al
    MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B.
    Oncogene. 2015 Jun 1. doi: 10.1038/onc.2015.
    Abstract     Related articles   

  1514. GUAN Y, Song H, Zhang G, Ai X, et al
    Overexpression of flotillin-1 is involved in proliferation and recurrence of bladder transitional cell carcinoma.
    Oncol Rep. 2014;32:748-54.
    Abstract     Related articles   

  1515. YAN Z, Jiang J, Li F, Yang W, et al
    Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin.
    Oncol Rep. 2015 Feb 16. doi: 10.3892/or.2015.3807.
    Abstract     Related articles   

  1516. LI Y, Liu H, Lai C, Su Z, et al
    Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
    Oncol Rep. 2015;33:2319-30.
    Abstract     Related articles   

  1517. HUANG Y, Zhang SD, McCrudden C, Chan KW, et al
    The prognostic significance of PD-L1 in bladder cancer.
    Oncol Rep. 2015;33:3075-84.
    Abstract     Related articles   

  1518. SUN E, Fan X, Wang L, Lei M, et al
    Recombinant hIFN-alpha2b-BCG inhibits tumor growth in a mouse model of bladder cancer.
    Oncol Rep. 2015 May 18. doi: 10.3892/or.2015.3985.
    Abstract     Related articles   

  1519. PARK SL, Cho TM, Won SY, Song JH, et al
    MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.
    Oncol Rep. 2015 Jul 9. doi: 10.3892/or.2015.4119.
    Abstract     Related articles   

  1520. LOMBARD AP, Lim RM, Nakagawa RM, Vidallo KD, et al
    Dicer ablation promotes a mesenchymal and invasive phenotype in bladder cancer cells.
    Oncol Rep. 2015 Jul 9. doi: 10.3892/or.2015.4117.
    Abstract     Related articles   

  1521. TAKEUCHI H, Mmeje CO, Jinesh GG, Taoka R, et al
    Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells.
    Oncol Rep. 2015 Aug 21. doi: 10.3892/or.2015.4220.
    Abstract     Related articles   

  1522. GAO D, Hu H, Wang Y, Yu W, et al
    CMTM8 inhibits the carcinogenesis and progression of bladder cancer.
    Oncol Rep. 2015 Sep 24. doi: 10.3892/or.2015.4310.
    Abstract     Related articles   

  1523. PAN XW, Li L, Huang Y, Huang H, et al
    Icaritin acts synergistically with epirubicin to suppress bladder cancer growth through inhibition of autophagy.
    Oncol Rep. 2015 Oct 16. doi: 10.3892/or.2015.4335.
    Abstract     Related articles   

  1524. YOON HY, Kim YJ, Kim JS, Kim YW, et al
    RSPH9 methylation pattern as a prognostic indicator in patients with non-muscle invasive bladder cancer.
    Oncol Rep. 2015 Nov 11. doi: 10.3892/or.2015.4409.
    Abstract     Related articles   

  1525. WANG X, Chen E, Yang X, Wang Y, et al
    5-Azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene.
    Oncol Rep. 2015 Dec 17. doi: 10.3892/or.2015.4492.
    Abstract     Related articles   

  1526. ROUPRET M, Malavaud B, Molinier L, Leleu H, et al
    [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France.]
    Prog Urol. 2015 Jan 17. pii: S1166-7087(15)00005.
    Abstract     Related articles   

  1527. CHARBIT D, Arnoux V, Gobet F, Pasquier D, et al
    [Usefulness of endoscopic evaluation with fluorescence after endovesical BCG in the management of non-invasive bladder tumors].
    Prog Urol. 2014;24:551-5.
    Abstract     Related articles   

  1528. BENADIBA S, Gauthier H, Ploussard G, Mongiat-Artus P, et al
    [Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy].
    Prog Urol. 2015 May 25. pii: S1166-7087(15)00129.
    Abstract     Related articles   

  1529. PIGNOT G
    [Role of blue-light cystoscopy in the management of non-muscle invasive bladder cancer].
    Prog Urol. 2015 Jun 15. pii: S1166-7087(15)00177.
    Abstract     Related articles   

  1530. NEUZILLET Y
    [Neoadjuvant chemotherapy for muscle-invasive bladder cancer: Complications and impact on cystectomy].
    Prog Urol. 2015 Jun 9. pii: S1166-7087(15)00133.
    Abstract     Related articles   

  1531. FIARD G, Pavillet J
    [The role of chemotherapy in bladder cancer].
    Prog Urol. 2015 Jul 21. pii: S1166-7087(15)00219.
    Abstract     Related articles   

  1532. COQUARD R
    [Neoadjuvant chemotherapy with MVAC in bladder carcinoma: Is the feasibility really established? Of: Benadiba et al.: Neoadjuvant chemotherapy in muscular invasive bladder cancer: Complications and consequences on cystectomy, Pr Urol 2015; 25: 549-554
    Prog Urol. 2015 Sep 23. pii: S1166-7087(15)00227.
    Abstract     Related articles   

  1533. LAILLER G, Neuzillet Y, Rouanne M, Lebret T, et al
    [Assessment of the optimization of the conditions of mitomycin C intravesical instillation completion in the setting of non-muscle invasive bladder cancer treatment].
    Prog Urol. 2015 Nov 30. pii: S1166-7087(15)00688.
    Abstract     Related articles   

  1534. LIANG S, Zou Q, Han B, Jing Y, et al
    Intra-Arterial Chemotherapy for Muscle-Invasive Bladder Cancer Following Transurethral Resection.
    Urol Int. 2015.
    Abstract     Related articles   

  1535. PICHLER R, Heidegger I, Klinglmair G, Kroiss A, et al
    Unrecognized paraganglioma of the urinary bladder as a cause for basilar-type migraine.
    Urol Int. 2014;92:482-7.
    Abstract     Related articles   

  1536. DECAESTECKER K, Lumen N, Ringoir A, Oosterlinck W, et al
    Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer: A Prospective Study.
    Urol Int. 2015.
    Abstract     Related articles   

  1537. WALDHOER T, Berger I, Haidinger G, Zielonke N, et al
    Sex Differences of >/=pT1 Bladder Cancer Survival in Austria: A Descriptive, Long-Term, Nation-Wide Analysis Based on 27,773 Patients.
    Urol Int. 2015.
    Abstract     Related articles   

  1538. DELLIS AE, Papatsoris AG, Skolarikos AA, Varkarakis IM, et al
    Modified S-ileal neobladder for continent urinary diversion: functional and urodynamic results after 20 years of follow-up.
    Urol Int. 2014;93:43-8.
    Abstract     Related articles   

  1539. JACKSON BL, Mohammed A, Mayer N, Dormer J, et al
    Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer?
    Urol Int. 2015.
    Abstract     Related articles   

  1540. HUPE MC, Merseburger AS, Gunter HH, Wustemann M, et al
    Successful Pregnancy and Neobladder Subsequent to Muscle Invasive Bladder Cancer and Fertility Preserving Surgery: Case Report and Review of the Literature.
    Urol Int. 2015.
    Abstract     Related articles   

  1541. LATZ S, Umbach T, Goltz D, Kristiansen G, et al
    Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.
    Urol Int. 2015.
    Abstract     Related articles   

  1542. BRISUDA A, Pazourkova E, Soukup V, Horinek A, et al
    Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer.
    Urol Int. 2015.
    Abstract     Related articles   

  1543. HORN T, Zahel T, Adt N, Schmid SC, et al
    Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy.
    Urol Int. 2015.
    Abstract     Related articles   

  1544. AZIZ A, Madersbacher S, Otto W, Mayr R, et al
    Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study.
    Urol Int. 2015;94:37-44.
    Abstract     Related articles   

  1545. COMPLOJ E, West J, Mian M, Kluth LA, et al
    Comparison of complications from radical cystectomy between old-old versus oldest-old patients.
    Urol Int. 2015;94:25-30.
    Abstract     Related articles   

  1546. HOFBAUER SL, Shariat SF, Chade DC, Sarkis AS, et al
    The Moreau Strain of Bacillus Calmette-Guerin (BCG) for High-Risk Non-Muscle Invasive Bladder Cancer: An Alternative during Worldwide BCG Shortage?
    Urol Int. 2015.
    Abstract     Related articles   

  1547. LIU B, Zhang C, Zhang Q, Liu G, et al
    Primary epithelioid hemangioendothelioma of the bladder: case report and review of the literature.
    Urol Int. 2015;94:240-3.
    Abstract     Related articles   

  1548. LEI Y, Tong S, Zu X, Li Y, et al
    Extraperitoneal and transperitoneal laparoscopic partial cystectomy for benign non-urothelial bladder tumors: an initial experience.
    Urol Int. 2015;94:149-55.
    Abstract     Related articles   

  1549. THOMAS AA, Wallner LP, Quinn VP, Slezak J, et al
    Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men's Health Study.
    Urology. 2015;85:388-93.
    Abstract     Related articles   

  1550. AL HUSSEIN AL AWAMLH B, Lee R, Chughtai B, Donat SM, et al
    A Cost-effectiveness Analysis of Management of Low-risk Non-muscle-invasive Bladder Cancer Using Office-based Fulguration.
    Urology. 2015;85:381-7.
    Abstract     Related articles   

  1551. KING AB, Zampini A, Vasavada S, Moore C, et al
    Is there an association between polypropylene midurethral slings and malignancy?
    Urology. 2014;84:789-92.
    Abstract     Related articles   

  1552. DOBRUCH J, Borowka A, Herr HW
    Clinical value of transurethral second resection of bladder tumor: systematic review.
    Urology. 2014;84:881-5.
    Abstract     Related articles   

  1553. LEVERIDGE MJ, Siemens DR, Mackillop WJ, Peng Y, et al
    Radical Cystectomy and Adjuvant Chemotherapy for Bladder Cancer in the Elderly: A Population-based Study.
    Urology. 2015 Feb 6. pii: S0090-4295(14)01403.
    Abstract     Related articles   

  1554. ANGULO JC, Caceres F, Cabrera PM, Garcia-Tello A, et al
    Two-port laparoscopic radical cystectomy with reusable umbilical system: a feasibility study.
    Urology. 2014;84:1088-93.
    Abstract     Related articles   

  1555. SIEMENS DR, Booth CM
    Reply: To PMID 25443899.
    Urology. 2014;84:1056-7.
    Abstract     Related articles   

  1556. MAYER E
    Editorial comment.
    Urology. 2014;84:1056.
    Abstract     Related articles   

  1557. CAI T, Tiscione D, Verze P, Pomara G, et al
    Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens.
    Urology. 2014;84:1141-6.
    Abstract     Related articles   

  1558. SVATEK RS, Clinton TN, Wilson CA, Kamat AM, et al
    Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy.
    Urology. 2014;84:1147-51.
    Abstract     Related articles   

  1559. CHOI SY, Kim SJ, Chi BH, Kwon JK, et al
    Modulating the Internalization of Bacille Calmette-Guerin by Cathelicidin in Bladder Cancer Cells.
    Urology. 2015 Feb 10. pii: S0090-4295(14)01404.
    Abstract     Related articles   

  1560. HAUTMANN RE, Abol-Enein H, Lee CT, Mansson W, et al
    Urinary diversion: how experts divert.
    Urology. 2015;85:233-8.
    Abstract     Related articles   

  1561. HADDAD AQ, Singla N, Gupta N, Raj GV, et al
    Association of distance to treatment facility on quality and survival outcomes after radical cystectomy for bladder cancer.
    Urology. 2015;85:876-82.
    Abstract     Related articles   

  1562. HARTMAN C, Williamson AK, Friedman AA, Palmer LS, et al
    Bladder Ganglioneuroma in a 5-Year-old Girl Presenting With a Urinary Tract Infection and Hematuria: Case Report and Review of the Literature.
    Urology. 2015;85:467-9.
    Abstract     Related articles   

  1563. THOMAS AA, Wallner LP, Quinn VP, Slezak J, et al
    Reply: To PMID 25623697.
    Urology. 2015;85:393.
    Abstract     Related articles   

  1564. KOCH MO
    Editorial comment.
    Urology. 2015;85:392-3.
    Abstract     Related articles   

  1565. AL HUSSEIN AL AWAMLH B, Lee RK, Chughtai B, Donat SM, et al
    Reply: To PMID 25623694.
    Urology. 2015;85:387.
    Abstract     Related articles   

  1566. HOLLENBECK BK
    Editorial comment.
    Urology. 2015;85:386.
    Abstract     Related articles   

  1567. SHAO P, Yin C
    Reply: To PMID 25623690.
    Urology. 2015;85:374.
    Abstract     Related articles   

  1568. GILL IS
    Editorial comment.
    Urology. 2015;85:373-4.
    Abstract     Related articles   

  1569. SHAO P, Li P, Ju X, Qin C, et al
    Laparoscopic radical cystectomy with intracorporeal orthotopic ileal neobladder: technique and clinical outcomes.
    Urology. 2015;85:368-73.
    Abstract     Related articles   

  1570. ZHOU J, Kelsey KT, Smith S, Giovannucci E, et al
    Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men: Results From the Health Professionals Follow-up Study.
    Urology. 2015 Apr 8. pii: S0090-4295(15)00199.
    Abstract     Related articles   

  1571. FARAJ SF, Munari E, Guner G, Taube J, et al
    Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma.
    Urology. 2015;85:703.
    Abstract     Related articles   

  1572. STERLING ME, Long CJ, Bosse KR, Bagatell R, et al
    A rapid progression of disease after surgical excision of a malignant rhabdoid tumor of the bladder.
    Urology. 2015;85:664-6.
    Abstract     Related articles   

  1573. PALLESCHI G, Pastore AL, Carbone A
    Reply: To PMID 25817111.
    Urology. 2015;85:889.
    Abstract     Related articles   

  1574. SCARPA RM, Cracco CM, Usai P
    Editorial comment.
    Urology. 2015;85:888-9.
    Abstract     Related articles   

  1575. PALLESCHI G, Pastore AL, Ripoli A, Silvestri L, et al
    Videourodynamic evaluation of intracorporeally reconstructed orthotopic U-shaped ileal neobladders.
    Urology. 2015;85:883-9.
    Abstract     Related articles   

  1576. PIETZAK EJ, Sterling ME, Smith ZL, Malkowicz SB, et al
    Outcomes of radical cystectomy in potential candidates for bladder preservation therapy.
    Urology. 2015;85:869-75.
    Abstract     Related articles   

  1577. HENDERSON SJ, Kearns PJ, Tong CM, Reddy M, et al
    Patients with urinary bladder paragangliomas: a compiled case series from a literature review for clinical management.
    Urology. 2015;85:e25-9.
    Abstract     Related articles   

  1578. MARIAPPAN P, Rai B, El-Mokadem I, Anderson CH, et al
    Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour (TURBT) vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
    Urology. 2015 Jul 2. pii: S0090-4295(15)00361.
    Abstract     Related articles   

  1579. NGUYEN DP, Al Hussein Al Awamlh B, Faltas BM, O'Malley P, et al
    Radical Cystectomy for Bladder Cancer in Patients With and Without a History of Pelvic Irradiation: Survival Outcomes and Diversion-related Complications.
    Urology. 2015;86:99-107.
    Abstract     Related articles   

  1580. WEGELIN O, Bartels DW, Tromp E, Kuypers KC, et al
    The effects of instrumentation on urine cytology and CK-20 analysis for the detection of bladder cancer.
    Urology. 2015 Jul 9. pii: S0090-4295(15)00633.
    Abstract     Related articles   

  1581. PIETZAK EJ, Mucksavage P, Guzzo TJ, Malkowicz SB, et al
    Heavy Cigarette Smoking and Aggressive Bladder Cancer at Initial Presentation.
    Urology. 2015 Jul 16. pii: S0090-4295(15)00651.
    Abstract     Related articles   

  1582. CARDONA-GRAU D, White MD
    Dr. Alan Yagoda and the Development of Systemic Therapy for Advanced Bladder Cancer.
    Urology. 2015 Jul 30. pii: S0090-4295(15)00644.
    Abstract     Related articles   

  1583. AGUIAR L, Danialan R, Kim C
    A Case of High-grade Transitional Cell Carcinoma of the Bladder in a Pediatric Patient With Turner Syndrome.
    Urology. 2015;85:1477-9.
    Abstract     Related articles   

  1584. COUFFIGNAL C, Desgrandchamps F, Mongiat-Artus P, Ravery V, et al
    The diagnostic and prognostic performance of urinary FGFR3 mutation analysis in bladder cancer surveillance: a prospective multicenter study.
    Urology. 2015 Sep 10. pii: S0090-4295(15)00802.
    Abstract     Related articles   

  1585. NGUYEN DP, Al Hussein Al Awamlh B, Scherr DS
    Reply: To PMID 26142590.
    Urology. 2015;86:107.
    Abstract     Related articles   

  1586. SIMONE G, Ferriero M, Gallucci M
    Editorial Comment.
    Urology. 2015;86:106-7.
    Abstract     Related articles   

  1587. SOAVE A, John LM, Dahlem R, Minner S, et al
    The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy.
    Urology. 2015;86:92-8.
    Abstract     Related articles   

  1588. SHAH SH, Movassaghi K, Skinner D, Dalag L, et al
    Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience.
    Urology. 2015;86:87-91.
    Abstract     Related articles   

  1589. TURATI F, Bosetti C, Polesel J, Zucchetto A, et al
    Coffee, Tea, Cola and Bladder Cancer Risk: Dose- and Time-Relationships.
    Urology. 2015 Sep 25. pii: S0090-4295(15)00911.
    Abstract     Related articles   

  1590. UMLAUF VN, Coerdt W, Leuschner I, Schroder A, et al
    How to Name Papillary Tumors of the Bladder in Children: Transitional Cell Carcinoma or Papillary Urothelial Neoplasm of Low Malignant Potential?
    Urology. 2015;86:379-83.
    Abstract     Related articles   

  1591. MOSCHINI M, Karnes RJ, Gandaglia G, Luzzago S, et al
    Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy during Radical Cystectomy: a Sensitivity Curve Analysis.
    Urology. 2015 Dec 9. pii: S0090-4295(15)01110.
    Abstract     Related articles   

  1592. ZHANG G, Miyake M, Lawton A, Goodison S, et al
    Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors.
    BMC Cancer. 2014;14:310.
    Abstract     Related articles   

  1593. APARICIO LA, Castosa R, Haz-Conde M, Rodriguez M, et al
    Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells.
    BMC Cancer. 2014;14:507.
    Abstract     Related articles   

  1594. ABE H, Kamai T, Hayashi K, Anzai N, et al
    The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells.
    BMC Cancer. 2014;14:412.
    Abstract     Related articles   

  1595. PASTORE AL, Palleschi G, Fuschi A, Silvestri L, et al
    Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection.
    BMC Cancer. 2015;15:1152.
    Abstract     Related articles   

  1596. MANI J, Vallo S, Rakel S, Antonietti P, et al
    Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101).
    BMC Cancer. 2015;15:224.
    Abstract     Related articles   

  1597. TODENHOFER T, Hennenlotter J, Guttenberg P, Mohrhardt S, et al
    Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer.
    BMC Cancer. 2015;15:155.
    Abstract     Related articles   

  1598. PASTORE A, Palleschi G, Fuschi A, Silvestri L, et al
    Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection.
    BMC Cancer. 2015;15:120.
    Abstract     Related articles   

  1599. TAMURA K, Kikuchi E, Konno T, Ishihara K, et al
    Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.
    BMC Cancer. 2015;15:317.
    Abstract     Related articles   

  1600. ITO Y, Kikuchi E, Tanaka N, Kosaka T, et al
    Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer.
    BMC Cancer. 2015;15:324.
    Abstract     Related articles   

  1601. ZHANG Z, Yu C, Li Y, Jiang L, et al
    Utility of SAM68 in the progression and prognosis for bladder cancer.
    BMC Cancer. 2015;15:364.
    Abstract     Related articles   

  1602. ZHOU B, Zhang P, Tang T, Liao H, et al
    Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.
    BMC Cancer. 2015;15:433.
    Abstract     Related articles   

  1603. HAYNE D, Stockler M, McCombie SP, Chalasani V, et al
    BCG+MMC trial: adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive bladder cancer: a randomised phase III trial (ANZUP 1301).
    BMC Cancer. 2015;15:432.
    Abstract     Related articles   

  1604. CASTELLANO D, Puente J, de Velasco G, Chirivella I, et al
    Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.
    BMC Cancer. 2014;14:779.
    Abstract     Related articles   

  1605. GREIFE A, Jankowiak S, Steinbring J, Nikpour P, et al
    Canonical Notch signalling is inactive in urothelial carcinoma.
    BMC Cancer. 2014;14:628.
    Abstract     Related articles   

  1606. KU JH, Kang M, Kim HS, Jeong CW, et al
    Lymph node density as a prognostic variable in node-positive bladder cancer: a meta-analysis.
    BMC Cancer. 2015;15:447.
    Abstract     Related articles   

  1607. LEE JY, Cho KS, Kang DH, Jung HD, et al
    A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging.
    BMC Cancer. 2015;15:566.
    Abstract     Related articles   

  1608. ACAR O, Ozkurt E, Demir G, Sarac H, et al
    Determining the origin of synchronous multifocal bladder cancer by exome sequencing.
    BMC Cancer. 2015;15:871.
    Abstract     Related articles   

  1609. SMOLENSKY D, Rathore K, Cekanova M
    Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro.
    BMC Cancer. 2015;15:927.
    Abstract     Related articles   

  1610. PINEDA S, Real FX, Kogevinas M, Carrato A, et al
    Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer.
    PLoS Genet. 2015;11:e1005689.
    Abstract     Related articles   

  1611. WITTMANN BM, Stirdivant SM, Mitchell MW, Wulff JE, et al
    Bladder cancer biomarker discovery using global metabolomic profiling of urine.
    PLoS One. 2014;9:e115870.
    Abstract     Related articles   

  1612. PAN J, Xue W, Sha J, Yang H, et al
    Incidental prostate cancer at the time of cystectomy: the incidence and clinicopathological features in chinese patients.
    PLoS One. 2014;9:e94490.
    Abstract     Related articles   

  1613. BHAT A, Heinzel A, Mayer B, Perco P, et al
    Protein interactome of muscle invasive bladder cancer.
    PLoS One. 2015;10:e0116404.
    Abstract     Related articles   

  1614. YANG S, Jin T, Su HX, Zhu JH, et al
    The Association between NQO1 Pro187Ser Polymorphism and Bladder Cancer Susceptibility: A Meta-Analysis of 15 Studies.
    PLoS One. 2015;10:e0116500.
    Abstract     Related articles   

  1615. LEI Y, Li B, Tong S, Qi L, et al
    miR-101 Suppresses Vascular Endothelial Growth Factor C That Inhibits Migration and Invasion and Enhances Cisplatin Chemosensitivity of Bladder Cancer Cells.
    PLoS One. 2015;10:e0117809.
    Abstract     Related articles   

  1616. WANG J, Zhang X, Wang L, Yang Y, et al
    MicroRNA-214 Suppresses Oncogenesis and Exerts Impact on Prognosis by Targeting PDRG1 in Bladder Cancer.
    PLoS One. 2015;10:e0118086.
    Abstract     Related articles   

  1617. WAN F, Cheng C, Wang Z, Xiao X, et al
    SATB1 Overexpression Regulates the Development and Progression in Bladder Cancer through EMT.
    PLoS One. 2015;10:e0117518.
    Abstract     Related articles   

  1618. TUNG MC, Hsieh MJ, Wang SS, Yang SF, et al
    Associations of VEGF-C genetic polymorphisms with urothelial cell carcinoma susceptibility differ between smokers and non-smokers in Taiwan.
    PLoS One. 2014;9:e91147.
    Abstract     Related articles   

  1619. ZHOU X, Zhang G, Tian Y
    p53 Status Correlates with the Risk of Recurrence in Non-Muscle Invasive Bladder Cancers Treated with Bacillus Calmette-Guerin: A Meta-Analysis.
    PLoS One. 2015;10:e0119476.
    Abstract     Related articles   

  1620. SUN JW, Zhao LG, Yang Y, Ma X, et al
    Obesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies.
    PLoS One. 2015;10:e0119313.
    Abstract     Related articles   

  1621. MO M, Zhou M, Wang L, Qi L, et al
    CCL21/CCR7 Enhances the Proliferation, Migration, and Invasion of Human Bladder Cancer T24 Cells.
    PLoS One. 2015;10:e0119506.
    Abstract     Related articles   

  1622. LIU S, Hou J, Zhang H, Wu Y, et al
    The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population.
    PLoS One. 2015;10:e0123617.
    Abstract     Related articles   

  1623. YE C, Zhao W, Li M, Zhuang J, et al
    delta-Tocotrienol Induces Human Bladder Cancer Cell Growth Arrest, Apoptosis and Chemosensitization through Inhibition of STAT3 Pathway.
    PLoS One. 2015;10:e0122712.
    Abstract     Related articles   

  1624. JACQUEZ GM, Shi C, Meliker JR
    Local bladder cancer clusters in southeastern michigan accounting for risk factors, covariates and residential mobility.
    PLoS One. 2015;10:e0124516.
    Abstract     Related articles   

  1625. NAIPAL KA, Raams A, Bruens ST, Brandsma I, et al
    Attenuated XPC Expression Is Not Associated with Impaired DNA Repair in Bladder Cancer.
    PLoS One. 2015;10:e0126029.
    Abstract     Related articles   

  1626. LEE MS, Kim JH, Lee JS, Yun SJ, et al
    Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray.
    PLoS One. 2015;10:e0125405.
    Abstract     Related articles   

  1627. LI X, Choi WW, Yan R, Yu H, et al
    The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder.
    PLoS One. 2014;9:e105326.
    Abstract     Related articles   

  1628. WANG YL, Jiang B, Yin FF, Shi HQ, et al
    Perioperative Blood Transfusion Promotes Worse Outcomes of Bladder Cancer after Radical Cystectomy: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0130122.
    Abstract     Related articles   

  1629. ALEXANDER RE, Williamson SR, Richey J, Lopez-Beltran A, et al
    The Expression Patterns of p53 and p16 and an Analysis of a Possible Role of HPV in Primary Adenocarcinoma of the Urinary Bladder.
    PLoS One. 2014;9:e95724.
    Abstract     Related articles   

  1630. ANDERSSON E, Dahmcke CM, Steven K, Larsen LK, et al
    Filtration Device for On-Site Collection, Storage and Shipment of Cells from Urine and Its Application to DNA-Based Detection of Bladder Cancer.
    PLoS One. 2015;10:e0131889.
    Abstract     Related articles   

  1631. BOSTROM MM, Irjala H, Mirtti T, Taimen P, et al
    Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer.
    PLoS One. 2015;10:e0133552.
    Abstract     Related articles   

  1632. YANG G, Xu Z, Lu W, Li X, et al
    Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC Method.
    PLoS One. 2015;10:e0134727.
    Abstract     Related articles   

  1633. KIM YW, Yun SJ, Jeong P, Kim SK, et al
    The c-MET Network as Novel Prognostic Marker for Predicting Bladder Cancer Patients with an Increased Risk of Developing Aggressive Disease.
    PLoS One. 2015;10:e0134552.
    Abstract     Related articles   

  1634. YANG Y, Qu A, Liu J, Wang R, et al
    Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer.
    PLoS One. 2015;10:e0135168.
    Abstract     Related articles   

  1635. PAN CX, Zhang H, Tepper CG, Lin TY, et al
    Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.
    PLoS One. 2015;10:e0134346.
    Abstract     Related articles   

  1636. BRITO RB, Malta CS, Souza DM, Matheus LH, et al
    1-Methyl-D-Tryptophan Potentiates TGF-beta-Induced Epithelial-Mesenchymal Transition in T24 Human Bladder Cancer Cells.
    PLoS One. 2015;10:e0134858.
    Abstract     Related articles   

  1637. SCHWENDER H, Selinski S, Blaszkewicz M, Marchan R, et al
    Correction: Distinct SNP Combinations Confer Susceptibility to Urinary Bladder Cancer in Smokers and Non-Smokers.
    PLoS One. 2015;10:e0137937.
    Abstract     Related articles   

  1638. KITCHEN MO, Bryan RT, Haworth KE, Emes RD, et al
    Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.
    PLoS One. 2015;10:e0137003.
    Abstract     Related articles   

  1639. FUKUHARA H, Kureishi M, Khoda T, Inoue K, et al
    The Utility of a Flexible Fluorescence-Cystoscope with a Twin Mode Monitor for the 5-Aminolevulinic Acid-Mediated Photodynamic Diagnosis of Bladder Cancer.
    PLoS One. 2015;10:e0136416.
    Abstract     Related articles   

  1640. DHAWAN D, Paoloni M, Shukradas S, Choudhury DR, et al
    Comparative Gene Expression Analyses Identify Luminal and Basal Subtypes of Canine Invasive Urothelial Carcinoma That Mimic Patterns in Human Invasive Bladder Cancer.
    PLoS One. 2015;10:e0136688.
    Abstract     Related articles   

  1641. COSTA C, Pereira S, Lima L, Peixoto A, et al
    Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.
    PLoS One. 2015;10:e0141253.
    Abstract     Related articles   

  1642. CHEN MC, Chen YL, Lee CF, Hung CH, et al
    Supplementation of Magnolol Attenuates Skeletal Muscle Atrophy in Bladder Cancer-Bearing Mice Undergoing Chemotherapy via Suppression of FoxO3 Activation and Induction of IGF-1.
    PLoS One. 2015;10:e0143594.
    Abstract     Related articles   

  1643. ZHANG X, Zhang Y, Liu X, Fang A, et al
    MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin.
    PLoS One. 2015;10:e0143441.
    Abstract     Related articles   

  1644. CHAWKI S, Ploussard G, Montlahuc C, Verine J, et al
    Bladder Cancer in HIV-infected Adults: An Emerging Issue? Case-Reports and Systematic Review.
    PLoS One. 2015;10:e0144237.
    Abstract     Related articles   

  1645. SUN L, Lu J, Niu Z, Ding K, et al
    A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer.
    PLoS One. 2015;10:e0144484.
    Abstract     Related articles   

  1646. HONG S, Kim SC, Kwon T, Jeong IG, et al
    Is bladder tumor location associated with prostate cancer detection after intravesical bacillus calmette-guerin instillation?
    PLoS One. 2014;9:e103791.
    Abstract     Related articles   

  1647. CHEAH MT, Chen JY, Sahoo D, Contreras-Trujillo H, et al
    CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer.
    Proc Natl Acad Sci U S A. 2015 Mar 30. pii: 201424795.
    Abstract     Related articles   


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;